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Abstract 
The B lineage specific mouse .15-VpreB1 locus was analysed to determine the 
patterns of epigenetic modification during lineage commitment and differentiation. 
The silenced state of the genes was investigated in precursor cells with different 
levels of plasticity to determine which epigenetic features of the domain are 
influenced by early fate decisions. Investigation of histone modifications linked with 
gene silencing and chromosome condensation such as di- and tri- methyl histone H3 
lysine 9 and the double histone H3 tri-methyl lysine 9 phosphorylated serine 10, 
showed similar levels of enrichment in embryonic stem (ES) cells, mesenchymal 
stem cells and mature B cells. However, in ES cells, a region that was previously 
found to be marked by histone H3 lysine 4 di-methylation (Szutorisz et al., 2005), 
displayed a lower level of lysine 9 di-methylation compared to the rest of the locus. 
This feature was not observed in mature B cells. These results imply that silencing 
within the B cell lineage is not accompanied by major increases in inactivating 
modifications. In contrast, very high enrichment in histone H3 lysine 9 di-
methylation was observed in non-lymphoid osteocyte cells. Analysis of DNA 
methylation across the X5-VpreB1 locus revealed significant epigenetic differences 
between the different stages of B cell development. In particular ES cells showed a 
complete absence of CpG methylation in the locus. Methylation was observed in 
repetitive regions at the pre-B cell stage, when the genes are expressed. DNA 
methylation increased in mature B cells, where it was detectable at a number of sites 
in the locus. 
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1. Introduction 
1.1 Overview 
Chromatin represents the condensed state of the DNA in the eukaryotic cell. The 
ability to package large genomes is associated with a fundamental shift in the logic 
of gene regulation between prokaryotes and eukaryotes. Whereas in prokaryotes the 
ground state is not restrictive, in eukaryotes transcriptional activity is generally 
impeded by nucleosomal packaging. In the past chromatin was regarded as a static, 
non-functional structure that evolved merely as a requirement for DNA packaging. 
Now there is experimental evidence that chromatin can provide control over gene 
expression (Felsenfeld, 1992) and a variety of proteins have been identified that 
modify or stabilise chromatin structure. Changes in chromatin structure within the 
compacted nuclear environment are thought to have an important regulatory role by 
modifying the accessibility of the transcription machinery to the DNA. Further, it is 
now recognised that heritable changes in gene expression occur without 
accompanying changes in linear DNA sequence. Research into 'epigenetic' control 
mechanisms of gene expression has intensified in recent years and there is now 
evidence that epigenetic memory acts to maintain differentiated states during cell 
division (Turner, 2002). 
All the differentiated cell types that constitute a metazoan organism share the 
same genome in its highly compacted form, but they use only part of it to 
accomplish their functions because they are structurally and functionally 
heterogeneous. The establishment of these unique cell types is owned to correct 
temporal and spatial patterns of gene expression, which also need to be stably 
inherited by daughter cells throughout a number of cell divisions. Different patterns 
of gene expression start to be established at the stage of the embryonic stem cells 
(ES). ES cells have the ability to self-renew and to differentiate into all tissues of the 
embryo, a state that is known as multipotency. Differentiation and commitment of 
multipotent precursor cells to specific lineages implies the activation and/or 
silencing of many tissue specific genes. Most of the studies on gene regulation have 
focused on mechanisms of transcriptional activation. However, cell identity can also 
be described in terms of genes that are actively silenced and gene silencing is known 
to be equally prominent in cell fate decision, developmental progression and cell 
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activation (Fisher, 2002; Fisher and Merkenschlager, 2002; Grewal and Elgin, 
2002). 
The aim of this project was to investigate the role of epigenetic modifications in 
developmental and long term silencing of the A5-VpreB1 B cell-specific domain. 
The silenced state of the A5-VpreB1 locus was investigated in precursor cells with 
different levels of plasticity and during B cell development. 
1.2 Eukaryotic chromatin organization 
The genetic information of a eukaryotic cell is stored in DNA molecules that are 
over two meters in length. This material is compacted nearly one hundred thousand 
times in order to fit into the limited volume of the nucleus (Chakravarthy et al., 
2005b). Folding of the DNA together with an equal mass of protein forms a compact 
nucleoprotein complex called chromatin (Widom, 1998). The first, and most well-
defined, level of chromatin organization is the nucleosome, which consists of 147 
base pairs (bp) of DNA wrapped in a left-handed spiral around the an octamer of 
basic proteins, the histones (Luger, 2003; Luger et al., 1997). About 80 per cent of 
genomic DNA is packaged into nucleosomes. The four core histone molecules H2A, 
H2B, H3 and H4 have been highly conserved through evolution (Wolffe, 1995). 
Histones are organised into the central (H3/H4)2 tetramer and the two peripheral 
H2A/ H2B dimers. The assembly of a stable nucleosome core depends on the initial 
heterodimerization of H3 with H4 and the subsequent dimerization to form the 
(H3/H4)2 tetramer (Eickbush and Moudrianakis, 1978). The (H3/H4)2 tetramer can 
form a stable complex with 121 bp of DNA (Hayes et al., 1991). Histones H2A and 
H2B form a stable heterodimer in a manner that is structurally homologous to 
H3/H4, but do not self-assemble into stable tetramer complexes (Arents et al., 1991). 
Binding of the H2A/H2B dimers to either side of the (H3/H4)2 tetramer extends 
binding of DNA up to 147 bp. DNA is wrapped around the histones about 1.65 
times, severely distorting its path and reaching a level of compaction of about 7-fold 
(Luger et al., 1997). There are more than 116 direct and 358 water-bridged 
interactions between the histone octamer and the DNA, which make the nucleosome 
a quite stable particle (Davey et al., 2002; Luger and Richmond, 1998) (Fig.1.2.1). 
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B 
H2A 11H2B MH3 
Fig.1.2.1 A) X-ray structure of the nucleosome core particle taken from (Luger et al., 1997). Half the 
core particle with four histone molecules and 73 bp of DNA is shown. The N-terminal tail of histone 
H3 is shown. B) The nucleosome at the lowest level of organisation in which approximately 146 base 
pairs of DNA is wound in two super helical turns around the outside of a histone octamer. The 
nucleosomes are connected to one another by short stretches of linker DNA. "Beads on a string" 
structure. 
Nucleosomes are arranged like 'beads on a string', separated by short segments 
of linker DNA, which account for the remaining 20 per cent of genomic DNA. The 
nucleosomal array is the basic functional unit of chromatin (Van Holde, KE. 1989, 
`Chromatin', Springer Verlag, New York) (Fig.1.2.1). 
The nucleosome core particle (NCP) can be assembled with histone variants 
(Suto et al., 2000) or with histones carrying functionally important mutations (Flaus 
et al., 2004; Muthurajan et al., 2004). These modified NCPs present subtle, yet 
important, modulation of the histone-histone or histone-DNA interaction but 
maintain the overall structure unchanged (Chakravarthy et al., 2005b). For example 
H2A.Z, which shares only 60% sequence identity with H2A, forms an NCP with an 
extended acidic patch on the surface (Suto et al., 2000). This change in the NCP 
surface has been shown to be important for the interaction between nucleosomes and 
non-histone proteins such us HP1-a (Fan et al., 2004). MacroH2A, another H2A 
variants, contains a large C teiiiiinal region, which has been shown to contain a 
binding site for histone deacetylases (HDAC). Evidence for such an interaction has 
been obtained consistent with the presence of macro H2A in the transcriptionally 
repressed X chromosome and pericentric heterochromatin (Chakravarthy et al., 
2005a). 
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Each histone can be divided into two functional domains: the histone fold, which 
is required for the organisation of the histone octamer and DNA binding, and the N-
and C-terminal domains (`tails'), which are the main targets for post-translational 
modifications. The N-terminal domains (NTDs) of the histones form interactions 
with linker DNA and other nucleosomes, thereby modulating the formation of 
chromatin higher order structure (Hansen, 2002; Hayes and Hansen, 2001). 
Unfortunately, because of their unstructured nature, most of the N terminal domains 
of the core histones are missing from X-ray data. These domains are important in 
promoting chromatin folding and compaction (Luger and Hansen, 2005). Dorigo 
and colleagues (Dorigo et al., 2003) showed that the histone H4 NTD is needed to 
assemble nucleosomal arrays in to an extensively condensed 30nm diameter 
secondary chromatin structure. Other studies have confirmed the importance of the 
specific H4 NTD-H2A interaction (Dorigo et al., 2004; Fan et al., 2004). 
The 30 nm fibre was originally suggested to have a solenoid structure with 
coiling of the linker DNA and formation of super helical turns (Fig.1.2.2). An 
alternative model proposed an irregular zigzag pattern with the linker DNA inside 
the fibre (Woodcock et al., 1993). In accordance with this model, Dorigo et al., have 
shown in vitro that nucleosome arrays are organised as a zigzag two-start helix 
(Dorigo et al., 2004). The two-start model comprises two crossed-linker adjacent 
stacks of helically arranged nucleosomes (Fig.1.2.2). Native chromatin can have 
more extreme compaction levels than the 30 nm fibre (Daban, 2000). However, less 
is known about how these fibres are further compacted (about 400-fold) into higher 
chromatin structures in the interphase nucleus. The 30 nm fibres could be further 
compacted or coiled, or just be arranged side to side, forming a hierarchy of folding 
levels, resulting in fibres of 300 nm (Hendzel et al., 1998). 
During the past several years it has been established, by in vitro studies, that 
many nucleosome-binding proteins possess the ability to assemble specific 
secondary and tertiary chromatin structures. Among these proteins, the linker 
histone H1 represents a special case, since it occurs in high abundance (up to 1 
molecule per nucleosome) and is usually considered to be a basic chromatin 
component. There is ample evidence that the globular domain of H1 binds close to 
the linker DNA entry—exit sites inducing a compact zigzag secondary structure and 
inhibiting nucleosome sliding and transcription in vitro (Woodcock et al., 2006). 
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Other chromatin architectural proteins are much less ubiquitous or abundant than 
HI. 
A 
	
B 
Fig. 1.2.2 Organisation of DNA within chromatin structure (adapted from Dorigo et al., 2004). 
(A) In the one-start solenoidal model nucleosomes are connected by short stretches of linker DNA 
and the 30 nm fibre is formed with linker histones (H1). The upper view shows the fibre axis running 
vertically. The lower views are down the fibre axis. The linker DNA running between nucleosome 
cores is orange. (B) The two-start twisted model of chromatin structure. 
MeCP2, originally identified as a methyl CpG binding protein, is of particular 
interest because specific mutations in this protein have been associated with most 
cases of the human neurodevelopmental condition Rett syndrome (Caballero and 
Hendrich, 2005). It has been identified as a chromatin architectural protein on the 
basis of the profound compaction it induces in nucleosomal arrays (Georgel et al., 
2003). The precise functions of MeCP2 are still uncertain, but there is evidence that, 
when bound to methylated DNA, it recruits HDACs, leading to local transcriptional 
repression (Suzuki et al., 2003). Furthermore, MeCP2 is required to stabilize large 
chromatin loops (Horike et al., 2005). 
Polycomb is a large multicomponent complex that is required to silence some 
early development genes (Ringrose and Paro, 2004). It has also shown to be able to 
compact nucleosomal arrays by binding to nucleosomes. A single polycomb 
complex has been shown to be able to bind three to four nucleosomes in a sequence-
independent way (Francis et al., 2004). Studies of the interactions of 
heterochromatin protein 1 a (HP1a) with nucleosomal arrays identified a 
fundamentally different type of chromatin architectural protein (Fan et al., 2004). 
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These studies showed that HP 1 a prefers to bind to folded nucleosomal arrays and 
that it induces local rearrangement of secondary chromatin structures. 
1.3 Euchromatin and heterochromatin 
The first to observe different types of chromatin in the nucleus was Emil Heitz in 
1928. Cytogenetic studies on plant cell nuclei stained with carmine acetic acid 
(Heitz, 1928) revealed a type of chromatin that remained condensed throughout the 
cell cycle. This darkly staining chromatin was called heterochromatin. The other 
type, which was undergoing normal cycles of condensation and de-condensation, 
was named euchromatin or 'true' chromatin. 
General characteristics of chromatin 
Euchromatin 
(active genes) 
Constitutive 
hetcrochromatin 
(mgr.:live DNA) 
Facultative 
hetcrochromatin 
(silenced genes) 
CpG 
Histone 
modifications 
Tipical protein 
factors 
Replication 
timing 
General 
chromatin 
features 
Transcription 
Hypomethylation 
H3/1-14 hyperacctylation 
1-13 K4 dimethylation 
1-13 Arg 2, Arg 7, Arg 26 
methylation. 
113 posphorylation 
H3 K79 methyiation 
Activator proteins 
Chromatin remodelling 
complexes 
Predominantly early 
'Open" chromatin 
Active gene transcription 
Non-genie transcription 
Meth:elation 
H3114 hyp:meetylation 
113 1C9 trimr,hyiscion 
I-14 K20 trErnethylation 
HP( I) proteEns 
Su(Var)3 -9 
Late 
Compacted chromatin 
Clustered centomeres 
Small RNA transcripts 
tviethylation 
H3,,H4 hypotteetylation 
H3 K27 timethylation 
113 K9 climethylation 
H4 K20 monometkylation 
Pc G complex 
H(P)1 ? 
Activator proteins 
Chromatin-remodelling 
complexes 
Variable 
Compacted chromatin 
No gene transcription 
Non-genie trascription unk 
Table 1.3.1 General characteristics of euchromatin, constitutive heterochromatin and facultative 
heterochromatin (adapted from Arney and Fisher, 2004). 
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1.3.1 Euchromatin 
Euchromatic regions of the genome are cytologically observed as more 
decondensed, and located near the centre of the interphase nucleus. Euchromatin 
normally contains a high density of functional genes and often replicates earlier in 
S-phase than heterochromatic DNA (Dimitri et al., 2005). Histones in euchromatin 
may be hyperacetylated (Table 1.3.1) and CpG dinucleotides in the associated DNA 
are often unmethylated, particularly in expressing genes (Eden et al., 1998). 
Methylation-free islands containing clustered CpG sequences occur near the 
transcription start site of many ubiquitously expressed genes and approximately 
40% of mammalian genes showing a tissue-specific expression pattern (Cross and 
Bird, 1995). A number of studies on accessibility of DNA within the nucleus to 
nucleases such as DNase I have shown that transcriptionally active or potentially 
active genes have nuclease hypersensitive sites (HS) located upstream and/or 
downstream of the gene. The increased sensitivity to DNase I observed at 
hypersensitive sites is likely to be due to displacement or modification of a 
nucleosome caused by transcription factor binding (Kornberg and Lorch, 1999). 
1.3.2 Heterochromatin 
Heterochromatin, or darkly stained chromatin as described by Heitz (1928), 
remains as a visible highly condensed region of the genome throughout the cell 
cycle. Constitutive heterochromatin is associated with repetitive DNA sequences 
and contains a low density of genes that replicate late in S phase. Heterochromatic 
DNA also tends to be highly methylated. It is predominantly located at 
pericentromeric chromosomal domains, which contribute to centromeres in 
mammals (Grewal and Moazed, 2003). Pericentromeric heterochromatin is 
associated with the presence of a regular arrangement of nucleosomes (Wallrath and 
Elgin, 1995). The heterochromatin surrounding centromeres (pericentromeric 
heterochromatin) is usually composed of repeat sequences that vary widely in size 
between species from the 5-7 bp satellite repeats in Drosophila to the 234 bp 
pericentromeric heterochromatin in mouse. The effect of such areas is to create a 
relatively uniform sequence composition over a large region and to reiterate 
sequences with specific properties i.e. factor binding sites and nucleosome 
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positioning elements. These features contribute to stable formation of condensed 
chromatin structures. Furthermore, the association of heterochromatin proteins such 
as heterochromatin protein 1 (HP1) with repetitive centromeric sequence motifs has 
shown to be important for efficient cohesion between sister-chromatids and 
chromosome segregation in fission yeast (Grewal and Moazed, 2003 and reference 
herein). Other experiments with fission yeast have indicated that small RNAs 
associated with the RNA interference (RNAi) pathway are transcribed from 
centromeric repeats (Volpe et al., 2002). 
Since its identification, heterochromatin has been a useful model for studying 
chromatin condensation and heritable gene silencing. More recently, studies that 
focus on the mechanisms that underlie its structure have been carried out to help to 
determine the link between visible heterochromatin structures and gene silencing. 
The observation that heterochromatin is epigenetically marked by specific histone 
modifications has enhanced our understanding of how it is formed. Epigenetic marks 
that have been associated with heterochromatin include generalised hypoacetylation 
of histones (Jeppesen and Turner, 1993) and trimethylation of lysine 9 of histone H3 
(H3K9me3) (see Table 1.3.1) (Dillon, 2004). The observation by Jenuwein and 
colleagues that the Su(Var)39H gene encodes a histone methyltransferase protein 
specific for H3K9 provided the first evidence that methylation of this residue is 
directly involved in heterochromatin formation (Rea et al., 2000). Highly specific 
methylation of H3K9 by Su(Var)39H histone methyltransferase creates a high-
affinity HP1 binding site. In turn, HP1 interactions are thought to promote the 
formation of condensed chromatin structures (Nielsen et al., 2001). 
Facultative heterochromatin is defined as a region of chromatin that becomes 
subject to large-scale condensation during development. The best-known example of 
facultative heterochromatin is formed during X chromosome inactivation in female 
mammals. During X inactivation, transition from a permissive chromatin state to 
transcriptionally inert heterochromatin is visible as the condensed Barr body located 
close to the nuclear periphery in female somatic cells (Barr, 1949). Facultative 
heterochromatin contains modifications that are associated with transcriptional 
repression: di-methylation of histone H3K9, hypoacetylation of lysine residues 
within histones H3 and H4, and DNA methylation (Table 1.3.1). Methylation of 
H3K27 is thought to be a feature of facultative heterochromatin and has been 
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associated with transcriptional silencing by Polycomb group proteins as well as 
being found on the inactive X chromosome. 
1.4 Overview of transcription 
In eukaryotes, transcription is a tightly regulated process by which three nuclear 
RNA polymerases (RNA pol I, pol II and pol III) and several small nuclear RNAs 
synthesise all of he RNAs encoded by the genome (Roeder and Rutter, 1969, 
reviewed by Sims et al., 2004). RNA pol I and III transcribe the genes for ribosomal 
RNA (rRNA) and transfer RNA (tRNA) respectively. RNA pol II is responsible for 
transcribing all the protein-encoding genes. RNA pol H consists of 12 subunits, 
which are remarkably conserved throughout eukaryotes (Young, 1991). The 
generation of a mature mRNA molecule involves multiple processes, some of which 
occur sequentially and others in parallel. The primary phases of this process form a 
cycle (transcription cycle) that includes pre-initiation complex (PIC) assembly, PIC 
activation, initiation, promoter clearance, elongation and termination (Kornberg, 
1999). 
Unlike the prokaryotic enzyme, eukaryotic RNA pol H is not able to recognise 
the promoters of its target genes. A series of general transcription factors (GTFs) are 
necessary for pol II to bind to the transcription start site (Orphanides et al., 1996). 
GTFs recognise conserved core promoter elements. Two important core promoter 
elements are the TATA box, located near position -30 to -25 and the initiator 
sequence (Inr) located at the start site of transcription. The TATA box is recognised 
by the TATA box binding protein (TBP), which is part of the TFIID complex, which 
also recognise Inn TFIID contains many TBP-associated factors (TAFs), which are 
implicated in sequence specific binding (reviewed by (Butler and Kadonaga, 2002)). 
Transcription initiation is thought to begin with the assembly of the RNA 
polymerase and five general initiation factors (TFBE, TFIID, TFIIE, TFIIF and 
TFIIH) into a pre-initiation complex (PIC) at the promoter (Orphanides and 
Reinberg, 2002; Reese, 2003). In the first step, TBP binds sequence-specifically to 
the promoter to establish a nucleoprotein recognition site for pol II on the DNA 
(Burley and Roeder, 1996). In the second step, TFIIB binds to the polymerase and to 
the TBP subunit of THU) to form the Dbpol II complex. TFIIF has the double role 
of stabilizing the Dbpol II intermediate and recruiting TF1lE and TFIIH into the 
complex (Dvir et al., 2001). Formation of this promoter-bound complex is sufficient 
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for a basal level of transcription. However, regulation of this process in response to 
environmental signals involves a number of additional co-activators. These are 
recruited to enhancers or upstream activating sequences (UAS) by gene-specific 
activators and operate by several distinct mechanisms involving alteration of the 
structure of chromatin and direct interaction with RNA pol II and GTFs. Three 
classes of general cofactors, including TBP-associated factors (TAFs), Mediator, 
and upstream activating sequence (USA)-derived positive and negative cofactors 
(PC1/PARP-1, PC2, PC3/DNA topoisomerase I, PC4, NC1/HMGB1) normally fine-
tune the promoter activity in a gene-specific or cell-type-specific manner (reviewed 
by (Martinez, 2002)). 
Once the PIC is fully assembled, an ATP-dependent process, which requires the 
action of the helicase TF1111, cause the opening of the double stranded DNA at the 
transcription start site (promoter melting) and the formation of the open complex. 
Transcriptional initiation then occurs upon addition of the two initiating nucleoside 
triphosphates (NTPs) depending on the DNA sequence and formation of the first 
phosphodiester bond (Goodrich and Tjian, 1994; Holstege et al., 1996; Kim et al., 
2000). 
Before RNA pol II engages in productive transcript elongation it must go through 
a stage known as promoter clearance. During this stage the PIC is partially 
disassembled. A subset of GTFs remain at the promoter where they constitute a 
scaffold for the formation of the next transcription initiation complex (Yudkovsky et 
al., 2000; Zawel et al., 1995). This stage is accompanied by massive 
phosphorylation at the C-terminal repeat domain of the largest subunit of RNA pol 
II (CTD). The CTD contains multiple repeats of the hepta-peptide sequence 
YSPTSPS. The number of these repeats increases with genomic complexity: 26 in 
yeast, 45 in Drosophila, and 52 in mammals (Sims et al., 2004). It has been 
demonstrated that RNA pol II in the PIC is un-phosphorylated (Laybourn and 
Dahmus, 1989; Lu et al., 1991), whereas the transcription-competent form is heavily 
phosphorylated on its CTD (Christmann and Dahmus, 1981). Serine 2 and 5 are the 
major sites of posphorylation in the YSPTSPS repeat, but it is not well understood 
which of these phosphorylation event is most important for the disruption of the 
connections with the promoter. It is also possible that while leading to disruption of 
one set of interactions, CTD-phosphorylation might be relevant for establishing 
another set (Svejstrup, 2004). 
22 
To ensure efficient elongation, the phosphorylation state of the CTD acquired at 
the initiation-elongation transition needs to be maintained (Lee and Greenleaf, 1997; 
Marshall and Price, 1995). ChIP data suggest that phosphorylation at Ser 5 is 
associated with promoter-proximal regions of transcribed genes and is apparently 
not detected in the 3-end region. At the same time, the amount of the enzyme 
phosphorylated at Ser 2 increases toward the 3-end of genes (Cho et al., 2001). 
These results, which are controversial, suggest that CTD phosphorylation at Ser 5 
correlates with transcription initiation and early elongation (promoter clearance), 
whereas Ser 2 phosphorylation is associated with RNA pol II farther away from the 
promoter (Cho et al., 2001). These data have been partly questioned by the finding 
that the Ser 2-specific antibody recognizes both the Ser 5 and Ser 2 phosphorylated 
forms (Jones et al., 2004) and the disappearance of Ser 5 phosphorylation at the 3' 
end will need to be confirmed. 
A variety of evidence suggests that purified RNA polymerase II lacks the ability 
to catalyze mRNA chain elongation in vitro at rates sufficient to account for the 
rates of mRNA synthesis observed in vivo (reviewed by Reines et al., 1999; 
Shilatifard et al., 2003). Several factors have been isolated that can alter the kinetics 
of transcription in vitro. This class of RNA polymerase II elongation factors 
includes TFIIF, the Elongins, DSIF, CSB and the ELL family of proteins. All these 
factors have similar kinetic properties, they interact directly with elongating 
polymerase and boost its elongation rate in vitro but they do not have overlapping or 
redundant functions in cells. Mechanistic studies have demonstrated that these 
factors function by suppressing transient pausing by the polymerase at all or most 
steps of nucleotide addition (reviewed by Sims et al., 2004). 
Other factors that do not have consequences on transcription kinetics have also 
been reported to be associated with the elongating RNA pol II. Among these is the 
Pafl complex, which function at both the initiation and elongation stages of 
transcription (Mueller and Jaehning, 2002; Pokholok et al., 2002). It has been 
demonstrated that the Paf 1 complex is physically associated with elongating RNA 
polymerase H and can function as a platform for the recruitment of the histone 
modifying machinery to the transcribing polymerase (Krogan et al., 2003a; Krogan 
et al., 2003b). The Elongator complex, which is associated with elongating, hyper 
phosphorylated, RNA pol II in yeast (Otero et al., 1999), has a HAT activity 
predominantly addressed to lysine 14 of histone 113 and lysine 8 of histone H4 
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(Winkler et al., 2002). In yeast it has been shown that transcription is reduced in 
genes that have low acetylation levels in the middle of the coding region, consistent 
with the idea that hypoacetylation can inhibit transcriptional elongation (Kristjuhan 
et al., 2002). The observation that mutation of the gene encoding the histone 
deacetylase Hos2 results in slow gene activation in yeast (Wang et al., 2002) 
coupled with the idea that hypoacetylation inhibits transcription suggest that not 
only hyperacelation of histones enables the passage of RNA pol II but also that 
immediate deacetylation after this passage could stabilize chromatin structure to 
ensure continued ability to be transcribed (Svejstrup, 2003; Svejstrup, 2004). 
The last step before starting the next round of transcription, termination, is 
critical for successful gene expression. It allows the release of transcripts from the 
site of transcription and also releases pol II from the template, facilitating its 
recycling back to the promoter for further rounds of transcription. Transcript 
termination is dependent on the presence of a functional poly(A) signal (reviewed by 
Proudfoot, 1989). Cleavage and polyadenylation of the nascent transcript are distinct 
from termination, which in principle releases the RNA. It has been shown that RNA 
pol II can transcribe up to 2 kb after RNA cleavage, although cleavage is necessary 
for termination. The only termination factor associated with early transcript 
elongation complexes (TECs) known until now is the RNA pol I and H specific 
termination factor (TTF2). TTF2 can terminate transcription at most positions along 
a DNA template and was shown to act independently of the state of CTD 
phosphorylation (Jiang et al., 2004). 
There is evidence that chromatin structure in the terminator region might play an 
important role and that ATP-dependent chromatin remodelling factors, such us yeast 
Chdl, Isw 1 or Isw2 play a role in the termination process (Alen et al., 2002; 
Morillon et al., 2003). DNA dependent ATPases capable of disrupting ternary 
complexes (RNA polII/DNA/RNA) and terminating transcription have been 
identified in both prokaryotes (Richardson, 2002; Selby and Sancar, 1993) and 
eukaryotes (Xie and Price, 1997). Transcription is a tightly regulated process, which 
involves many steps and the concerted action of many different factors. The 
presence of cis-regulatory elements other than promoter element is without any 
doubt imposing a further level of control over the transcription process. 
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1.5 Cis-acting regulatory sequences: promoters and 
enhancers 
DNA is packaged as chromatin within the nuclei of eukaryotes, a structure that 
must be disrupted when the genes are transcribed by RNA pol II. Many sequences 
located upstream of the transcriptional start site of the gene (promoter) and around 
or within the gene itself are important in the control of gene expression (Table1.5.1). 
DNase I hypersensitive sites are stretches of DNA, usually 200 bp, that are rich in 
binding sites for transcription factors. When a sufficient level of associated binding 
proteins are present, these sites are often exposed as sequences hypersensitive to 
digestion with DNAse I. Hypersensitive sites (HS) have a prominent role during cell 
differentiation since the formation of specific hypersensitive sites in progenitor cells 
often precedes transcriptional activation at later stages (Blom van Assendelft et al., 
1989; Hatzis and Talianidis, 2002; Szutorisz et al., 2005). 
Gene promoters were the first of a number of functional DNA sequences to be 
described that are required for gene expression and that are targets for regulatory 
proteins. Promoters are defined as spatially constrained regions that specify the site 
of transcriptional initiation. Protein-coding genes have them typically located 
immediately upstream of the site of transcriptional initiation. 
Enhancers are DNA sequences that can activate a promoter and control its 
efficiency and rate of transcription independently of orientation and with some 
flexibility with respect to distance. Promoters and enhancers contain groups of 
transcription factor binding sites, which are often repeated. The spacing and 
combination of sites is believed to be significant for enhancer function (Zenke et al., 
1986). 
25 
Fimctional definitions used to classify cis -acting sequences that affect transcription 
Promoter 
Enhancer 
Spacially constrained region that specifies site of transtxiptional initiation in in vitro and 
in vivo assays. Promoters bind the basal transcriptional machinery and are generally 
located upstream of the site of transcriptional initiation for protein encoding genes 
DNA element, linked in cis to the purnoter (upstream cr downstream), which acts to 
increase transcription in an orientation independent imnner and with some flexibility 
with itvect to distance. Originally defined in transient expression assays in cultured 
cells. However, the level of haiku 	iptional enhancement or the assay used to measure it 
is not specified 
Locus Control Region (LCR) Dominant activating sequences that allow a gene to be expressed independently of its 
site of integration into the genome. LCRs confer position-independent and copy-
dependent expression on a linked gene in transgetic nice and are capable of activating 
oqxession at single copy 
DNase I hypersensitive site 	Consist of a region of 150-300 bp with an increased sensitivity to DNase I digestion 
(11S) 	 compared to sunouncing 6101111in. HS have a high density of binding sites for trans -
acting factors, and are detected by digesting isolated nuclei with increasing antunts of 
DNase I 
Table 1.5.1 Glossary of terms 
In eukaryotes, activator proteins bind at distinct sites upstream or downstream of 
the promoter and interact in a synergistic manner with co-activators and core 
promoter elements (CPE) (Ptashne and Gann, 1997). The core promoter is defined 
as the minimal DNA region that is sufficient to direct low levels of activator-
independent (basal) transcription by RNAP II in vitro. The core promoter typically 
extends 40 bp upstream and downstream of the start site of transcription and can 
contain several distinct sequence elements. In higher eukaryotes, CPEs are highly 
diverse in structure, and each of them is only found in a subset of genes. So far, only 
the TATA box and INR (initiator) element have been shown to be capable of 
directing accurate RNA pol II transcription initiation independent of other core 
promoter elements. Transcription is controlled by a combination of CPEs and gene-
specific enhancer elements that co-operatively define expression patterns (Dynan, 
1989). Enhancers are often found proximal to the core promoter and may include 
canonical sequence elements such as the GC box and CCAAT box (Nussinov, 
1990). 
A further level of complexity is added by distal enhancer elements such as 
hormone response element (HREs) (Archer et al., 2005; Kardassis et al., 1997). 
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Enhancers act in conjunction with linked promoters to increase transcription. They 
function as autonomous regulatory units with respect to orientation and distance 
from sites of initiation and often contain clusters of activator binding sites. The 
`classical' enhancer effect was first characterised in studies of the SV40 enhancer 
(Treisman et al., 1983). Weintraub and colleagues (1988) showed that the SV40 
enhancer increases the probability of a transfected template to become active but its 
presence or absence does not change the activity (the amount of transcript produced 
by the gene in a given period of time) of an active template (Weintraub, 1988). 
Enhancers in transgenic mouse studies have been shown to increase the proportion 
of cells expressing the transgene (Sutherland et al., 1997). 
1.6 Locus Control Regions (LCRs) 
Early transgenic experiments indicated that inclusion of enhancer and promoter 
sequences within a construct was not sufficient to ensure correct levels of tissue 
specific expression. Also, mouse lines with multicopy transgene exhibited 
expression levels that had no relationship with the number of integrated transgene 
copies. These findings suggested that both chromosomal location and lack of 
transcriptional activation from cis-acting elements can exercitate a negative effect on 
tissue specific expression. 
Repression resulting from translocation of genes to abnormal locations had been 
observed in very early studies (Dobzhansky, 1936; Lewis et al., 1992; Muller, 
1930). The phenomenon was first observed in 1930 when Herman Muller described 
mutation in the drosophila white mottled-4 gene that gave phenotypes with 
mottled/variegated, red or white eyes (Muller, 1930). This phenotype was traced to 
the fact that when the white-eye colour gene was juxtaposed next to pericentromeric 
heterochromatin it was often subject to unstable repression. Therefore, the 
variegation observed was the result of placement next to the heterochromatin and 
not due to mutations in the gene itself. This phenomenon was termed Position 
Effect Variegation (PEV). 
Locus control regions (LCRs) are regulatory elements able to overcome such 
position effects. LCRs can direct tissue-specific expression of a transgene at high 
levels irrespective of the site of integration in the host genome (Grosveld et al., 
1987). This implies that this element is capable of inducing the changes in 
chromatin structure that are required for expression of the genes. In their native 
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chromosomal locations, LCRs are required for the initial chromatin activation of a 
locus and subsequent gene transcription. 
1.6.1 The pi-globin locus control region 
The first LCR was identified in the human 13-globin locus (Grosveld et al., 1987), 
since then LCRs have been identified for many genes (Table 1.6.1). The human 
fi-globin cluster consists of five erythroid specific genes arranged along the 
chromosome in the order in which they are expressed during development 
(Fig 1.6.1). Upstream of the genes there are five DNAse I hypersensitive sites (HSs) 
within a 20kb region. Each HS contains numerous binding sites for ubiquitous and 
erythroid restricted trans-acting factors. Early studies showed that a 5kb /3-globin 
gene segment, including a 1.5kb promoter region give uniform gene expression in 
transgenic mice (Kollias et al., 1986; Magram et al., 1985; Townes et al., 1985). The 
gene was expressed only in a small proportion of transgenics, with expression levels 
far below the normal and subject to position effects. These studies implied that a 
regulatory element present in the native locus was missing in these constructs. 
Locus or gene Tissue specificity Reference Organism 
b-globin gene erythroid cells Grosveld 1987 Human 
CD2 gene T cell specific Greaves 1989 Human 
CD4 gene T cell specific Boyes 1997 Human 
TCR a/d T cell specific Diaz 1994 Human 
MHC class II Ea gene B cell specific Carson 1993 Mouse 
S100b gene neuron Friend 1992 Human 
Lysozyme gene macrophage Bonifer 1990 Chicken 
LAP liver Talbot 1994 Rat 
15-VpreBl locus B cell specific Sabbattini 1999 Mouse 
Table 1.6.1 Examples of gene loci with LCR activity modified from Li et al 1999 
It was observed that in some forms of 13-thalassemia the genes of the fi-globin 
locus are intact but not expressed (Driscoll et al., 1989; Kioussis et al., 1983). A 
common defect underlying these conditions is the presence of large deletions 
upstream of the 13-like globin genes (Duch and Hispanic deletions) (Fig. 1.6.1). The 
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Gy Ay 	 5 13 
3' HS1 
a 
5kb 
hispanic deletion results in a closed chromatin conformation spanning the whole 
locus that leads to suppression of gene expression (Forrester et al., 1990). The 
existence of a regulatory element was also suggested by the presence of 
developmentally stable, erythroid-specific, DNAse I HS s located 5' of the e-globin 
gene (Forrester et al., 1986; Tuan et al., 1985). Definitive evidence for the presence 
of the LCR came from transgenic mouse experiments. Linkage of this region to a 
/3-globin gene resulted in expression of the gene at level comparable to the 
endogenous mouse /3-globin gene in a position-independent, copy number-
dependent manner (Grosveld et al., 1987). 
LCR 
1 
5 4 3 2 	1 
Figure 1.6.1 The Locus Control Region of the human I3-globin gene cluster. HS are indicated by 
vertical arrows (Grosveld et al., 1987). The Hispanic (3 thalassemia deletion is shown as a red 
rectangle. The genes are arranged along the locus in the order in which they are expressed. The t is 
expressed during embryogenesis, Gy and Ay during foetal development and 5 and in the adult. 
1.6.2 Properties of LCRs: transcriptional enhancer activity 
The most prominent property of the LCRs is their strong, transcription-enhancing 
activity. When the human /3-globin LCR is deleted transcription of the human 13-
globin gene is usually less then 1% of the endogenous murine /3-globin mRNA in 
transgenic mice (Kollias et al., 1986; Magram et al., 1985; Townes et al., 1985). 
Inclusion of the LCR increases the fl-globin gene expression to a level comparable 
with that of the endogenous gene in transgenic mice indicating a strong enhancer 
activity of the LCR (Grosveld et al., 1987). 
The /3-globin LCR enhancer activity is also significant at its endogenous location 
as demonstrated by deletion experiments (Bender et al., 1998; Epner et al., 1998; 
Reik et al., 1998). The enhancer activity of the LCR resides in HS2, 3 and 4 but not 
in HS 1 and 5. HS 2 enhancer activity can be detected by transient transfection 
assays, while enhancer activity from HS 3 and 4 could only be detected when they 
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are integrated into chromatin. Importantly, the enhancer activity of the /3-globin 
LCR is tissue specific. Expression of the I3-globin genes is confined to erythroid 
cells when linked to the Aglobin LCR. In addition, the LCR is able to enhance the 
expression of linked non-globin genes promoters in erythrocytes. However, ectopic 
expression was observed for these genes in some transgenic mice. The natural 
promoter in this case allowed expression outside the erythroid compartment. Tissue 
specific control of basal transcription may reside in the promoter while tissue 
specific enhancement of gene expression may be a property of the LCR. Very 
important for the understanding of enhancer activity of the /3-globin LCR was the 
identification of the transcription factors mediating enhancer activity. Deletion 
analysis of factor binding motifs within the HS was carried out to determine their 
role (Philipsen et al., 1990; Pruzina et al., 1991; Talbot and Grosveld, 1991). This 
analysis defined the essential sequences of 5' HS sites 2, 3 and 4 in the human 
Aglobin LCR. The HS fragments were shown to contain binding sites for erythroid-
specific proteins GATA1 and NF-E2 and a number of general transcription factors 
that included SP1 and AP1. A notable feature was the recurring presence of a G-rich 
sequence flanked by GATA1 binding sites, particularly at HS3. At the core of HS3 
are closely spaced triple repeats of GATA1 binding sites and G-rich sequences 
(Philipsen et al., 1990). When introduced into cultured cells or transgenic mice, HS3 
was shown to be sufficient for copy number dependent expression of a (3-globin 
gene (Fraser et al., 1990). Deletions of HS3 factor-binding sites revealed that a 
specific arrangement of binding sites and the cooperation of at least three proteins 
was required to achieve position independent expression (Philipsen et al., 1990). 
1.7 Domains and genetic functional units 
1.7.1 Strong and weak domain models 
The characterisation of specific cis-acting regulatory sequences and the factors 
that bind to them is not enough to unravel the mechanisms of gene regulation. 
Correctly regulated expression of a eukaryotic gene in vivo is not simply a function 
of a single sequence element but more often of multiple sequences acting 
co-operatively and spread over large distances. These sequence elements define the 
complete functional domain that can correctly regulate a gene locus. In higher 
organisms, genomes comprise multiple unique gene loci with quite different patterns 
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of expression located in close proximity to one another on the chromosome. 
Autonomy of the adjacent loci must be maintained with respect to gene expression 
patterns. Understanding how adjacent loci are independently regulated has formed 
the basis for a number of models aimed at defining the functional gene expression 
domain (Dillon and Sabbattini, 2000). 
The classical picture of domain arose from early light and electron microscopy 
studies of the interior of the nucleus where genomic DNA appeared to form loops 
anchored to a nuclear matrix (Manuelidis, 1990). The anchoring DNA sequences 
were postulated to participate in demarcating selected chromosome domains isolated 
by these 'boundaries'. The concept of a structural domain physically separated from 
neighbouring domains by boundaries was considered to mirror a functional 
compartmentalisation of gene loci. Recent functional assays have shown that these 
matrix attachment regions (MARs) do not generally constitute boundaries between 
active or inactive chromatin (Wang et al., 1996). The next generation of domain 
models proposed that transcriptionally active genes are located within region of 
"open" extended chromatin. Neighbouring inactive domains would instead have a 
closed compacted chromatin structure and the borders between the active and 
inactive domains would be defined by discrete boundary or insulator elements which 
would have the specific function of blocking against incursions from surrounding 
chromatin domains. This type of model has been termed the 'strong' domain model 
(Dillon and Sabbattini, 2000). 
The strong domain model has been based mainly on studies of two loci, the 
drosophila 87A7 heat-shock locus and the chicken fi-globin locus. The 87A7 heat-
shock locus is the site of a heat-inducible chromatin puff on polytene chromosomes 
(Udvardy et al., 1985), which suggests the formation of a decondensed chromatin 
region upon activation of the genes. In 1991, Kellum and Schedl were the first to 
test by functional assay whether two DNAseI HS located at each side of the puff 
(scs and scs') could establish a domain of independent gene activity in vivo and 
insulate against chromosomal position effects (Fig.1.7.1). The scs and scs' sequences 
have been shown act as insulators against position effects on a white gene. The 
insulator activity was dependend on the the gene been positioned in between the two 
elements (Kellum and Schedl, 1991). Recently, experiments from the Geyer 
laboratory have cast doubt on the ability of the scs and scs' elements to form 
boundaries to chromatin domains (Kuhn et al., 2004). In the chicken fi-globin locus 
31 
a DNAseI HS, HS4, which is located close to the edge of a DNase I sensitive and 
hyperacetylated region, also has the properties of an insulator (Chung et al., 1993). 
Upstream of this element is located the independently regulated folate receptor gene. 
The region between the /3-globin and folate receptor loci is rich in repetitive 
sequences and in erythroid cells is largely DNase I insensitive, hypoacetylated and 
hypermethylated (Hebbes et al., 1994; Prioleau et al., 1999). Insulators are 
operationally defined as sequences that can interfere with enhancer-promoter 
interactions when placed between them, and that can buffer transgenes from position 
effects (Bell et al., 2001). 
Insulators have now been identified associated with a number of unrelated gene 
loci and in a variety of organisms from yeast to man (Bell et al., 2001). They have 
also been frequently associated with sequences that have other functions (Dillon and 
Sabbattini, 2000). The scs' element in the Drosophila heat shock locus for example 
has shown to be also the promoter of the Aurora gene (Glover et al., 1995), which is 
involved in spindle formation. Among the best-characterised examples of a 
sequence that has insulator effects associated with other functions is the Drosophila 
eve promoter. Analysis of the insulator effect showed that it is partly dependent on 
the presence of a GAGA sequence located between the TATA box and the initiation 
site (Ohtsuki and Levine, 1998). Removal of the GAGA sequence did not abolish 
the insulator effect of the eve promoter. This result suggested that the insulator 
effect is dependent on synergism between several different promoter components 
rather than being solely generated by the GAGA element (Dillon and Sabbattini, 
2000). The vertebrate insulator element cHS4 at the 5' end of the chicken globin 
locus prevents the spread of methylated condensed heterochromatin from the 
adjacent folate receptor gene and it also acts as an enhancer-blocker separating the 
regulatory elements of the two nearby loci (Fig.1.7.1) (Prioleau et al., 1999). 
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Figure 1.7.1 Insulator and enhancer blocking effects identified in different eukaryotic systems 
(adapted from Sabbattini and Dillon, 2000). (A) Insulator effects of 'specialised chromatin 
sequences' (SCS) at the Drosophila 87A7 heat-shock locus. The SCS and SCS' insulators (indicated 
by vertical arrows) exist as a pair of strong DNase I hypersensitive sites flanking the Drosophila 
87A7 heat-shock locus. SCS' is also the Aurora gene promoter. These elements act as insulators and 
were identified on the basis of their ability to give position-insensitive expression when placed either 
side of a transgene (Kellum and Schedl, 1991). (B) The 5' end of the chicken globin LCR contains an 
insulator (HS4) which can block the spread of methylated condensed heterochromatin from the 
adjacent folate receptor gene. 
The observations made above imply that insulator activity may not be a specific 
function. The insulator can be bound by factors that can disrupt productive 
interactions between promoter-enhancer, and/or it can have a blocking effect that 
prevents active or inactive chromatin from spreading into adjoining domains. 
Therefore communication between a gene and positive cis-regulatory elements, 
rather than the presence of specialized boundary elements, would define an active 
domain organisation. The 'weak' domain model proposed by Dillon and Sabbattini 
(2000) explain insulator distribution in terms of differential selection. It suggests 
that specificity of enhancer-promoter interactions is key to maintaining the 
functional autonomy of adjacent genes (Dillon and Sabbattini, 2000). Sequences that 
interfere with enhancer-promoter interactions i.e. insulators would be evolutionary 
selected against if they occurred within the domain but not at the edges. As a 
consequence, insulators would be found near the borders of domains without 
necessarily being selected to act as boundaries. 
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1.72 Long-range chromosomal interactions 
In higher eukaryotes genes can overlap and cis-regulatory sequences can be 
found hundreds of kilobases away from the target gene they control. Often there are 
unrelated genes in between. In particular developmental and tissue-specific genes 
can be found in gene-dense regions and, unlike housekeeping genes, do not cluster 
on the chromosomes. Transcriptional activation of genes by the long-range action of 
regulatory sequences has long been recognised. Several models have been proposed 
to explain this phenomenon (Fig.1.7.2). In the looping model enhancers 
communicate with promoters through direct interactions between proteins bound to 
the DNA elements with the intervening DNA looping out (Ptashne, 1986). 
An alternative model, the linking model, implies a role for the DNA in between 
the enhancer and promoter in supporting the transmission of a signal to create an 
environment favourable for transcription (Fig.1.7.2). According to this model 
transcription factors would bind to DNase I HS and the protein complexes 
assembled at the HS would extend along the chromatin fibre between the LCR and 
the target gene (Bulger and Groudine, 1999). Basic elements in this model are 
insulators, which have a position dependent ability to block the spreading of 
inhibitory or closed chromatin structures from neighbouring loci (Bell and 
Felsenfeld, 1999). Two other models have been proposed, the tracking or scanning 
model, which hypothesized that the transcription-activating complex recruited by the 
enhancer linearly tracks along chromatin until it encounters a competent promoter 
(Tuan et al., 1992). The facilitated tracking model instead incorporates aspects of 
both the looping and the tracking models (Blackwood and Kadonaga, 1998). An 
enhancer and its activation complex migrate along the chromatin fibre until they 
encounter the promoter. The chromatin between the enhancer and the promoter 
`reels out' through the enhancer complex and form a loop, which is progressively 
enlarged during tracking. 
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Fig. 1.7.2 Long-range chromatin interactions. From (Li, Q et al, 2006) Schematic representation 
of the looping, tracking, facilitated tracking and linking model. The first three models imply that the 
enhancer communicates with the gene promoter through direct interactions between proteins bound 
to the DNA elements with the intervening DNA looping out. The linking model instead proposes that 
"linking" proteins mediate the communication between the enhancer the gene. 
1.7.3 The Active Chromatin Hub (ACH) 
Recent studies would seem to support the looping model. Chromosome 
conformation capture (3C) and tagging and recovery of associated protein (TRAP) 
assay have been used to investigate the spatial organization of the Pglobin locus in 
expressing and non-expressing tissues (Carter et al., 2002; Tolhuis et al., 2002). 
Tolhuis and colleagues used 3C to show that expressing adult mouse /3-globin genes 
(/3major and ) minor) spatially interact with the HS of the LCR in erythroid cells. 
The inactive embryonic adult genes did not participate in this interaction and instead 
`looped out' (Tolhuis et al., 2002). Carter et al., (2002) reported similar results using 
RNA TRAP. In particular they observed that the 5'HS2 is in close spatial proximity 
to the active globin genes (Carter et al., 2002). The finding that these HS interact 
with each other to form a spatial cluster with the active genes was not confined to 
the cis-regulatory elements of the LCR. Data collected by de Laat and Grosveld 
showed that two sets of HS at either side of the locus, 3' HS1 and two additional 
5'HS, were also present in this spatial cluster and may be involved in globin gene 
regulation in erythroid cells. Importantly, the transcriptionally silent olfactory 
receptor (OR) genes located in between the 5' HS and the LCR, like the inactive 
embryonic globin genes, did not participate in clustering, but looped out (Fig.1.7.3). 
Analysis of non-expressing brain cells revealed that the whole region adopts a linear 
conformation in nuclear space in these cells (Tolhuis et al., 2002). Formation and/or 
stabilization of the interaction require trans-acting factors such as erythroid Kruppel 
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like factor (EKLF), GATA-1 and Fog-1 (Drissen et al., 2004; Vakoc et al., 2005). 
This complex structure containing multiple loops has been termed an "Active 
Chromatin Hub" (Fig.1.8.3). Using the same approach it was shown that a 
chromatin loop is formed between the TH2 LCR and its cognate gene encoding 
interleukin 4 (IL-4), IL-5 and IL-13 in T-helper type 2 cells (Spilianakis and Flavell, 
2004). In addition to enhancer-promoter loops, parent-specific loop formation was 
observed between the differentially methylated regions in imprinted insulin like 
factor 2 (IGF2) and H19 a maternally expressed non-coding gene (Murrell et al., 
2004). Taken together these studies show that chromatin looping brings cis-
regulatory elements close together. 
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Figure 1.7.3 Long-range interactions in the mouse /3-globin (from Tolhuis et al., 2002). (A) 
Schematic of the 200 kb mouse /3-globin locus LCR containing several DNase I HS spread over a 15 
kb region and others located 40-60 kb away from the genes in linear sequence. The grey boxes 
indicate the inactive genes (6-y and Ai). In the 14.5dpc foetal liver the active globin genes (/3maj and 
fimin) are shown as red boxes. (B) Clustering of active genes and hypersensitive sites in the mouse 
hub, the active chromatin hub (ACH). Red loops indicate the active regions (hypersensitive sites and 
active genes) of the locus the inactive regions of the locus loop out, with the inactive Al and ty 
globin genes on one loop, and the 5' OR 1-3 genes on another loop. 
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1.8 Chromatin remodelling 
Nuclear processes such us transcription, replication, recombination and repair are 
regulated and initiated by DNA binding factors. Interaction of these factors with 
their target elements requires that that the tight and repressive chromatin 
organization is partially unravelled. Chromatin needs to accommodate transitions 
between active and inactive states. This dynamic, interconvertible structure has been 
achieved through two major general mechanisms. These are modification of the N 
terminal histone-tails through post translational modifications (discussed in detail in 
section 1.9) and the action of nucleosome remodelling factors which are able to alter 
histone-DNA interaction so that nucleosomal DNA becomes more accessible to 
regulatory proteins. These perturbations of nucleosomes may lead to the relocation 
of histone octamers from a particular DNA fragment to available acceptor DNA in 
cis- or trans- establishing a "fluid" state of chromatin in which the overall packaging 
of DNA is maintained, but individual sequences are transiently exposed to 
interacting factors (Kingston and Narlikar, 1999). Histone and DNA in nucleosomes 
are held together by a large number of weak interactions and therefore nucleosome 
remodelling requires an energy input, which is given by ATP hydrolysis. ATP 
dependent chromatin remodelling enzymes belong to the SNF2 family of DNA 
dependent ATPase, which all have a helicase-like ATP domain (Bork and Koonin, 
1993; Henikoff, 1993). They can be divided into three classes based on the identity 
of their catalytic ATPase subunit. These are SWI/SNF, ISWI and Mi-2/CHD (Eisen 
et al., 1995). All of these complexes contain a highly conserved ATPase core 
domain flanked by N- and C- terminal domains that differ considerably between the 
three families. 
The SWI/SNF family complexes are generally, but not exclusively, implicated in 
the activation of transcription. They comprise yeast Snf2 and Sth2, Drosophila 
melanogaster brahma (BRM) and mammalian BRM and brahama-like 1 (BRG1). 
These proteins are characterised by the presence of a bromo-domain, which binds 
acetylated histones (Hassan et al., 2002). By contrast, ISWI family enzymes appear 
to have a role in transcriptional repression pathways and nucleosome assembly. 
ISWI proteins contain a SANT domain that is thought to act as a histone-binding 
domain (Boyer et al., 2004) and may recognise specifically modified histones. There 
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are two ISWI homologues in yeast (Isw 1 and Isw2) and mammals (SNF2H and 
SNF2L). The third family, Mi-2/CHD complexes are involved in transcriptional 
repression and form complexes with HDACs. The Mi-2 family is characterised by 
the presence of two amino-terminal chromo-domain, which can interact with 
methylated histone tails (Bannister and Kouzarides, 2004; Lachner et al., 2001). 
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Figure 1.8.1 Models of actions of ATP-dependent chromatin remodellers (adapted from Flaus and 
Owen-Hughes, 2004). (A) Small local alterations from mean DNA twist propagate around the 
nucleosome. (B) The DNA is unpeeled from the histone octamer at the entry and exit point of the 
nucleosome. Rebinding of more distal sequences to the same contact points would cause the looping 
out of DNA to form a 'bulge'. As the bulge moves around the nucleosome, the nucleosome would 
appear to move in the direction of the bulge. In effect the nucleosome appears to make a sliding 
movement. Both the twist and bulge diffusion would result in nucleosome repositioning and exposure 
of previously occluded DNA sequence. 
Two potential mechanisms by which the remodelling complexes alter the 
accessibility of DNA through nucleosome mobilisation are 'twist defect diffusion' 
and 'bulge diffusion' (Fig. 1.8.1). The first mechanism involves the repositioning of 
intact nucleosomes on DNA by small, local alterations that propagate around the 
nucleosome with the effect of 'sliding' the nucleosome along the DNA. In the 
second mechanism, DNA is `unpeeled' from the histone octamer by changes in 
histone-DNA or histone-histone contacts, to form loops 'bulging out'. Movement of 
the bulge around the nucleosome would result in nucleosome repositioning. Bulge 
diffusion could also expose previously occluded DNA sequences (Flaus and Owen-
Hughes, 2003; Flaus and Owen-Hughes, 2004). 
Nucleosomes have been shown to prevent binding of TBP to the TATA element 
in vitro in the absence of an activator (Kuras and Struhl, 1999) but they only 
modestly inhibit binding of a variety of activator proteins to their target sites. 
Activators and repressors regulated by cell cycle and developmental signals can also 
recruit chromatin-modifying activities to promoters. The relationship between 
transcriptional regulation and nucleosomal organisation has been studied in depth 
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both in the mouse mammary tumour virus MMTV (Richard-Foy et al., 1987) and in 
the yeast HO promoters 
1.8.1 The yeast HO promoter 
The yeast HO gene is expressed in late G1 and encodes an endonuclease involved 
in mating-type switching. Correct regulation of HO transcription requires the 
transcription factor Swi5p (Stern et al., 1984), which is expressed early in cell cycle 
and has largely or completely disappeared in late G1 ChIP experiments by Cosma et 
al (1999) showed that at the end of anaphase, Swi5 binds to the HO promoter. Swi5 
recruits the remodelling complex SWI/SNF, which facilitates the binding and action 
of the HAT complex SAGA. It is possible to speculate that SWI/SNF might either 
directly recruit SAGA or remodel the surrounding nucleosomes to make them better 
substrates for acetylation. Swi5 remains bound for only a short time while SWI/SNF 
and SAGA persist and facilitate the binding of the heterodimeric activator 
Swi4/Swi6 that finally triggers transcription (Cosma et al., 1999). It has also been 
shown that prior to activation, a domain of histone H3 and H4 acetylation of 
approximately 1 kilobase is established in mid-G1, prior to and independent of HO 
transcription. The presence of acetylated histones over the promoter implies that 
nucleosomes are not removed by the remodelling action of SWI/SNF. Nevertheless 
the establishment of this acetylation domain has been shown to require the presence 
of SWI/SNF, consistent with its prior recruitment to the promoter (Krebs et al., 
1999). 
1.8.2 The mouse MMTV promoter 
At the mouse mammary tumor virus (MMTV) promoter, six precisely positioned 
nucleosomes play a key role in the regulation of transcription. Regulatory sequences 
for the MMTV promoter extend to 1.3 kb upstream of the gene and include a long 
terminal repeat (LTR) in which the six nucleosomes are positioned (designated 
nucleosomes A-F). Within the LTR, several cis-acting regulatory sites have been 
characterised. These include a negative regulatory element, a positive enhancer 
containing transcription factor binding sites that are required for tissue-specific 
expression, and hormone response element (HRE) binding sites for steroid receptors. 
The gene is silent in the absence of hormones but is rapidly activated in the presence 
of glucocorticoids or progestins (Smith et al., 1993). Upon activation the region 
39 
containing nucleosome B becomes hypersensitive to DNase I at the site where the 
HRE is located, implying a nucleosome core- remodelling event (Archer et al., 
1992). The remodelled chromatin allows for the occupancy of all factor binding 
sites. This series of events results in to the formation of the pre-initiation complex 
and activation of the MMTV promoter leading to activation of the gene (Lee and 
Archer, 1994). There is evidence that the human SWI/SNF complex acts in concert 
with the estrogen receptor to remodel the nucleosomes over the promoter and 
activate transcription (Fryer and Archer, 1998; Trotter and Archer, 2004). 
1.9 Epigenetic regulation 
In 1942 Conrad Waddington defined epigenetics as 'the branch of biology that 
studies the causal interactions between genes and their products which bring the 
phenotype into being'. The term epigenetics is now used to describe heritable 
changes in genome function that occur without a change in nucleotide sequence 
within the DNA. Epigenetics is linked to cell identity and to how this identity is 
transmitted to daughter cells through the processes of DNA replication, chromatin 
assembly, and DNA re-packaging that accompany cell division (Turner, 2002). The 
amino terminal tails of the four histones have long been considered to be the main 
repository of this information. Histone tails are exposed on the nucleosome surface 
and subject to a variety of enzyme-catalyzed post-translational modifications such as 
lysine acetylation, lysine and arginine methylation, serine phosphorylation, 
ubiquitination and ADP ribosylation (Turner, 2000) (Fig. 1.9.1). Those 
modifications, together with DNA methylation, are considered epigenetic marks of 
gene expression that can be stably transmitted to progeny cells through many cell 
divisions. Recently it has been shown that the globular core domain of the histone 
proteins can be subject to covalent modifications as well (Mersfelder and Parthun, 
2006). While modifications on the histone tails are thought to act primarily by 
altering the ability of non-histone proteins to interact with chromatin, it is likely that 
some core histone modifications will also affect chromatin structure. The locations 
and the evolutionary conservation of these modifications support this idea 
(Mersfelder and Parthun, 2006). Mapping of their positions onto the nucleosome 
crystal structure, has shown that they fall into clusters that can be organised into 
three different classes: those at the histone-histone interfaces, those at the histone 
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Fig. 1.9.1 Histone modifications identified in vivo (from Turner BM, 2002). Legend key. acK : 
acetylable lysine ; meR : methylable arginine ; meK : methylable lysine ; PS : phosphorylable serine ; 
uK : ubiquitinable lysine. 
The idea that modifications on histone tails could be recognised by specific 
binding proteins, which in turn can influence gene expression was put forward a 
number of years ago (Turner, 1993; Turner et al., 1992) and this is now being 
substantiated by experimental data. Bromodomains, chromodomains and SANT 
domains are able to interact with chromatin and/or with its modified components 
and play a crucial role in the process of targeting specific histone modifying 
enzymes, to their substrates. What still remains controversial is the existence of a 
histone code constituted by specific histone tail modifications, or their combination, 
which could play a role not only in putting in place transcription patterns but also in 
determining their heritability (Jenuwein and Allis, 2001; Spotswood and Turner, 
2002). Cells are obviously able to replicate while maintaining their identity and one 
of the question still to be answered is if cellular memory could actually operate 
through patterns of histone modifications. The implications of an epigenetic code 
determining cellular memory are tremendous. Changes to histone modifications, due 
to metabolic or environmental influences, would change not only the cells subjected 
to them but their progeny as well. Obviously a heritable epigenetic code should have 
a predictive value, which means it should be able to provide an indication that a 
certain function will occur when the specific set of modifications is in place. It has 
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been proposed a distinction to be made between a histone code, which refers to the 
combination of modifications known to be involved in ongoing cellular processes, 
and an epigenetic code, which instead refers to the heritable code that could be 
involved in cellular memory (reviewed by Nightingale, 2006 ). 
1.10 Histone methylation 
Histone methylation occurs on both arginine and lysine residues. While histone 
arginine methylation generally correlates with transcriptional activation, histone 
lysine methylation can signal either activation or repression, depending on the 
particular lysine residue that is methylated (Kouzarides, 2002; Mang and Reinberg, 
2001). Even within the same lysine residue, the biological consequence of 
methylation can differ depending on the methylation state (Santos-Rosa et al., 2002; 
Wang et al., 2003). 
At least five methylatable lysine positions exist in the N termini of histone H3 
(K4,K9,K27,K36) and H4 (K20); another occurs in the histone fold domain of 
histone H3 (K79). The position of the methylated lysine within histone H3 and H4 
marks a gene for either activation or repression. Moreover, a lysine residue has the 
ability to be modified by mono-, di- or tri- methylation and histone 
methyltransferase (HMTases) display remarkable specificity for the level of 
methylation they catalyse (Zhang and Reinberg, 2001). In mice it has been shown 
that that pericentric heterochromatin is specifically enriched in histone H3 lysine 9 
trimethylation (H3K9me3) and histone H4 lysine 20 trimethylation (H4K2Ome3). 
By contrast mono and dimethyl histone H3 lysine 9 and histone H4 lysine 20 are 
found in euchromatin (Peters et al., 2003; Rice et al., 2003; Schotta et al., 2004). It 
has been suggested that the differential methylation status at specific lysines recruits 
specific methyl binding proteins that are dedicated to unique functions. For example, 
three different isoforms of the heterochromatic protein 1 (HP1) are linked to 
different degrees of H3K9 methylation. HP1 a and (3 are localised to pericentric 
heterochromatin while the HP1y isoform is localised to euchromatin (reviewed by 
Eissenberg and Elgin, 2000). 
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1.10.1 Heterochromatin formation: lysine 9 tri-methylation 
Heterochromatin formation has been connected to methylation of lysine 9 thanks 
to studies of PEV in Drosophila. The identification of Su(var)39 as a suppressor of 
variegation established the importance of this gene, which encodes a HMTase, in 
chromatin modification (Tschiersch et al., 1994). The mammalian homologs 
SUV39H1 and Suv39h1 were later discovered to have specificity for histone H3 
lysine 9 (Rea et al., 2000). It has been shown in mice that Suv39h1/Suv39h2 
specifically catalyse trimetylation of lysine 9 (Peters et al., 2003; Rice et al., 2003). 
Suv39h1/ Suv39h2 null cells showed a significant decrease in H3K9me3 within 
major satellite repeats compare to wild type cells (Peters et al., 2003). This decrease 
was concomitant with an increase in H3K9 mono-methylation. These finding 
suggest that H3 lysine 9 must be mono-methylated prior to conversion to the tri-
methylated form by Suv39h1/h2. In vitro analysis demonstrated that mono-methyl 
H3 lysine 9 is the preferred substrate for both Suv39h1 and Suv39h2 (Rice et al., 
2003). 
The catalytic activity of SUV39H1 was shown to be dependent on the 
evolutionarily conserved SET domain, a protein domain that is present in many 
known chromatin modifier. The SET domain is found in more than 300 proteins in a 
wide range of species and was initially defined by homology between the suppressor 
of PEV, Su(var)3-9 (Tschiersch et al., 1994), the polycomb group (Pc-G) protein 
enhancer of zeste (E[z]) (Jones and Gelbart, 1993) and the activating thritorax group 
(trx-G) protein Thritorax (Jenuwein et al., 1998). Other prominent members include 
the S. cerevisiae Set 1, which affects mating-type switching and telomeric silencing 
(Nislow et al., 1997), the S. pombe C1r4 which is involved in centromere function 
(Ekwall et al., 1996), and the human trx homologue HRX (Djabali et al., 1992; Gu 
et al., 1992; Tkachuk et al., 1992) which is implicated in the onset of 
translocation-induced leukaemia. 
Metylation of histone H3 lysine 9 by SUV39H1 provides a binding site for the 
chromodomain of heterochromatin protein 1 (HP1). These mechanisms are highly 
conserved and in yeast C1r4 recruits Swi6 (Swi6 is the fission yeast homologues of 
HP1) (Bannister et al., 2001; Lachner et al., 2001). HP1 is a small protein with two 
conserved domains, the N-terminal chromodomain and the C-terminal 
43 
chromoshadow domain, which are critical for its function in heterochromatin. HP1 
interacts stably with SUV39H1 via its chromoshadow domain and with the H3K9 
methyl mark via its chromodomain in flies and mammals (Aagaard et al., 1999; 
Nakayama et al., 2001). 
Studies in fission yeast have revealed a role for the RNA interference pathway in 
heterochromatin formation. The current model proposes that small interfering RNA 
(siRNA) molecules (produced by the RNA-directed RNA polymerase complex 
(RDRC) target the RNA-induced transcriptional silencing (RITS) complex to RNA 
transcripts that are associated with heterochromatic loci. This would lead to the 
recruitment of C1r4 and the methylation of H3-K9 (Hall et al., 2002; Motamedi et 
al., 2004; Verdel et al., 2004; Volpe et al., 2002). This model requires further 
clarification since one of the components of RITS, Chpl, contains a chromodomain 
that interacts specifically with methylated lysine 9 on histone H3. Also C1r4, and 
presumably histone H3K9 methylation, are required for the association of Chpl and 
RITS with heterochromatin. If the RNAi machinery directs heterochromatin 
formation to repeat—rich regions, one would not expect it to be dependent upon the 
histone methyl transferase. The self-reinforcing loop model, were C1r4 is recruited 
by RITS/RDRC and methylation of H3K9 by C1r4 helps recruit RITS and RDRC 
might explain this contradiction (Noma et al., 2004; Yamada et al., 2005). In mice, 
two C1r4 homologues, SUV39h1 and Suv39h2 are responsible for H3K9 
trimethylation at heterochromatic regions such us pericentric heterochromatin 
(Lachner et al., 2001; Peters et al., 2003; Rice et al., 2003). This modification 
recruits HP1 cc and HP113, homologues of Swi6 (Bannister et al., 2001; Lachner et 
al., 2001). The contribution of the RNAi pathway to mammalian heterochromatin 
formation has not yet been established. 
1.10.2 Heterochromatin formation: histone H4 lysine 20 
Trimethylation of lysine 20 on histone H4 is also associated with heterochromatin 
formation. SUV4-20h1 and SUV4-20h2, two set domain-containing proteins, are 
responsible for this modification. It has been shown that H4-K20 methylation is 
abolished at pericentric regions in the absence of SUV39h1/SUV39h2 function 
(Schotta et al., 2004). Schotta et al proposed the following mechanism for 
heterochromatin formation in mammals. In the first step, SUV39h enzymes would 
be targeted to repeat-rich sequences at pericentric heterochromatin. Because 
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pericentric heterochromatin is also enriched for 113-K27 monomethylation, and the 
Suv39h enzymes prefer an H3-K9 monomethylated substrate (Peters et al., 2003), 
they suggested that the first step could require the activity of currently unknown 113-
K27 and H3-K9 monomethylases. HP1 would then bind to H3-K9 trimethylated 
nucleosomes, and recruit the Suv4-20h enzymes, which in turn could trimethylate 
H4-K20. This model would involve collaboration of at least four distinct HMTases 
to induce the observed combination of H3-K9 trimethyl, H4-K20 trimethyl, and H3-
K27 monomethyl marks at pericentric heterochromatin. This pathway is not 
conserved in fission yeast and might therefore be restricted to metazoans. 
1.10.3 Transcriptional silencing: histone H3 lysine 9 mono- and 
dimethylation and histone H3 lysine 27 methylation 
Histone 113 lysine 9 mono and di-methylation have been associated with 
silencing of euchromatic loci in mammals (Peters et al., 2003; Rice et al., 2003) but, 
histone H3 lysine 9 methylation, has been found completely absent from the 
"activated genome" of S.cerevisiae (Briggs et al., 2001). Mono and di-methylation 
at H3 lysine 9 in euchromatin are catalysed by G9a and G9a-related protein (GLP). 
Both form complexes with HP17 and a subset of E2F transcription factors (Ogawa et 
al., 2002). G9a and GLP have also been found to be responsible for the vast majority 
of H3K9me2 and most H3K9me in mouse embryonic stem cells. Lack of G9a 
resulted in a global increase in histone modifications associated with transcription as 
well as in a dramatic phenotype of early embryonic lethality due to severe 
differentiation defects (Tachibana et al., 2002). These results imply that H3K9me 
and H3K9me2 play an important role in the establishment and maintenance of 
developmentally regulated gene silencing. It has been shown that H3K9me induced 
by the SET domain bifurcated 1 (SETDB1) HKMT can induce gene silencing in 
euchromatic regions, which involves recruitment of HP1 at a reporter gene promoter 
used (Ayyanathan et al., 2003). Spreading of HP1, which could contribute to 
heterochromatin formation, from the promoter region was not observed. These 
findings suggest that different processes mediate the downstream events that silence 
genes in heterochromatin and euchromatin even though both regions are marked by 
H3K9me and HP1 recruitment. 
Histone 113 lysine 27 has been linked to several silencing phenomena including 
homeotic-gene silencing, X inactivation and genomic imprinting (Cao and Zhang, 
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2004). The Pc-G protein enhancer of zeste [E(z)] contains a SET domain and 
becomes a HMTase when complexed with another early-acting Pc-G protein, extra 
sex combs (Esc). The Drosophila E(z)-Esc complex (Czermin et al., 2002; Muller et 
al., 2002) and its mammalian Ezh-Eed counterpart (Cao et al., 2002; Kuzmichev et 
al., 2002) have an apparent preference for H3-K27 but might also target H3-K9. 
Ezh/Eed-mediated nucleosome methylation increases in vitro binding to histone 113 
of the chromodomain protein polycomb (PC), which is a component of the 
polycomb repressive complex-1 (PRC1)(Czermin et al., 2002; Kuzmichev et al., 
2002). In E(z) mutants, methylation of H3-K27, and probably also H3-K9, is 
impaired in a manner suggesting that extended H3-K27 di- and tri-methylation 
across several nucleosomes (Cao et al., 2002) or dual tri-methylation of H3-K27 and 
H3-K9 (Czermin et al., 2002) might induce stable recruitment of Pc-G complexes. 
PcG proteins have shown to be involved in female X chromosome inactivation 
[reviewed by (Avner and Heard, 2001; Heard, 2004)]. H3-K9 methylation is 
associated with the inactive X chromosome (Xi) but H3-K27 tri-methylation might 
also be a prominent, if not the major, mark (Boggs et al., 2002; Heard et al., 2001; 
Peters et al., 2002). It has been observed that components of the mouse EZH2 and 
PRC1 complexes are transiently recruited to the inactive X chromosome during the 
initiation stage of both imprinted and random X inactivation. Recruitment of these 
proteins coincides with the appearance of methyl H3K27 (Plath et al., 2003; Silva et 
al., 2003). These findings are consistent with X-inactivation being independent of 
the Suv39h HMTases and of the HP1 proteins (Peters et al., 2002). However, there 
is no evidence for stable association of PC or other Pc-G complexes at the Xi (Silva 
et al., 2003). 
1.10.4 Histone metylation and transcriptional activation 
In addition to transcriptional repression, histone lysine methylation has been also 
associated with transcriptionally competent euchromatin. Sites of methylation in 
transcriptionally active regions are lysine 4 (H3K4), lysine 36 (H3K36) and lysine 
79 (H3K79) on histone 113. In the case of H3K4 and H3K36, studies in yeast have 
identified two separate histone lysine methyl-transferase (HKMT) containing 
complexes that functionally associate with RNA pol II and its machinery during 
elongation resulting in histone methylation in the coding regions (Krogan et al., 
2003; Li et al., 2002; Ng et al., 2003). 
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It has been shown that methylation of H3K4 impairs Suv39h1-mediated 
methylation of H3K9 and preclude binding of the histone deacetylase NuRD 
repression complex (Nishioka et al., 2002; Zegerman et al., 2002), which suggests a 
function for H3K4 in preventing heterochromatin spreading. In S.cerevisiae the 
HKMT Sea is responsible for all the three methylated states of H3K4. Analysis of 
H3K4 methylation in different organisms indicate that both H3K4me2 and 
H3K4me3 are enriched at actively transcribed genes. While H3K4me2 appear to be 
generally distributed across the body of the active genes, chromatin 
immunoprecipitation experiments have shown that H3K4me3 is localised 
specifically at their 5' ends (Ng et al., 2003; Santos-Rosa et al., 2002). In fact 
H3K4me3 is linked to the association of Setl with the phoshorylated form of 
elongating RNA pol II that is confined to the 5' region of genes. It has been 
proposed that association of Sea with the phoshorylated RNApo1 II causes a 
conformational change into the catalytic site of the protein, which is then converted 
into a trimethylase (Ng et al., 2003). Another possibility is that Set! becomes a 
trimethylase as a result of post translational modifications when it is associated with 
RNA pol II (Laribee et al., 2005; Schlichter and Cairns, 2005). 
Lysine 4 methylation has also been linked with chromatin remodelling activity. 
Genome wide analysis by Chip-on-chip showed that the yeast Isw 1, part of the Isw 1 
ATP dependent chromatin remodelling complex, is recruited to a specific set of 
genes in a manner that is dependent of H3K4 methylation. In particular, Iswlp is 
associated with chromatin only in presence of H3K4me2 or H3K4me3. The binding 
is not direct but probably mediated by an intermediary factor(s) (Santos-Rosa et al., 
2003). 
Recently two proteins have been shown to interact specifically with methylated 
H3K4, CHD1 and WDR5 (Flanagan et al., 2005; Sims et al., 2005; Wysocka et al., 
2005). CHD1 (chromo-ATPase/helicase-DNA-binding proteinl) is a member of the 
SNF2-like family of proteins, which has two chromodomains (Woodage et al., 
1997), thus linking covalent histone modifications with chromatin remodeling. The 
WD40-repeat protein WDR5A, which is a common component of MLL1, MLL2, 
and hSetl H3 K4 methyltransferase complexes (Dou et al., 2005), directly associates 
with histone H3 di- and trimethylated at K4. WDR5 is required for binding of the 
methyltransferase complex to the K4 dimethylated H3 tail as well as for global H3 
K4 trimethylation (Wysocka et al., 2005). 
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It has also been shown that the largest subunit of NURF, BPTF (bromodomain 
and PHD finger transcription factor), mediates a direct preferential association with 
H3K4me3 tails via its PHD2 domain. Depletion of H3K4me3 has been shown to 
cause partial release of the NURF subunit from chromatin and defective recruitment 
of the associated ATPase, SNF2L (also known as ISWI), to the HOXC8 promoter 
(Wysocka et al., 2006). These findings confirmed methylation of H3 K4 as a 
binding platform for proteins involved in gene transcription. 
1.10.5 Histone H3 lysine 36 and 79 
In S.cervisiae Set2 is responsible for K36 methylation. Set2 is physically 
associated with the elongating form of RNApol 11 (Li et al., 2003; Xiao et al., 2003). 
The association in maintained throughout the body of transcribed genes. In yeast, the 
Dot 1 enzyme is responsible for K79 methylation. Dot 1 and its homologues are the 
only methyltransferases that lack a SET domain (Feng et al., 2002b). Dotl has been 
shown to prevent the spreading of histone deacetylases (Lacoste et al., 2002; van 
Leeuwen et al., 2002). Recent studies provide evidence that H3K79 methylation 
might represent a binding site for the mammalian protein 53BP1, a conserved 
protein with properties of a DNA double-strand breaks (DSBs) sensor (Huyen et al., 
2004). Huyen and colleagues showed that the 53BP1 domain that recruits the protein 
to sites of DSBs consists of two tandem tudor folds with a deep pocket at their 
interface. In vitro, the 53BP1 tandem tudor domain binds histone H3 methylated on 
Lys 79 using residues that form the walls of the pocket; these residues are also 
required for recruitment of 53BP1 to DSBs. Suppression of Dot 1, the enzyme that 
methylates Lys 79 of histone H3, also inhibited recruitment of 53BP1 to DSBs. 
These findings indicate a role for H3K79 in DNA repair but there is no evidence of a 
link between 53BP1 and gene transcription. Another as yet unidentified protein, 
which would bind to methylated H3K79 might be involved in linking Doti, H3K79 
methylation and transcriptional regulation (Huyen et al., 2004). 
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1.11 Demethylation of histones 
Unlike other histone modifications such as acetylation, methylation has long been 
considered a "permanent" modification. This view was based on the early 
observation that the half-lives of histones and total histone methyl groups were 
comparable, which led to the conclusion that histone methylation is stable and 
irreversible (Byvoet et al., 1972). Turnover of methylation marks has long been 
considered to be by dilution during replication, by exchange on chromatin, or by 
proteolytic cleavage of the protein portion carrying the methyl group (Ehrenhofer-
Murray, 2004). Additionally, identification of the histone H3.3 variant as 
participating in replication-independent nucleosome assembley targeted to 
transcriptionally active loci, provided evidence of a mechanism for turnover of 
methylated histone H3 and gene activation (Henikoff and Ahmad, 2005). The view 
of histone methylation as enzymatically irreversible has recently been abandoned 
after the discovery of enzymes that can demethylate arginine as well as lysine 
residues. These include LSD1, which acts on H3K4me and H3K4me2 (Shi et al., 
2004); JHDM1, which specifically demethylates H3K36me2 (Tsukada et al., 2006) 
and lately JMJD2, which demethylates H3K9me3 and H3K936me3 (Whetstine et 
al., 2006) . 
The first example of an enzyme that was capable of turning over a methylated 
residue was the human peptidylarginine deiminase 4 (PAD4/PADI4). PAD4/PADI4 
converts monomethyl-arginine in histone H3 and H4 to citrulline by 
demethylimination (Cuthbert et al., 2004; Wang et al., 2004). However, since 
PAD4/PADI4 catalyzed demethylimination does not generate arginine and given 
that PAD4/PADI4 also acts on unmethylated arginine to generate citrulline, 
PAD4/PADI4 is not a strict demethylase. A recent study has uncovered a true 
histone lysine demethylase. Shi and colleagues demonstrated that LSD1/ BHC110 is 
able to specifically demethylate mono- and dimethyl H3K4 in a FAD (flavin adenine 
dinucleotide)-dependent oxidative reaction (Shi et al., 2004). LSD1 was previously 
identified in several histone deacetylase complexes (Hakimi et al., 2002; Shi et al., 
2003; You et al., 2001). When part of a complex with the androgen receptor, LSD1 
has also been shown to demethylate H3-K9Me2, thereby expanding its substrate 
repertoire (Metzger et al., 2005). 
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A second histone demethylase, JHDM1, has also been identified (Tsukada et al., 
2006). JHDM1 specifically demethylates H3-K36Me2 via an oxidative reaction 
catalyzed by the evolutionarily conserved JmjC domain. Both LSD1 and JHDM1 
demethylate only di- or monomethylated histones. The most recent discovery is the 
one of the JMJD2 subfamily of histone lysine trimethyl demethylases. The JMJD2 
family is composed of four members (JMJD2A, JMJD2B, JMJD2C, and JMJD2D) 
(Katoh and Katoh, 2004). JMJD2A interacts with the tumour suppressor Rb, with 
histone deacetylases (HDACs), and with the corepressor N-CoR and functions as a 
repressor in part through the recruitment of HDACs and N-CoR, respectively (Gray 
et al., 2005; Yoon et al., 2003a; Zhang et al., 2005). However, molecular 
mechanisms by which JMJD2A represses transcription are incompletely understood. 
JMJD2C is also known as GASC-1 (gene amplified in squamous cell carcinoma) 
and has been implicated in tumorigenesis (Yang et al., 2000). Cloos et al have 
shown that three members of the JMJD2C subfamily of proteins demethylate 
H3K9me3/me2 in vitro through a hydroxylation reaction requiring iron and 
a-ketoglutarate as co factors. Furthermore, they have demonstrated that ectopic 
expression of GASC-1 or other JMJD2 members markedly decreases 
H3K9me3/me2 levels, increases H3K9me 1 levels, delocalizes HP1 and reduces 
heterochromatin in vivo (Cloos et al., 2006). 
JMJD2A has been shown to act as a lysine trimethyl-specific histone 
demethylase, which catalyzes demethylation of H3K9Me3 and H3K36Me3 
(Whetstine et al., 2006, Klose et al, 2006). In particular Klose et al showed that 
JHDM3A (JMJD2A) has a further demethylase activity directed towards lower 
modification states such as H3K9/H3K36me2/mel and that overexpression of 
JHDM3A abrogates recruitment of HP1 (heterochromatin protein 1) to 
heterochromatin. This indicates a role for JHDM3A in antagonizing methylated 
H3K9 nucleated events (Klose et al., 2006). SiRNA-mediated knockdown of 
JHDM3A also showed to lead to increased levels of H3K9 methylation and 
upregulation of a JHDM3A target gene, ASCL2, indicating that JHDM3A may 
function in euchromatin to remove histone methylation marks that are associated 
with active transcription (Klose et al., 2006). 
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1.12 Histone acetylation 
Acetylation and deacetylation of histone lysine residues in the N termini of 
histones play a fundamental role in many chromatin-based processes. Histone 
acetyltransferases (HATs) and deacetylases (HDACs) have shown to act as 
coregulators in transcription, DNA replication and DNA repair. Sites of acetylation 
include at least four highly conserved lysines in histone H4 (K5,K8, K12 and K16) 
and five in histone H3 (K9, K14, K18, K23 and K27) as well as less conserved sites 
in histone H2A and H2B. HATs can be organized into families, which display 
different mechanisms of histone substrate binding and catalysis (Table 1.12.1). The 
Gcn5/PCAF family of HAT proteins (GNATs) function as co-activators for a subset 
of transcriptional activators. They contain both a HAT domain and a bromodomain 
(de la Cruz et al., 2005). 
Characteristics of HAT families 
HAT group 
HAT (and its associated 	Histones acetylated by HAT 
complexes) 	 complex Interactions with other HATs 
1. GNAT 
2. MYST 
Gcn5 (SAGA, ADA, A2) 	H3, H2B 
PCAF (PCAF) 	 H3,114 
Hatl (HatB) H4, H2A 
E1p3 (elongator) 	 H2A, H2B, I-13, H4 
Hpa2 	 1-13>H4 
esal (nuA4) 	 H2A, H4 
MOF (MSL) H4 
Sas2 	 unknown 
Sas3 (nuA3) 	 I-13 
MORF 	 H4>H3 
Tip60 H4>H3, H2A 
Hbol (ORC) 	 H3, H4 
p300; CBP 
p300; CBP 
3. p300/CBP 	p300 
	
H2A, H2B, H3, H4 
	
PCAF; Gcn5 
CBP H2A, H2B, H3, H4 PCAF; Gcn5 
4. Basal transcriptior TAFR250 (11-11D) 	 H3»l-f2A 
factors 	11-111C 	 H3, H4>H2A 
Nutl (mediator) 	 H3>>H4 
5. Nuclear receptor ACTR* 	 H3>H4 
cofactors 	SRC1 H3>H4 
p300: CBP; PCAF 
p300: CBP; PCAF 
* also known as RAC3, A1131, PCIP, TRAM 
histones acetylated by recombinant HAT 
Table 1.12.1 Characteristics of HAT families (adapted from Roth et al 2001) 
The p300/CBP family is another major group of nuclear HATs. The members of 
this family are more global regulators of transcription and contain a very large HAT 
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domain, a bromodomain and three cysteine-histidine rich domains (TAZ, PHD, ZZ) 
that are believed to mediate protein-protein interaction. The MYST family of HAT 
proteins contain a highly conserved 370 residue MYST domain, which uses a 
different catalytic mechanism from that shared by the other HATs (Yang, 2004). 
There are two main mechanisms by which histone acetylation and deacetylation are 
thought to play a role in transcriptional activation. Firstly acetylation of lysine 
residues could directly inhibit chromatin condensation by altering the normal core 
histone tail domain function. In vitro studies in fact have shown that above a certain 
threshold of acetyl groups per nucleosome condensation of chromatin is blocked 
(Tse et al., 1998). Secondly, covalently modified termini have shown to serve as a 
signal for the binding of trans-acting factors. For example, some activating factors, 
including several HATs, possess a region termed the bromodomain that interacts 
specifically with acetylated core histones (Dhalluin et al., 1999; Hassan et al., 2002). 
Bromodomains are found in many eukaryotic transcription factors, such as the 
HAT Gcn5 and Tafl (TFII250), which is the largest subunit of the TFIID 
transcription initiation complex, as well as in proteins in chromatin-remodeling 
complexes, such as Snf2 of the yeast SWI/SNF complex. 
The presence of sites of localized histone acetylation (Litt et al., 2001) supports 
the idea that histone acetylation facilitates protein—DNA interactions within 
chromatin in general. Many cases in which activating transcription factors recruit 
HAT-containing co-activators to specific promoters have now been documented 
(Brown et al., 2000). 
The mammalian HAT GCN5/PCAF and the homologous yeast SAGA complex, 
together with the CBP/p300 proteins, function as co-activators of transcription after 
their recruitment to promoters via their interaction with numerous DNA binding 
proteins. Histone acetyltransferase activity of these complexes is critical for 
activation of transcription (Berger, 1999; Struhl, 1999). In the case of the yeast HO 
promoter, activator-dependent recruitment of SWI/SNF is required for subsequent 
recruitment of SAGA followed by histone acetylation and DNA binding of an 
additional activator, SBF (Cosma et al., 1999; Krebs et al., 1999). Studies on PHO5 
promoter instead showed that is SAGA-dependent histone acetylation that facilitates 
SWI/SNF induced chromatin remodelling and transcriptional activation (Syntichaki 
et al., 2000). 
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More recently Hassan et al. investigated the binding of the SWI/SNF chromatin 
remodeling complex and the SAGA and NuA4 HAT complexes to chromatin in 
vitro. The SWI/SNF complex was recruited to chromatin by the activator 
Ga14-VP16. The authors have shown that prior acetylation by SAGA or NuA4 
complexes does not enhance SWI/SNF binding but does allow retention of the 
complex when the activator Ga14-VP16 is removed (Hassan et al., 2001). Retention 
of SWI/SNF requires the bromodomain of the Swi2/Snf2 subunit of the complex. 
They also showed that the SAGA complex itself is anchored to acetylated chromatin 
following removal of VP16, but only if the bromodomain of the Gcn5 subunit is 
intact. In contrast, the NuA4 complex, which lacks a bromodomain, is not retained 
following removal of Ga14-VP16 (Hassan et al., 2002). 
Studies on the IFN-/3 promoter have also demonstrated the existence of a link 
between histone acetylation and chromatin remodeling (Agalioti et al., 2000). 
Agalioti and co-workers have shown that activation of the IFN- fi gene in response to 
viral infection is accompanied by the progressive acetylation of H4K8, H3K9 and 
K14. In vitro experiments have shown that acetylation at K8 is necessary for 
recruitment of the SWI/SNF complex and that H3K9 acetylation and H3K14 
acetylation are necessary for recruitment of 	probably through binding of the 
double bromodomain of the TAFII250 subunit. Acetylation and transcription 
complex assembly required ordered recruitment of the GCN5 and CBP/PolII 
holoenzyme complexes followed by recruitment of SWI/SNF. SWI/SNF recruitment 
and subsequent chromatin remodelling was found to be greatly enhanced by histone 
acetylation, indicating that this modification is a prerequisite for the remodeling 
function of the SWI/SNF complex. These observations suggested a model in which 
transcription initiation involves sequential modifications at defined sites on the 
histone tails, each of which facilitates recruitment/binding of the next element. 
Broad domains of acetylation have also been observed. In yeast the ground state of 
chromatin is characterized by intermediate levels of H3 and 114 acetylation, a state 
caused by a mix of untargeted HAT and HDAC activities (Vogelauer et al., 2000). 
Site-specific acetylation or deacetylation is believed to lead to locally restricted 
activation or repression of transcription, respectively. However, this overall level of 
flexibility seems to be a specific feature of the highly active yeast genome. In 
differentiated, higher eukaryotic cells, most of the genome consists of 
hypoacetylated, inactive chromatin, which may be considered the 'ground state'. 
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Activation of house-keeping and cell-type-specific genes may involve the 
acetylation of histones across broad chromatin domains. An example is provided by 
the /3-globin loci, which exhibit a pattern of broad acetylation that correlates with 
transcriptional competence (Litt et al., 2001; Schubeler et al., 2001). Broadly 
distributed acetylation is also observed in the dosage compensated male X 
chromosome in Drosophila (Gu et al., 1998; Lucchesi, 1998), where the acetylation 
of histone H4 at lysine 16 (H4K16) by MOF (Males absent on the First) correlates 
with increased transcription of many genes throughout most of the male X 
chromosome (Akhtar and Becker, 2000; Smith et al., 2001). Broad acetylation of 
histone H3/H4 has shown to lead to partial decondensation and is not tightly 
correlated with active transcription per se, but rather marks regions of transcriptional 
competence (Verdone et al., 2005). 
1.13 Histone deacetylases (HDACs) 
Mammalian deacetylases can be grouped into four classes. Class I deacetylases 
(HDACs 1, 2, 3 and 8) share homology in their catalytic sites and are homologous to 
yeast Rpd3. Class II deacetylases include HDACs 4, 5, 6, 7, 9 and 10. Of these 
HDACs 4, 5, 7 and 9 share homology in two regions: the C-terminal catalytic 
domain and the N-terminal regulatory domain. These HDACs are homologous to 
yeast Hdal. HDAC6 and 10 have two regions of homology with the class II catalytic 
site (de Ruijter et al., 2003; Grozinger et al., 2001). The third class of deacetylases is 
the conserved nicotinamide adenine dinucleotide-dependent Sir2, or sirtuins, family 
of deacetylases (Grozinger et al., 2001). Class I and H HDACs are inhibited by 
trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and related 
compounds; class HI HDACs are not inhibited by these compounds. The fourth class 
are proteins related to the recently identified human HDAC11, which contains 
conserved residues in the catalytic core regions shared by both class I and II 
mammalian enzymes (Gregoretti et al., 2004). The HDAC enzymes possess a highly 
conserved catalytic domain of approximately 390 amino acids and appear to 
deacetylate their substrates by activating a water molecule with a divalent zinc 
cation coupled to a histidine-aspartate charge-relay system (Finnin et al., 1999). The 
sirtuin deacetylases contain a conserved 275 amino acid catalytic domain, which is 
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unrelated to that of the other HDACs, and operates by a very different mechanism 
that requires NAD as a substrate (Frye, 2000). 
HDACs are not redundant in function. Levels of HDACs 1, 2, 3, 5, 6, 7 and 10 
are approximately the same in normal tissue, whereas HDAC4 is expressed in 
embryonic but not adult muscle tissue (de Ruijter et al., 2003; Khochbin et al., 
2001). Class I HDACs are found almost exclusively in the nucleus; however, class II 
HDACs shuttle between the nucleus and cytoplasm upon certain cellular signals (de 
Ruijter et al., 2003; Grozinger et al., 2001). HDACs 1 and 3 can deacetylate all four 
core histones at every lysine tested, although with different degrees of efficacy 
(Turner, 2002). HDAC6 has greater deacetylation activity on histone 4, Lys 5 and 
Lys 8. 
HDACs do not bind directly to DNA but are recruited by protein complexes that 
differ in their subunit composition (Khochbin et al., 2001) (Fig. 1.13.1). For 
example, HDACs 1 and 2 have been found in complexes with Sir3, NuRD 
(nucleosome remodeling and deacetylation) and CoREST (Andres et al., 1999). A 
"core complex," consisting of HDAC1 and 2 and the histone binding proteins 
RbAp46 and 48, has been described (Zhang et al., 1999) in all of them. 
Sin3 Complex 
	
NuRD Complex 
Fig.1.13.1 Schematic rapresentation of complexes containing HDACs. 
The Sin3 complex consists of the core complex, along with SAP30 and SAP18. 
SAP30 is necessary to target the mSin3A-HDAC complex to a subset of repressors 
that utilize the nuclear hormone co-repressor N-CoR (Ayer, 1999), and SAP18 is 
required for maximal repression at some yeast promoters (Laherty et al., 1998; 
Lusser et al., 1997). The mSin3A protein instead serves as a scaffold for the 
assembly of the entire complex and for its interaction with various DNA binding 
proteins (Eilers et al., 1999). The NuRD complex (nucleosomal remodeling and 
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deacetylation) contains the HDAC1 and 2 core complex and the CHD3 and CHD4 
proteins (also called Mi-2a and Mi-2(3), which posses the DNA helicase/ATPase 
domain found in the SWI/SNF family of chromatin remodeling proteins (reviewed 
in Knoepfler and Eisenman, 1999). 
Another distinguishing feature of NuRD is the inclusion of the protein MTA2. 
MTA2 is related to protein MTA1, which is overexpressed in metastatic tumor cells 
(Toh et al., 1994) and contains a zinc finger and a SANT domain (Aasland et al., 
1996; Solari et al., 1999). Unlike Sin3 and NuRD, the CoREST complex contains 
HDAC1 and HDAC2 but does not appear to include RbAp46 or RbAp48. Two 
SANT domains have been identified in CoREST, the N-terminal one has shown to 
be required for the recruitment of HDAC1 to promoters (You et al., 2001). 
1.13.1 Regulation of tanscriptional silencing by HDACs 
In order for transcription to be silenced, HDACs must be targeted to the promoter 
regions of genes because they cannot directly interact with DNA or histone proteins. 
Four mechanisms for regulating HDAC activity have been described. The first three 
mechanisms involve recruiting HDACs to genes via interactions with specific DNA 
binding proteins, whereas the fourth mechanism involves a higher order regulatory 
system in which HDACs are inactivated by sequestration (reviewed in (Burke and 
Baniahmad, 2000; Wade, 2001). 
In the simplest case, HDACs can directly interact with a DNA binding protein 
that specifically associates with a set of promoters. For example, HDAC1 appears to 
interact directly with the factor YY1 (Yang et al., 1996), whereas HDAC4, 5, 7, and 
9 bind to the MEF (myeloid Elf-1 like factor) family of transcription factors. The 
second mechanism sees the HDAC proteins recruited by the interaction of a DNA-
binding protein with other members of the complex (reviewed in (Cress and Seto, 
2000)). Alternatively, the NuRD complex is recruited by the polycomb and 
hunchback repressors, which are involved in silencing gene expression from clusters 
of homeotic genes (Knoepfler and Eisenman, 1999). A third mechanism for 
regulating HDAC activity involves blocking the binding of a HDAC to a 
transcription factor. Such a mechanism regulates the interaction between HDAC4 
and MEF2 (Myocyte enhancer factor 2) (Youn et al., 2000). The fourth mechanism 
for regulating HDAC activity involves sequestration of HDACs in an extranuclear 
compartment. This method of regulation thus operates at a higher level than the 
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previously described mechanisms. This process has been characterized for the class 
II HDACs 4, 5, and 7. These HDACs can be phosphorylated in their N-terminal 
domains. This phosphorylation both disrupts the HDAC-MEF interaction 
(McKinsey et al., 2001) and allows binding at the phosphorylated sites and results in 
the shuttling of the HDACs out of the nucleus into the cytoplasm (Grozinger and 
Schreiber, 2000). 
1.13.2 Sirtuin deacetylases 
Several sirtuins have been identified in prokaryotes and eukaryotes, and these can 
be divided into five classes based on sequence homology. S. cerevisiae has five 
sirtuins, including the founding member, Sir2, and four homologs, Hst1-4 (homolog 
of Sir two). Four sirtuins have been identified thus far in C. elegans, and five in 
Drosophila. Seven sirtuins (SIRT1-7) have been identified in humans. Several 
bacterial species, including E. coli, Streptomyces, and Bacillus subtilis, also have 
sirtuins (reviewed by (Frye, 2000). Yeast Sir2 is the best-characterized sirtuin 
protein. Sir2 is found in two major complexes, one of which is responsible for 
silencing expression from the telomeric and HM loci (Sir2, Sir3, and Sir4), and a 
second that suppresses genetic recombination by forming a closed chromatin 
structure at the rDNA locus (Sir2, Netl, Cdc14) (reviewed in Gartenberg, 2000). 
When tethered to telomeric loci, Sir2 performs several functions aside from 
silencing gene expression. Telomeric Sir2 is required for the maintenance of 
genomic integrity and may play a role in the DNA damage response (Palladino et 
al., 1993). At the rDNA locus, yeast Sir2 inhibits genetic recombination (Straight et 
al., 1999). In yeast, Sir2 has been linked to aging, an effect that is thought to be 
mediated by its NAD dependence and repression of rDNA recombination [reviewed 
(Guarente, 2000)]. Regulation of transcriptional silencing by Sir2 is similar to that 
observed in the HDAC family of histone deacetylases in that Sir2 must be initially 
recruited to a specific promoter or to chromosomal domains via DNA binding 
proteins (Braunstein et al., 1996; Muth et al., 2001). Finally, Sir2 is generally 
regulated by a higher level of organization similar to the class II HDACs in that it is 
inactivated by sequestration within the nucleus (Cockell and Gasser, 1999). 
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1.14 Histone phosphorylation 
Phosphorylation occurs in all four core histones, histone variants and histone H1 
at specific serine and threonine residues. The overall charge of the histone is altered 
by phosphorylation and this can disrupt the electrostatic interactions between 
histones and DNA. Similar to acetylation, this modification is reversible, and we 
now know that acetylation or phosphorylation of histones can activate transcription 
whereas deacetylation or dephosphorylation of histones leads to transcriptional 
repression [reviewed by (Cheung et al., 2000a; Iizuka and Smith, 2003)]. 
In addition Ser 10 phosphorylation of histone H3 has a major role in chromosome 
condensation and segregation during mitosis and meiosis (Gurley et al., 1978). 
Mitosis-specific phosphorylation of histone H3 also occurs at Ser 28 (Goto et al., 
1999) and at threonine 11 (Thr 11) (Preuss et al., 2003). Members of the aurora 
AIR2 — Ipl 1 kinase family have been found to govern histone H3 phosphorylation at 
Ser 10 during mitosis in several organisms (de la Barre et al., 2000; De Souza et al., 
2000; Giet and Glover, 2001). The action of these particular kinases is thought to be 
required for the proper recruitment of the condensin complex and assembly of the 
mitotic spindle in a phosphorylated histone H3-dependent manner (Giet and Glover, 
2001). These kinases are counter-balanced by the activity of type 1 phosphatases 
(PP1) (Hsu et al., 2000; Murnion et al., 2001). 
The link between phosphorylation of histone H3 and transcriptional activation 
was first postulated in 1991, when Mahadevan and co-workers observed a rapid 
phosphorylation of histone H3 molecules concomitant with the activation of the c-
fos and c-jun immediate-early (1E) response genes. This effect was dependent upon 
the stimulation of the cells with growth factors, phorbol esters, protein synthesis and 
protein phosphatases inhibitors (Mahadevan et al., 1991). In vitro, experiments 
revealed that the yeast GCN5 histone acetyltransferase displayed a preference for 
binding to a portion of the histone H3 tail that is pre-phosphorylated at the Ser 10 
position (Cheung et al., 2000b). 
Histone H3 phosphorylation at serine 10 has been coupled to both acetylation and 
methylation of other residues on the same histone tail. Phosphorylation of histone 
H3 at serine 10 and acetylation of histone H3 lysine 9 and 14 are linked to 
transcriptional activation. Antibodies generated specifically to histone H3 tails that 
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were both phosphorylated and acetylated provided the first direct proof that the 
double-modified I-13 isoform existed in vivo (Cheung et al., 2000b; Clayton et al., 
2000). 
Nucleosome particles containing acetylated and phosphorylated histone H3 tails 
have been detected at the promoters of several MAP-kinase-activated IE genes and 
at the promoters of c-fos pathway genes by chromatin immunoprecipitation (ChIP) 
assays (Cheung et al., 2000b). Phosphorylation and acetylation however are each 
deposited via independent pathways, suggesting that, at least in some cases, histone 
H3 phosphorylation at Ser 10 is not just a signal for subsequent acetylation at Lys 
14. Analysis of c-jun induction suggests that the presence of a phosphorylated 
histone I-I3 tail does not necessarily predispose that particular tail to acetylation at 
Lys 14. In another study, the mouse mammary tumour virus (MMTV) promoter was 
shown to be inactivated via a mechanism whereby histone H1 is dephosphorylated 
in response to glucocorticoids. Removal of glucocorticoids resulted in the 
rephosphorylation of histone H1 and reactivation of transcription by the promoter. 
This study indicated that phosphorylated H1 bound at the MMTV promoter is linked 
with the activation of transcription in vivo (Lee and Archer, 1998). 
Coupling of H3 phosphorylation at serine 10 and methylation of Lys 9 has also 
been studied. It has been shown that phosphorylation of a synthetic peptide by 
recombinant Ip11 aurora kinase decreased when the H3K9 residue was methylated, 
and that phosphorylation of Ser 10 prevented methylation of Lys 9 by the SUV39H1 
methyltransferase. Mouse embryonic fibroblasts with mutations in suv39h1 have 
increased levels of Ser 10-phosphorylated histone H3 (Rea et al., 2000). More 
recently two studies in particular have investigated the relationship between 
H3K9me3 and H3S lOph. Fischle et al have shown that H3S lOph during M phase 
cause release of HP1a, -13 and -y from chromatin even though the level of H3K9me3 
remained unchanged. Inhibition of the mitotic kinase Aurora B, which is necessary 
for Ser 10 phosphorylation, caused retention of HP1 on mitotic chromosomes. These 
findings lead to the conclusion that H3S lOph is necessary for dissociation of HP1 
from chromatin in M phase (Fischle et al., 2005). In contrast to these results 
Matescuu et al showed that HP1 a binding to chromatin was actually favoured, 
rather than prevented HP1 by histone H3 serine 10 phosphorylation. In this case, 
dissociation of HP1 from the methylated histone H3 tails was observed only after 
the appearance of a third modification, acetylation of lysine 14, which occurs only in 
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prophase (Mateescu et al., 2004). However, it should be noted that most of the 
experiments showed by Fischle et al were performed with the isoform HP1r3 and not 
with HP 1 a. It has also been shown that decrease in the levels of JIL-1, a H3S10 
kinase, lead to spreading of H3K9methylation and the presence of HP1 at ectopic 
sites. This finding suggest a mechanism for antagonizing the recruitment of HP1 by 
Su(var)3-9, making repression readily reversible (Zhang et al., 2006). 
1.15 Ubiquitination of histones 
Ubiquitination is a reversible modification, primarily seen on the histone tails of 
H2A and H2B. Ubiquitin (Ub) is a 76 amino acid protein that covalently attaches to 
a target protein through an isopeptide bond between its C-terminal glycine and the 
of a lysine residue on the acceptor protein (Pickart, 2001b). Ub modification is a 
complex process involving an Ub-activating enzyme (El), an Ub-conjugating 
enzyme (E2), and E3 ligase enzyme; with E3 mediating specific recognition and 
ligation on the target. Poly-Ub chains can form, or alternatively, some proteins are 
mono-ubiquitinated on one or multiple lysine residues. The functional significance 
of these various forms of ubiqitination is still unclear. Generally, Ub induces 
proteasome-dependent degradation (Pickart, 2001a) and also regulates nuclear-
cytoplasmic trafficking of transcriptional regulators (Shcherbik and Haines, 2004). 
In Drosophila, Sauer and colleagues identified a histone-ubiquitinating enzyme, the 
coactivator TAF 11250, the central subunit of the THID complex, which is part of 
the basal transcription machinery. TAME are known to interact with DNA, general 
transcription factors and transcription factors to facilitate activation of transcription 
and, binding of TFILD to promoter regions is thought to represent an initial step in 
transcription. They went on to show that TAFI1250 mono-ubiquitinates histone H1 
in vitro (Pham and Sauer, 2000). Other studies have also provided evidence that 
H2A ubiquitination is a novel epigenetic marker for the inactive X chromosome. A 
link was demonstrated between H2A ubiquitination and H2A lysine 119 ubiquitin 
E3 ligase Ring lb, a Polycomb group protein, and the initiation of X inactivation 
(Fang et al., 2004). 
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1.16 DNA methylation 
DNA methylation in eukaryotes occurs at cytosine bases within CpG 
dinucleotides (CpGs) and it is associated with transcriptional repression. Early 
studies revealed that high levels of CpG methylation are observed in 
heterochromatic regions. Also, it has been shown that DNA that has been 
methylated in vitro when transfected into cells and integrated into the genome, 
forms a repressed chromatin structure. Other work revealed that unmethylated 
CpG-island chromatin is enriched in hyperacetylated histones (reviewed by Bird and 
Wolffe, 1999). In mice, DNA methylation is essential for viability, with targeted 
disruption of the DNA methyltransferase (Dnmt) enzymes resulting in lethality (Li 
et al., 1992; Okano et al., 1999). 
DNA methyltransferases can be grouped into two general classes, maintenance 
and de-novo. Maintenance methyltransferase Dnmtl (Bestor et al., 1988) copies pre-
existing methylation patterns onto the new DNA strand. Dnmtl recognises and 
modifies hemimethylated sites (Yoder and Bestor, 1998; Yoder et al., 1997) 
generated during DNA replication, preserving in this way the tissue-specific 
methylation pattern. The de novo methyltransferases Dnmt3 and Dnmt3b (Okano et 
al., 1998a; Xie et al., 1999) are mainly responsible for introducing cytosine 
methylation at previously unmethylated CpG sites. By this process methylation 
patterns can be changed by the introduction of new methyl groups at sites in which 
neither strand was previously methylated. A fourth DNA methyltransferase, 
DNMT2, shows weak DNA methyltransferase activity in vitro (Hermann et al., 
2003), but targeted deletion of the DNMT2 gene in embryonic stem cells causes no 
detectable effect on global DNA methylation, suggesting that this enzyme has little 
involvement in setting DNA methylation patterns (Okano et al., 1998b). DNMT3L 
is a DNMT-related protein that does not contain intrinsic DNA methyltransferase 
activity, but physically associates with DNMT3a and DNMT3b and modulates their 
catalytic activity (Suetake et al., 2004). 
DNA methylation patterns undergo two periods of genome wide DNA methylation 
reprogramming, one during primordial germ cell differentiation and one during pre-
implantation development (Dean et al., 2005). In mice it has been shown that after 
fertilization the DNA of the male pronucleus is rapidly demethylated. In contrast the 
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maternal genome initially maintains its methylation status, which then progressively 
drops until the 8 cell stage when the methylation content appear to be equivalent 
between maternal and paternal genome. De novo methylation at the late-morula 
early-blastocyst transition begins to restore methylation to both of the newly defined 
lineages of the blastocyst. De novo methylation results in an asymmetric amount of 
methylation in the differentiated lineages, with the inner cell mass (ICM) being 
hypermethylated in comparison to the trophectoderm (TE) (reviewed by (Dean et 
al., 2005). 
There are two general mechanisms by which DNA methylation can inhibit gene 
expression: first, modification of cytosine bases can prevent the association of DNA-
binding factors with their DNA recognition sequences (Watt and Molloy, 1988), 
second, DNA methylation can act via methyl binding proteins (MBPs), that 
recognize methylated CpG, and recruit co-repressors to silence gene expression 
directly (Boyes and Bird, 1991; Hendrich and Bird, 1998; Nan et al., 1998). 
1.16.1 Methyl binding proteins and transcriptional repression 
Methyl-CpG-binding proteins (MBPs) use transcriptional co-repressor molecules 
to silence transcription and to modify surrounding chromatin, providing a link 
between DNA methylation, chromatin remodelling and histone modifications 
(Meehan, 2003). Proteins that recognize methyl-CpG were identified more than a 
decade ago (Lewis et al., 1992; Meehan et al., 1989). They contain a methyl-binding 
domain (MBDs), which is responsible for binding to methylated CpG dinucleotides. 
So far six methyl binding protein have been identified, MeCP2, MBD1-4, and Kaiso 
(Fig.16.1). 
T es 
Fig.1.16.1 Methyl-CpG-binding proteins (MBPs) (from Klose, RJ 2006) Six mammalian MBPs 
have been characterized so far. Kaiso is an atypical MBP, because it depends on a zinc-finger domain 
(ZF) to recognize methylated DNA and a POZ/BTB domain to repress transcription. All the others 
MBPs possess a methyl-binding domain, even though the one in MBD3 does not recognize 
methylated DNA owing to crucial amino acid changes 
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MBD1 has shown to be associated with a H3 K9 methyltransferase activity and 
the ESET/SETBD1 H3 K9 histone methyltransferase has been shown to be a 
MBD1-interacting partner. ChIP studies suggested that H3 K9 methylation could be 
dependent on MBD1 and on DNA methylation at specific loci. MBD1 also forms a 
complex with CAF-1 (chromatin assembly factor 1) (Sarraf and Stancheva, 2004). 
This complex is thought to be involved in the maintenance of histone methylation 
patterns during DNA replication. MBD1 contains, in addition to the MBD and the 
transcription repressor domain (TRD), up to three zinc-co-ordinating CXXC 
domains, depending on the splice variant. The third CXXC domain has been shown 
to bind specifically to non-methylated CpGs. 
MBD2 possesses an MBD domain that overlaps with a TRD domain and a GR 
repeat at the N terminus. MBD2 is part of the MeCP1/NURD complex that remodels 
and deacetylases methylated chromatin templates in vitro (Zhang et al., 1999). 
MBD3 is the only member of the family to have a MBD that do not recognize 
methylated CpGs owing to amino acid changes (Hendrich and Bird, 1998). The 
protein has also been identified as a core component of the Mi-2/NURD 
transcriptional corepressor complex containing HDACs (Feng et al., 2002a; Feng 
and Zhang, 2001). MBD4 has a C-terminal glycosilase domain that is important for 
its function in DNA repair (Hendrich et al., 1999; Millar et al., 2002). 
MeCP2 is the founding member of the MBD family and contains the conserved 
MBD domain and an adjacent TRD domain. This protein is involved in a co-
repressor complex containing Sin3 and HDAC, and with a histone methyltransferase 
activity directed against histone H3 lysine 9 in vivo (Fuks et al., 2003). Recently it 
has also been shown that the SWI/SNF ATPase remodelling complex is associated 
with transcriptional repression and it is part of the MeCP2 repressor complex 
(Harikrishnan et al., 2005). MeCP2 seems to have a reinforcing activity on 
repressive chromatin states by acting as a bridge between two global epigenetic 
modifications, DNA methylation and histone methylation. These findings extend the 
link between histone modifications, DNA methylation, chromatin remodelling 
activities and repression. 
Kaiso instead is an atypical MBP that does not posses an MBD domain. It can 
recognize DNA sequences containing two methylated CpG dinucleotides or a related 
sequence that does not contain methyl-CpG DNA (Daniel et al., 2002; 
Prokhortchouk et al., 2001). Kaiso recognizes methyl-CpG using zinc-finger 
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domains present in the C terminus and mediates repression of methylated genes by 
associating with the histone-deacetylase-containing N-CoR co-repressor complex 
(Yoon et al., 2003b). 
1,16.2 DNA methylation, histone deacetylation and H3K9 
methylation 
Histone deacetylation, and histone H3 lysine 9 methylation work hand-in-hand 
with DNA methylation to repress transcription (Freitag and Selker, 2005; Tariq and 
Paszkowski, 2004). The existence of an epigenetic 'conversation' between histones 
and DNA, involving cytosine methylation, histone deacetylation, and H3K9 
methylation, and leading to transcriptional silencing, is now well established. What 
remains unclear is the precise sequence of events. As already mentioned, there is 
evidence that DNA methylation influences the histone modification pattern through 
the action of MeCP2 and MBD1. Nevertheless some studies have suggested that 
histone modifications are a prerequisite for DNA methylation. Observations made in 
fungi, plants and mammals highlight methylation at lysine 9 of H3 as a potential 
`sign' for DNA methylation (Jackson et al., 2002; Lehnertz et al., 2003; Tamaru and 
Selker, 2001). These observations led to the hypothesis that methyl binding proteins 
could be responsible for setting up a self-reinforcing cycle of repression, which may 
be necessary for the maintenance and heritability of repressed states. A DNA 
methyltransferase (DNMT) bound to an adaptor molecule (e.g. HP1) would add a 
methyl group to DNA when the chromatin is marked by H3K9me. Generation of 
methylated DNA would then allow binding of MBD proteins to DNA. Some of 
these proteins are able to recruit histone deacetylase (HDAC) complexes in addition 
to H3 K9 methyltransferases (H3K9 HMTs). Deacetylation of histone H3 at lysine 9 
is necessary for methylation to take place on this residue, therefore H3K9 
deacetylation would be followed by histone methylation, which, in turn, might result 
in recruitment of the HP1 adaptor. Thus, epigenetic information in residue 
methylation states would flow from histone to DNA and back (Fuks, 2005). This 
self-reinforcing cycle might be relevant to situations in which a gene or locus are 
heritably 'locked' into a repressed chromatin state; for example, at hypermethylated 
genes in cancer or at imprinted genes. 
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1.17 Embryonic stem cells 
The pre-implantation mouse embryo at the blastocyst stage is composed of three 
distinct cell types: the trophectoderm, the primitive endoderm, and the inner cell 
mass (ICM). The trophectoderm gives rise to the placenta and the primitive 
endoderm forms the visceral and parietal endoderm that lines the yolk sac cavity. 
The ICM is organized into a pluripotent epithelial layer (the epiblast) from which 
embryonic and other extraembryonic tissues are derived (Gardner and Beddington, 
1988). Embryonic stem (ES) cells are derived from the inner cell mass (ICM). They 
can be propagated in culture in an undifferentiated state (self-renewal) while 
maintaining the capacity to generate any cell type in the body (pluripotency). Self-
renewal requires that the ES cell genome maintain a cellular memory that specifies 
its pluripotent capacity. At the same time, the genome in pluripotent ES cells must 
be highly plastic to be able to enter any distinct differentiation pathway. Once 
differentiation is initiated, lineage specification is accomplished by the execution of 
genome-expression programmes, which are unique for each cell type. The molecular 
mechanism behind the self-renewal capacity and pluripotency of ES cells will be 
described in section 1.17.2. Recent findings point to a role for epigenetic 
mechanisms, including chromatin structure, chromatin dynamics and histone 
modifications, in these fundamental processes. 
1.17.1 Chromatin structure in ES cells 
Chromatin structure can influence gene function by affecting the accessibility of 
regulatory proteins to their target site and by modulating the affinity of 
transcriptional regulators with their targets (Meshorer et al., 2006). Studies in 
several systems indicate that ES cells are rich in euchromatin and, as differentiation 
progresses, accumulate highly condensed, transcriptionally inactive heterochromatin 
regions. For example, spatial heterochromatin rearrangement and an increase in the 
number of heterochromatin foci have been observed after differentiation of 
embryonal teratocarcinoma F9 stem cells (Cammas et al., 2002) and in murine ES 
cells (Meshorer et al., 2006). Direct visualization of centromeric heterochromatin 
with a probe against the major satellite-repeat sequence revealed a more diffuse 
heterochromatin structure in undifferentiated ES cells versus more compact 
heterochromatin with well-defined foci in ES-derived neuronal progenitor cells 
(NPCs) (Meshorer et al., 2006). Consistent with these observations, the genomic 
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disruption of chromatin remodelling proteins, including BRG1 (Bultman et al., 
2000), SNF5 (Klochendler-Yeivin et al., 2000) and SNF2H (Stopka and Skoultchi, 
2003), results in premature embryonic death prior to implantation. Lethality 
occurred at the blastocyst stage, when the inner cell mass (ICM), the source of all 
ES cells, is formed. In mouse ES cells, the chromatin remodelling NuRD 
(nucleosome remodelling and histone deacetylation) complex is essential for 
differentiation (Kaji, K. et al. 2006). Although the detailed mechanism of their 
functions is unknown, these observations strongly point towards an active role for 
chromatin-remodelling factors in the maintenance of stem-cell identity and the 
initial steps of differentiation. 
Recent observations in pluripotent ES cells indicate that some DNA-binding 
proteins undergo remarkably transient interactions with native chromatin in vivo. 
Dynamic measurements and biochemical analysis indicate that residence times 
range from a few minutes for linker histones to a few seconds for most transcription 
factors, remodellers and structural proteins, including heterochromatin protein HP1 
(Meshorer et al., 2006). The loosely bound proteins have been suggested to have two 
opposite effects. They could provide essential building blocks for the formation of 
chromatin domains as the cells engage their specific expression programmes by the 
targeted sequestration of genes into active and repressive chromatin domains. 
Chromatin-assembly factors and remodellers would facilitate their incorporation at 
these sites and would attract histone- and DNA modifying enzymes to mark these 
regions epigenetically. On the other side the dynamic nature of chromatin-associated 
proteins might also make it easier for regulatory factors to gain access to regulatory 
sequences, and to rapidly activate complex lineage-specific gene expression 
programmes (Meshorer et al., 2006) 
1.17.2 Embryonic stem cells regulators 
Self-renewal of mouse embryonic stem (ES) cell in culture depends upon 
extrinsic signals from leukaemia inhibitory factor (LIF) and bone morphogenetic 
protein (BMP). The key positive event occurring upon LIF stimulation of ES cells is 
the tyrosine phosphorylation, dimerization and translocation to the cell nucleus of 
the signal transducer and activator of transcription, STAT3 (Matsuda et al., 1999; 
Niwa et al., 1998). In the absence of LIF signalling, induced either by LIF 
withdrawal or by the expression of a dominant interfering form of STAT3, ES cells 
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differentiate into a morphologically mixed cell population expressing genes 
characteristic of endoderm and mesoderm (Niwa et al., 1998; Niwa et al., 2000). The 
BMP requirement for ES cell self-renewal is strictly dependent upon continued LIF 
stimulation, since in the absence of LIF, BMP directs differentiation into cells 
morphologically similar to those formed upon LW withdrawal in the presence of 
serum. In contrast, without BMP, neural differentiation occurs (Harland, 2000). 
BMPs acutely stimulate the transcription of Id genes (Ruzinova and Benezra, 2003). 
That Id induction is the critical event occurring downstream of BMP was 
demonstrated by the circumvention of the BMP requirement in ES cells 
constitutively expressing a loxP flanked Id] transgene (Ying et al., 2003). 
Subsequent excision of the loxP flanked Idl expression cassette restored BMP 
dependence. 
In the past few years some intrinsic regulators of ES cell pluripotency have been 
identified. The best characterized is the homeodomain protein Oct4, a member of the 
POU class of transcription factors. When the Oct4 gene is deleted in vivo, 
blastocysts form in which cells become allocated to the interior but fail to adopt a 
pluripotent identity, differentiating instead into the trophectodermal lineage (Nichols 
et al., 1998). The use of a cell line in which Oct4 expression was solely under 
exogenous control allowed the examination of the effect of maintaining Oct4 
expression in cells from which LW is withdrawn. In this case an apparently similar 
differentiation occurred to that which occurs when LIF is withdrawn from 
genetically unmanipulated cells. This indicates that Oct4 is not simply a downstream 
mediator of LIF signalling and that Oct4 and LW are both required for ES cell 
maintenance. Unexpectedly, when Oct4 is over-expressed, ES cells differentiate into 
cells expressing markers of endoderm and mesoderm (Niwa et al., 2000). 
Another homeodomain protein, Nanog, has been shown to be important for ES 
cell function. When over expressed in ES cells this protein maintains self-renewal in 
the absence of STAT3 activation, conditions under which ES cells would normally 
differentiate (Chambers et al., 2003; Mitsui et al., 2003). Experiments in which a 
loxP flanked Nanog transgene was integrated into ES cells showed that Nanog is 
able to sustain ES cell pluripotency (Chambers et al., 2003). Genetic deletion of 
Nanog showed that the protein is required for the maintenance of pluripotency, since 
cells from the interior of the blastocyst do not maintain their pluripotency but rather 
differentiate into primitive endoderm cells (Mitsui et al., 2003). Compared to Oct4 
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mutants, the ability of Nanog mutant embryos to produce the temporally more 
mature primitive endoderm indicates that Nanog function is critical at a later time 
during development than Oct4. Deletion of Nanog from ES cells also results in 
primitive endoderm differentiation. While Nanog is capable of maintaining ES cells 
in the absence of STAT3 activation, self-renewal occurs with maximal efficiency 
when ES cells are both responding to STAT3 and overexpressing Nanog (Chambers 
et al., 2003). This cooperative interaction between Nanog and activated STAT3 
suggests that each is dependent on the other for maximal function. The fact that 
Nanog overexpression blocks differentiation induced by LIF withdrawal could 
suggest that Nanog is downstream of STAT3 but is incapable of being maximally 
activated by STAT3. However, Nanog does not appear to be a transcriptional target 
of STAT3 nor is STAT3 activated by Nanog over expression (Chambers et al., 
2003). In addition, genetic deletion of Nanog produces primitive endodermal 
differentiation whereas withdrawal of LIF causes differentiation to a mixed 
endoderm/mesoderm population. This suggests that either STAT3 may interact with 
molecules other than Nanog or that Nanog may be necessary in the ectoderm to 
allow development to a stage capable of mesodermal differentiation. Nanog function 
has been shown to be dependent upon continued Oct4 expression (Chambers et al., 
2003). 
Very recently ChIP-Chip analysis of hES cells showed the presence of a complex 
network of interactions between the two variant homeodomain proteins, OCT4 and 
NANOG, and SOX2, a HMG factor, at specific promoter elements (Boyer et al., 
2005). NANOG occupied 9% of the promoter regions, SOX2 7%, and OCT4 3%. 
These data point to a high contribution of these transcription factors to the cellular 
phenotype, rather than a model in which each regulates a very limited number of 
target genes in a cascade. The frequent co-occupancy of the gene promoters by 
OCT4, NANOG, and SOX2, led to the conclusion that these three factors work 
together to control a whole set of target genes in ES cells. 
In a second level of analysis, Boyer et al. (2005) showed that roughly half of the 
genes bound by OCT4, NANOG, and SOX2 are expressed in ES cells. Among these 
are the promoters of the genes themselves, as well as components of signalling 
pathways such as the TGF-fl and Wnt. Those pathways that have been implicated in 
ES cell self-renewal. Genes whose promoters are co-occupied by OCT4, NANOG, 
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and SOX2 and are not expressed include many transcription factors believed to be 
critical for germ-layer-specific differentiation. 
Two regulatory network models have been proposed to account for these new 
findings. One model (feed forward loop) suggests that OCT4 and SOX2 converge 
on the regulation of NANOG, which, in turn, acts with these proteins to control a 
vast array of downstream targets. This model allows for both stability and 
developmental switching, depending on the activities and concentrations of the 
individual factors, and also suggests that NANOG maintains a central position in the 
regulatory hierarchy. The other model, consistent with the co-occupancy of the 
promoters of the genes that produce the factors, propose that OCT4, SOX2, and 
NANOG are each forming an auto-regulatory loop. It seems that OCT4, SOX2, and 
NANOG are likely to promote their own expression and the expression of other 
pluripotency/self-renewal genes, while simultaneously preventing expression of 
differentiation-promoting genes. 
1.17.3 Models for embryonic stem cell pluripotency 
Altered chromatin structure can contribute to the unique properties of stem cells, 
including pluripotency and their potential to self-renew. A number of distinct 
models have been proposed. The gene-specific early marking model envisions that 
tissue specific genes, not active in ES cells, are epigenetically marked for expression 
at a later stage. According to this model transcription competence of lineage-specific 
genes is determined by localized marks of histone modifications established by 
binding of sequence-specific transcription factors to discrete regions at the ES cell 
stage. These early transcription competence marks would help to maintain 
pluripotency by preventing the spread of repressive chromatin modifications and 
would act as recruitment centres for transcriptional activators as ES cells commit to 
different lineages (reviewed by Szutorisz and Dillon, 2005). After lineage 
commitment genes belonging to different fate choices would loose their mark and 
become permanently silenced. This early transcription competence marks model 
(ETCM) is based on the observation that several lineage-specific genes, which are 
repressed in ES cells, contain active chromatin marks (Chambeyron and Bickmore, 
2004; Forsberg et al., 2000; Szutorisz et al., 2005; Vieira et al., 2004). Two other 
models have been proposed to explain ES cells pluripotency, the hierarchical 
activation (HA) and the promiscuous transcription (PT) model. The first proposes 
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that ES cells express, in addition to their housekeeping genes, a minimal set of genes 
that are responsible for self-renewal and maintenance of pluripotency. Following 
differentiation, these genes, specific for stem cells, would be silenced and expression 
of lineage-specific transcription factors would trigger sets of lineage-specific genes 
(Fisher, 2002; Szutorisz and Dillon, 2005). The promiscuous transcription (PT) 
model, quite similar to the HA model, suggest that ES cells express a set of stem 
cell-specific genes controlled by stem cell-specific transcription factors but, in 
contrast to a strictly hierarchical activation, proposes that the rest of the genome is 
expressed at low levels. Upon differentiation, a global reduction of gene activity 
would occur, causing silencing of the stem cell specific genes and activation of sets 
of lineage-specific genes. Activity of tissue specific genes would be reinforced by 
increased expression of lineage-specific transcription factors (Munoz-Sanjuan and 
Brivanlou, 2002). 
1.18 B cell biology 
B cells are generated from multipotent haematopoietic stem cells first in the 
foetal liver and, after birth, in the bone marrow. They are responsible for humoral 
immunity, which allows the immune system to respond to almost any antigen to 
which it is exposed, because of the diversity of the antibody repertoire. The B cell 
pathway can be divided in a series of discrete developmental states (Fig.1.18.1) 
(Singh et al., 2005). Each state can be described on the basis of a unique 
constellation of cell surface markers and/or gene expression patterns, as well as from 
the rearrangement status of the immunoglobulin (Ig) genes. The first functional B 
cells are known as immature B cells and are defined by expression of IgM at the cell 
surface. Immature B cells exit the bone marrow and enter the spleen, where they 
further differentiate through several transitional stages and eventually become 
mature follicular or marginal-zone B cells. These cells can also undergo terminal 
differentiation to become antibody producing plasma cells (Sabbattini and Dillon, 
2005). 
The expression of IgM at the cell surface depends on the correct rearrangements 
of the cell's heavy (IgH ) and light (IgL) chains which pair to form the antigen-
binding site. Specificity and variation are generated by the diverse assembly of the 
germiline V (variable), D (diversity) and J (joining) segments through a series of 
highly regulated site-specific recombination events. The newly created V(D)J 
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segments, are located upstream of another element of the receptor, the constant (C) 
region. As an example of the potential for recombination, the IgH locus contains 
approximately 200 variable genes, 12 diversity genes and 4 joining genes. 
Variations generated by V(D)J recombination are myriad because they do not 
simply rely on the number of gene segments. Further diversity is generated by the 
introduction of small insertions and deletions at the junctions between rearranged 
gene segments. However, not all gene rearrangement events are successful. A high 
proportion will produce a non in-frame DNA sequence that cannot be translated into 
protein. A successful gene rearrangement, termed as a productive rearrangement, 
leads to the synthesis of the protein product that represent the signal for the cell to 
progress to the next stage of development. 
HSC Common 
Lymphoid 
Precursor 
pro-B pre-B I 	pre-B II immature and mature B 
Fig.1.18.1 Stages of B cell development. HSC = haematopoietic stem cell. SLC = surrogate light 
chain. 
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c-kir+.CD41+ 	c-kit+.CD43+ 	CD19, 	IpM+flek- 
Table 1.18.1 Stages of B-lymphocyte development (adapted from Martensson and Ceredig 2000) 
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1.19 B cell development 
In stem cells, as well as in any other non-lymphoid cell, the immunoglobulin 
genes are in the germline configuration. The first rearrangement event occurs in 
early pro-B cells at the heavy chain locus, promoted by the recombination-activating 
proteins RAG1 and RAG2 which introduce double strand breaks at conserved 
recombination signal sequences (RSSs) that flanks all Ig genes. Artificial expression 
of the RAG proteins in mammalian cells other than B or T lymphocytes suggests 
that they are the only lymphocyte-specific factors required for this recombination 
event to occur (Schatz et al., 1989). In RAG-1- mice V(D)J recombination is 
completely abolished. These mice have neither mature B nor T cells and this causes 
a severe combined immunodeficiency syndrome (SCID) (Mombaerts et al., 1992; 
Shinkai et al., 1992). Severe immunodeficiency, called Omenn syndrome, is seen in 
humans with miss sense mutations in either of their RAG genes (Villa et al., 1998). 
At the early pro-B cell stage DH and JH segment are rearranged and the cell 
proceeds to the late pro-B cell (pre-B I) stage where VH to DJH rearrangement 
occurs. V(D)J rearrangements are subject to allelic exclusion, which means that 
productive recombination at one allele and expression of a functional IgH chain 
inhibit further rearrangements on the other allele. The phenotype of early pre-B cells 
is also characterized by the expression on the membrane proteins B220 and CD19, 
which are expressed throughout B-cell development. At this stage CD43 is also 
expressed, but it is downregulated at the immature B cell transition. C-kit, is 
expressed at the late pro-B cell stage and is lost when the cells move towards the 
large pre-B cell stage. 
A productive VDJH joining leads to the expression of an intact immunoglobulin 
heavy chain (1.t) at the cell surface as part of the pre-B cell receptor (pre-BCR). 
Association of the p. heavy chain with the SLC proteins A.5 and VpreB1, and the 
signal transducing heterodimer Iga and 13 forms the pre-BCR (Karasuyama et al., 
1990), which is mainly expressed within the cell and in small amounts at the cell 
surface. These events precede rearrangement and expression of the light chain genes 
and marks a critical step in B-cell differentiation as the pre-BCR mediates signalling 
for cell survival and proliferation. Early B cells that fail to express a functional pre-
BCR are compromised in further development. At this stage, cell viability and 
72 
proliferation are dependent on additional factors such as interleukin-7 (IL-7) and its 
receptor (IL-7R). Evidence from studies in IL-7-deficient mice (von Freeden-Jeffry 
et al., 1995) and in mice treated with anti-IL-7 monoclonal antibodies in vivo 
(Grabstein et al., 1993), indicate that only small numbers of B lineage cells develop 
beyond the pro-B cell stage in the absence of IL-7. Stimulation by IL-7 also appears 
to play a role in the differentiation of B cells by promoting rearrangement of [t H 
chain genes in pro-B cells (Corcoran et al., 1998). It has been shown that certain 
precursor B cell lines rapidly undergo apoptotic cell death following IL-7 
withdrawal (Griffiths et al., 1994). 
After a few divisions large pre-B cells give rise to small pre-B cells, in which 
light chain rearrangements begins and the !I heavy chain is expressed in the 
cytoplasm only. At this stage the RAG genes are up-regulated and VL to JL 
rearrangements are initiated at the light-chain loci. Despite the presence of an active 
recombinase, IgH loci containing a DJH rearrangement are not targeted for further 
V-DJH recombination in pre-B cells. Upon complete rearrangement of the light-
chain genes, the cells express a complete IgM molecule at their surface and become 
immature B cells. 
The next stage of development sees the production of a 8 heavy chain as well as 
of a µ heavy chain by a mechanism of alternative mRNA splicing, and it is marked 
by the additional appearance of IgD on the cell surface. Immature B cells are also 
called naive B cells until they encounter their specific antigen. 
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1.20 Transcriptional regulation during B cell development 
The control of B-lymphocyte development from haematopoietic stem cells (HSC) 
is known to involve the action of two cytokine receptors (F1k2/F1t3 and IL-7R) and 
at least six transcription factors (PU.1, Maros, E2A, Bc111a, EBF, and Pax-5) which 
regulates distinct developmental aspects (Fig 1.20.1). The earliest regulatory events 
that seem to trigger B cell development are the loss of long-term self-renewal 
capacity of the HSC accompanied by the expression of the tyrosine kinase receptor 
foetal liver kinase 2/3  (F1k2/F1t3) within a subset of multipotential progenitor 
(MPP). 
Id2 
Pu 
Nolchl 
Fig.1.20.1 Transcriptional control of B-cell development (adapted from Busslinger, 2002). HSC = 
haematopoietic stem cell. At an early stage, low levels of PU.1 activate expression of the IL-7R gene 
and the cell continues down the lymphoid pathway (CLP = common lymphoid progenitor). 
Expression of the transcription factors E2A, EBF, and Pax5 further commit the cell to B-cell 
development. Notch 1 signalling specifies a T-cell fate and the activity of Id2 interferes with E2A 
and promotes commitment to the natural killer (NK) cell lineage. 
These events also restrict the engagement to the myeloid pathway (Adolfsson et 
al., 2001). Targeted inactivation of Flk2/Flt3 genes results in a severe deficiency in 
B lineage precursors (Mackarehtschian et al., 1995). The signalling pathway through 
which Flk2/Flk3 selectively favours the generation of B lineage progenitors is 
unknown but in vitro data suggest that activation of this receptor promotes 
expression of the interleukin-7 receptor (IL-7R) (Borge et al., 1999). The IL-7 
receptor is expressed primarily on lymphoid progenitors and is important for the 
74 
development of both B and T lymphocytes (Kondo et al., 1997; Sudo et al., 1993). It 
has been shown that combined loss of Flk2/F1t3 and IL-7R results in a complete 
failure to develop B lineage cells during both foetal and adult haematopoiesis 
(Sitnicka et al., 2003; Vosshenrich et al., 2003). 
The transcription factor PU.1 and Ikaros regulate expression of these two 
cytokine receptor genes. Ikaros null and ikaros DNS haematopoietic progenitors 
show impaired expression of Flk2/F1t3 (DeKoter et al., 1998; Nichogiannopoulou et 
al., 1999) and a reduction of 5-10 folds in c-Kit (tyrosine kinase receptor) levels 
(Wang et al., 1996). PU.1 4- progenitors, also present defects in the expression of 
IL-7R and complete absence of B lineage precursors. This is due to the fact that 
PU.1 is involved in directly regulating the transcription of the IL-7Rachain gene. 
Retroviral transduction of the IL-7Ra-chain in PU.14" cells partly restored B 
lymphopoiesis, suggesting additional critical functions for PU.1 in B lymphocyte 
development (DeKoter et al., 2002). It has been shown that low expression of PU.1 
induces B cell development whereas high levels suppress the B cell fate and 
promote machrophage differentiation under in vitro culture conditions (DeKoter and 
Singh, 2000). This suggests that graded expression of PU.1 specifies either the 
myeloid or lymphoid fate of early progenitors by controlling their responsiveness to 
IL-7. 
1.20.1 Role of EBF, Pax5 and E2A during B cell development 
PU.1 affects multiple hematopoietic lineages, whereas the loss of other 
transcriptional regulators specifically affects early B cell development and the entry 
to the pro-B cell stage (Scott et al.,1994). These transcription factors include early B 
cell factor (EBF), E2A and B cell-specific activator protein (BSAP or Pax5) (Bain et 
al., 1994; Urbanek et al., 1994; Zhuang et al., 1994; Lin and Grosschedl, 1995; 
Singh, 1996; Reya and Grosschedl, 1998). EBF and E2A help to specify B-cell fate 
by inducing expression of the surrogate light genes A5 and VpreB, of the signalling 
molecules Iga (mb-1) and 46 (B29), which form the pre-BCR, and of the two 
components of the rearrangement machinery, the RAG1 and RAG2 proteins. The 
E2A gene encodes, by differential splicing (Murre et al., 1989), the two basic helix-
loop-helix proteins (bHLH) E 12 and E47, whose expression and activities are 
induced during early B cell development (Murre et al., 1994). Although these 
proteins are widely expressed and normally form heterodimers with tissue-restricted 
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bHLH proteins, they specifically function as homodimers (E47 homodimer, also 
called B cell factor-1) in the B-lymphoid lineage (Murre et al., 1991; Shen and 
Kadesch, 1995). Targeted disruption of E2A in mice causes a severe and specific 
defect in early B cell development, which is arrested at its earliest stages prior to 
DH-JH rearrangements at the IgH locus (Bain et al., 1994; Zhuang et al., 1994). 
EBF also forms homodimers and recognise DNA via an N-terminal domain 
containing a zinc finger motif (Hagman et al., 1993; Hagman et al., 1995). EBF is 
expressed in pro-, pre- and mature- B cell but not in terminally differentiated plasma 
cells. In addition EBF is also expressed in adipose tissue, in brain and in olfactory 
epithelium (Hagman et al., 1993; Hagman et al., 1991; Wang and Reed, 1993). Loss 
of EBF results in a similar arrest of early B cell development to that observed in 
E2A mutants (Lin and Grosschedl, 1995). The few early B cell precursors 
expressing B220 and IL-7R found in the bone marrow of EBF'- mice fail to 
transcribe the Ragl and 2, Iga (mb-1), Ig/3 (B29), A5, VpreB , CD19 and Pax5 
genes. It has been shown that E2A and EBF act in synergy to induce transcription of 
the endogenous A5 and VpreB1 genes when they are expressed ectopically in the 
early-proB cell line BaF3 (Sigvardsson et al., 1997). It has also been demonstrated 
that EBF and E2A bind to and activate the promoters of A5 (Sigvardsson, 2000; 
Sigvardsson et al., 1997), VpreB (Gisler and Sigvardsson, 2002), and Iga genes 
(Sigvardsson et al., 2002). Ig/3 seems to be regulated by EBF alone (Akerblad et al., 
1999). 
Chromatin immunoprecipitation experiments have confirmed the presence of 
E2A at all four target genes (Greenbaum and Zhuang, 2002). Some findings suggest 
that E2A may act upstream of EBF in the genetic hierarchy of B cell development. It 
has been shown that a fraction of EBF-1 early pro B cells express normal levels of 
E2A mRNA, whereas EBF transcripts are reduced in E2111  bone marrow cells (Bain 
et al., 1997; Lin and Grosschedl, 1995). Also, ectopic expression of E2A activates 
the endogenous EBF gene in a machrophage cell line while EBF is unable to induce 
E2A transcription in the same cells (Kee and Murre, 1998). Finally, the activity of 
the EBF promoter seems to depend on a functional E2A-binding site (Smith et al., 
2002). It has been shown that transduction of EBF facilitates the rapid generation of 
B cell precursor from PU.14- progenitors. This suggests that the block to B cell 
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differentiation in the PU.1-1 embryos is due to impaired expression of the EBF gene 
(Medina et al., 2004). 
The activation of B-cell specific genes and V(D)J recombination by E2A and 
EBF is not sufficient to commit B cell progenitor to the lymphoid lineage in the 
absence of PaxS, also known as B-cell-specific activator protein (BSAP) . B cell 
development is arrested at an early pro-B cells stage in the bone marrow of Pax.5-1
mice (Urbanek et al., 1994). Pax5 pro-B cells can be cultured ex vivo in the 
presence of IL-7 and stromal cells. The characterization of these cells revealed that 
they are not yet fully committed to the B lymphoid lineage but instead retain a broad 
lympho-myeloid differentiation potential. Upon IL-7 withdrawal and appropriate 
cytokines stimulation the PaxS null pro-B cells can be induced to differentiate into a 
variety of lineages, including granulocytes, dendritic cells, osteoclast, NK cells and 
T cells. However this multilineage potential is suppressed by retroviral restoration of 
Pax5 expression (Nutt et al., 1999). Moreover, Pax51" pro-B cells can reconstitute T 
cell development in vivo when injected into RAG2 deficient mice (Rolink et al., 
1999). 
Pax5 is expressed from the pro-B to the mature B cell stage (Adams et al., 1992) 
and it seems to play a role in maintaining B cell identity. Pax5 fulfils a dual role by 
repressing lineage-inappropriate genes and simultaneously activating B-cell-specific 
genes consolidating the B lymphoid gene expression program (Nutt et al., 1999). It 
has been shown to activate expression of essential components of the pre-BCR 
signalling pathway, such us Ig a (mb-1) (Fitzsimmons et al., 1996; Nutt et al., 1997), 
CD19 (Kozmik et al., 1992; Nutt et al., 1998) and BLNK (Schebesta et al., 2002) and 
to repress the expression of several lineage inappropriate genes such as M-CSF-R 
and Notchl (Souabni et al., 2002). The mechanisms by which Pax5 regulates the 
transcriptional activity of its targets are likely to be diverse. It activates the 
transcription of lef-1 and mb-1 by recruitment of the Ets family of transcription 
factors (Nutt et al., 1998), which are known to activate acetyltransferase complexes 
(Li et al., 2000). It was also found that Pax5 transcriptional repressor activity 
involve interaction with Groucho-like co-repressor proteins, which act by reducing 
chromatin accessibility (Eberhard et al., 2000). 
Pax5 seems to take part to the control of B lineage commitment by shutting down 
inappropriate signalling system and by simultaneously facilitating signal 
transduction from the pre-BCR and BCR, which both execute important checkpoints 
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functions in B cell development. E2A, EBF, and their target genes are normally 
expressed in Pax 4" pro-B cells (Nutt et al., 1999; Nutt et al., 1998), while Pax5 
expression is reduced in pro-B cells of heterozygous E2A+/-EBF+1 mice (O'Riordan 
and Grosschedl, 1999). It has also been shown that Pax5 is unable to rescue B cell 
development from either PU.11- or EBF' progenitors (Medina et al., 2004). All of 
these results indicate that Pax5 functions downstream of E2A and EBF in the control 
of B cell development. 
1.20.2 Role of Ikaros, Aiolos and Dedalos in B cell development 
Ikaros, together with Helios, Aiolos and Dedalos constitute a family of zinc 
finger transcription factors involved in haematopoietic cell fate decision 
(Georgopoulos, 2002). The Ikaros gene can give rise, by alternative splicing, to eight 
different Ikaros isoforms. These proteins can form homo- or heterodimers via two 
C-terminal zinc finger domains, while their DNA-binding specificity is determined 
by the N-terminal zinc finger (Georgopoulos et al., 1994). Homo- and 
heterodimerization of isoforms with intact DNA-binding domains greatly increases 
both their affinity for DNA and their transcriptional activity. Some of the Ikaros 
isoforms lack the DNA binding domain and function as dominant-negative proteins 
by sequestering other members into inactive heterodimers (Sun et al., 1996). It has 
been shown that targeted deletion of the N-terminal zinc finger exons results in a 
dominant negative (DN) Ikaros allele, which interferes with Aiolos and Helios 
function (Georgopoulos et al., 1994), whereas inactivation of the C-terminal zinc 
fingers eliminates the dimerization function and thus creates an Ikaros null allele. 
Ikaros DN mice fail to generate any B, T NK and DC cells. In the null mutation 
(Ikaros"/") all the component of the B cell pathway are absent, from the earliest 
described precursor in the foetal liver and bone marrow to the mature populations in 
peripheral lymphatic centres, NK development is prevented and a strong reduction 
of the DC differentiation is observed. All stages of foetal T cell differentiation are 
also absent, while an abnormal T-lymphopoiesis is present in post-natal mice (Wang 
et al., 1996). 
In sharp contrast to the severe impairment in the production of B and T cells 
precursors in Ikaros knockout mice, common myeloid precursor and the more 
restricted granulocyte precursors are present at the near normal numbers 
(Nichogiannopoulou et al., 1999). These results suggest that Ikaros regulates HSC 
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activity and enables the differentiation of its multipotent progeny along the 
lymphoid pathway, whereas it might prohibit the myeloid fate. An Ikaros binding 
site within the TdT promoter has been shown to be important for promoter activity 
in immature lymphocytes, which suggested that lkaros might function as a 
transcriptional activator (Lo et al., 1991). However, other findings suggest the 
functional activator of TdT transcription is the Ets protein Elf-1 (Ernst et al., 1996) 
and that Ikaros acts instead as a repressor or a competitive inhibitor. FISH and 
confocal microscopy studies have provided evidence of Ikaros co-localization with 
centromeric heterochromatin and inactive genes in B cells (Brown et al., 1997). 
Mutation of an Ikaros binding site in the 25 gene promoter provided evidence 
that the protein can mediate transcriptional repression in vivo. Analysis of transgenic 
mice in fact showed that the mutation causes high levels of expression of the /15 
transgene, in activated mature B-cells (Sabbattini et al., 2001). Integration of the 
same mutant transgene into pericentromeric heterochromatin provided a direct test 
for the role of centromeric localization in Ikaros mediated silencing. The 
pericentromeric integration did not rescue silencing, and it was concluded that 
Ikaros does not repress transcription solely through a re-localisation mechanism. 
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1.21 The mouse X5-VpreBl locus 
The X5 and VpreB genes are located on chromosome 16 in mice and on 
chromosome 22 in humans. In the mouse there is one AS and three VpreB genes. 15 
and VpreBl are closely linked and are separated by only 4.6Kb. They encode for the 
component of the surrogate light chain proteins and are expressed only at the pro-
and pre-B cell stages (Li et al., 1993; Okabe et al., 1992). Analysis of the locus in 
transgenic mice has shown that all of the sequences required for efficient correctly 
regulated expression of the genes are located within a 18.3 Kb region containing 
both genes (Sabbattini et al., 1999). This region extends from 2.8 Kb upstream of 
the VpreBl transcription start site to 7.4 Kb downstream from the 15 poly A site 
(Fig.1.21.1). 
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Figure 1.21.1 The 25 and VpreBl locus. Vertical arrows indicate the positions of DNase I 
hypersensitive sites in the domain. Bold arrows indicate constitutive HS and pro/pre-B cell specific 
HS are indicated by non-bold arrows. 
1.21.1 Transcriptional regulation of the A5-VpreBl locus 
The A5 and VpreBl are activated at the pro-B cell stage and are transcribed in 
pro- and pre-B cells before being silenced during the transition to the immature B 
cell stage (Dul et al., 1996; Karasuyama et al., 1994; Kudo and Melchers, 1987; 
Sakaguchi and Melchers, 1986). Transcription of the 25-VpreBl locus is co-
ordinately activated by an LCR which comprises a cluster of 5 DNase I HS sites 
located in a 6Kb region 3' of the X5 gene (Minaee et al., 2005; Sabbattini et al., 
1999). The promoters of the two genes belong to the initiator family of promoters in 
that they lack TATA boxes and initiate transcription at multiple sites (Mai and 
Martensson, 1995). 
The gene promoters for both X5 and VpreBl contain multiple binding sites for the 
transcription factors EBF and E2A (Martensson and Martensson, 1997; Sigvardsson 
et al., 1997). Evidence of the role of the two transcription factors in A5 and VpreBl 
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regulation has been provided by a study in which EBF and CBF-1 (E47 homodimer) 
were transfected into the Ba/F3 early pro-B cell line. Ba/F3 cells express a number 
of B cells markers but they represent a stage where AS and VpreB1 expression is not 
yet activated. Transfection of A5 was activated by expression of EBF alone but was 
enhanced by co-expression of CBF-1. The E47 homodimer acted in synergy with 
EBF to activate the 25 promoter but was not effective on his own. Mice lacking E2A 
and EBF gene products do not express A5 and VpreB1 (Bain et al., 1994). 
Another transcription factor that may play a role activating A5 and VpreB1 is 
Pax5. Pax5 binds to the A5 and VpreB1 promoters (Tian et al., 1997), but the 
significance of the binding is still unclear since Pax5 deficient mice showed normal 
expression levels for A5 and VpreB1, implying that Pax5 is not required for the 
activation of the genes (Rolink et al., 1999). It has also been shown that Pax5 is not 
essential for in vitro propagation of pro-B cells in the presence of interleukin-7 and 
stromal cells (Nutt et al., 1997). Pax5 could cooperate with EBF and E2A to activate 
A5 and VpreB1 expression at the pre-B cell stage, as has been shown to be the case 
for mb-1 gene, which encodes for the Igor subunit of the pre-BCR (Sigvardsson et 
al., 2002). 
The 25 promoter also contains two adjacent binding sites for the transcription 
factor Ikaros Old and 1k2). Ikaros has been implicated as a transcriptional regulator 
of 25 and VpreB1, which would promote silencing in the transition to the immature 
B cell stage. The binding site Ed overlaps with a functional EBF binding site that 
has been shown to be important for promoter activity (Lo et al., 1991; Martensson 
and Martensson, 1997). The fact that Ikaros binds DNA more efficiently as a dimer 
(Sun et al., 1996) suggested that co-operative binding of Ikaros to the two sites 
could repress 26 transcription by preventing binding of EBF to the overlapping site. 
Analysis of the effects of a mutation in the Ik-2 binding site in the 25 promoter has 
shown a substantial increase in expression of the gene in mature B-cells, which do 
not normally express 25 (Sabbattini et al., 2001). However, Ikaros is present in 
developing lymphocytes even when 25 and VpreB1 are active. The implication is 
that there must be an additional determinant of Ikaros stage specificity. This may 
involve co-operation with other regulatory proteins such as IRF-4 and IRF-8 that 
have been shown to be involved in activating Ig light chain transcription (Lu et al., 
2003). Another possibility is that post-translational modifications could affect the 
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ability of Ikaros to bind its DNA target site (Sabbattini and Dillon, 2005). 
Phosphorylation of Ikaros has been shown to block DNA binding during mitosis 
leading to dissociation from satellite sequences (Dovat et al., 2002). 
1.21.2 Transgenic analysis of the A5-VpreB1 locus 
All of the regulatory sequences required for the full expression of the locus are 
contained in an 18.3 kb region that extends from an EcoRI site located 2.9kb 
upstream from the VpreB1 transcription start site to a BamHI site 6.92 kb 
downstream from the 25 polyadenylation site (Minaee et al., 2005; Sabbattini et al., 
1999). Transgenic analysis of the locus has shown that, in addition to the gene 
promoters, expression of /1.5 is regulated by an LCR-like element which includes a 
cluster of five DNase I HS located in a 6 kb region 3' of the AS gene (Fig. 1.21.2). 
This region has shown to be required for position independent expression of the 
genes at single copy (Sabbattini et al., 1999) and to have strong enhancer activity (S. 
Minaee PhD Thesis 2002). 
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Fig. 1.21.2. Location of sequences that activate A5 and VpreB1 expression. (from Sabbattini and 
Dillon, 2005). The blue lines represent fragments of the locus that have been shown to display 
enhancer activity or to give efficient expression of A5 and VpreB1 in transgenic mice. Vertical arrows 
indicate the position of DNase I hypersensitive sites (black, pro/preB cell specific; red, constitutive). 
Four of the hypersensitive sites (HS 2 to 5) are pro- and pre-B cell specific while 
HS1 has also been detected in non-lymphoid tissues. It has been shown that small AS 
transgenic constructs lacking the 3' HSs are able to promote efficient copy-
dependent expression when integrated into the genome as tandem repeats of three or 
more copies. This indicated that other elements located elsewhere within the locus 
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could contribute to the LCR effect. Sequences that can enhance transcription have 
been identified in the AS promoter and in an intergenic region containing two 
hypersensitive sites (HS7 and HS8). Enhancer activity has also been detected in 
constitutive HS1 (Minaee et al., 2005; Sabbattini et al., 1999). Three-dimensional 
FISH studies of the mechanisms of transcriptional activation in heterochromatin 
showed that integration into pericentromeric heterochromatin of a A5 transgene and 
of the 3' HS resulted in PEV (Lundgren et al., 2000). Moreover, in the same study, 
was showed that the transgene was mostly located on the outside of the 
heterochromatin complex both in pre-B cells and fibroblasts, irrespective of whether 
it was transcribed or not. The external location in fibroblasts was dependent on a 
constitutive DNase I hypersensitive site (HS 1). When the region containing HS1 
was deleted, the transgene was embedded within the complex in most fibroblasts but 
was still located mainly on the outside of the complex in pre-B cells. The fact that 
these two different locations were observed in different cell types is particularly 
significant because it excludes the possibility that the external localization is an 
effect of different integration sites in the heterochromatin. EBF dosage showed to be 
important for localization of the AS transgene as well. Reduction of EBF in pre-B 
cells, resulted in a reduced frequency of localisation of the transgene to the outside 
of the pericentromeric heterochromatin complex and in lower levels of transcription. 
The nature of the EBF sensitive element is not yet been established, but the AS 
promoter region represent a strong candidate (Lundgren et al., 2000). 
Sequence analysis identified a third gene, Topoisomerase 313 (Topo3fl), which 
transcription start site is only 1.5 kb upstream from the one of the VpreBl gene. 
Topo3/3 is transcribed on the opposite strand respect to VpreBl and A.5 and has been 
shown to be expressed in all the tissues analysed (Szutorisz et al., 2005). The 
Topo313 gene promoter was also found to overlap with a CpG island and with an HS 
(HS11). The location of the AS-VpreBl functional domain in close proximity to 
Topo3fl, a housekeeping gene has implications for how the two genes are 
differentially regulated (Szutorisz et al., 2005). 
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2. Materials and methods 
2.1 Standard stock solutions 
10 x TBE 	890 mM Tris, 890 mM Boric Acid, 20 mM EDTA, pH 8.0 
20 x SSC 	3 M NaC1, 0.3 M Tri-sodium Citrate, pH 7.0 
TE buffer 	10 mM Tris-HC1, pH 7.4, 1 mM EDTA 
PBS-A 	 137 mM NaC1, 2.68 mM KCI, 4 mM Na2HPO4, 1.76 mM 
KH2PO4 
10 % SDS 	10 % weight/volume (w/v) Sodium Dodecyl Sulphate 
50 x Denhardt's 	10 g/1 Ficoll (Type 400, Pharmacia), 1g/lPolyvinylpyrolidone, 
10 g/1 Bovine Serum Albumin (Fraction V) 
2.2 Solutions for bacterial culture and transformations 
LB-broth with ampicilin 	10 g/1 Bacto-tryptone (Merck), 5g/1 Bacto-yeast extract 
(GIBCO BRL), 1 g/1 NaC1, 100 mg/1 Ampicilin 
LB-agar with ampicilin 	1.5 % Bacto-agar (Merck) in LB-broth, 10 µg/m1 
Ampicilin 
2 x YT 	 8 g/1 Tryptone, 5 g/1 NaC1, 5 g/1 yeast extract, 100 mg/1 
Ampicilin 
Resuspension buffer TE 	50 mM Tris, pH 8.0, 10 mM EDTA, 100 ug/m1 
RNaseA 
Unless otherwise stated all chemicals were obtained from Sigma (Sigma-
Aldrich.com). 
2.3 Isolation of nucleic acids 
2.3.1 Mini-prep of plasmid DNA 
QIAGEN Ltd (UK) QIAprep Miniprep® (Crawley, West Sussex, UK) 
A single colony of transformed bacteria was used to inoculate 4 ml of LB-broth 
(containing ampicillin 10 µg/ml) and incubated overnight in 37 °C shaker. 
QlAprep® Spin Miniprep Kit was used to prepare the plasmid DNA according to 
the manufacturers instructions. 
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2.3.2 Maxi-prep of plasmid DNA 
QIAGEN Ltd (UK) EndoFree TM Plasmid Maxi Kit 
A 25 µ1 aliquot of starter culture described above was used to inoculate either 100 
ml or 250 ml (high-copy plasmids, low-copy plasmids respectively) of 2x YT broth 
(containing ampicillin) and incubated overnight at 37 °C with shaking. The 
EndoFreeTM Maxi Kit was used to prepare plasmid DNA according to 
manufacturers instructions. 
2.3.3 Isolation of mouse genomic DNA from brain and liver 
tissue 
Tail buffer 	0.05 M Tris-HC1, pH 8.0, 0.1 M EDTA, 0.1 M NaC1,1 % (w/v) SDS 
Adult mice were sacrificed by cervical dislocation and brain and liver tissues 
were harvested and each placed into individual sterile 15m1 falcon tube. To each 
tube, 1 ml Tail buffer and 20 µI proteinase K (10 mg/ml) were added. Samples were 
incubated at 55 °C overnight with rotation. The day after a volume of 1 ml 1:1 
phenol-chloroform was added to each sample. The samples were then extracted by 
vigorous shaking for 2 minutes at RT on IKA vibrax VXR shaker moved to a 10 ml 
corex tube and recovered after spinning at 13000 g for 10 minutes in a centrifuge 
(the phenol-chloroform extraction step was repeated three times to ensure a clean 
preparation of DNA). The upper aqueous phase was moved to a new sterile falcon 
tube and 2.5 ml of 99.7-100% ethanol were added to precipitate the DNA. After 
addition of ethanol the DNA became visible as a white cotton-like precipitate, which 
could be spooled with a plastic rod. Each sample was placed into 500 µI of TE 
buffer. The DNA was allowed to fully dissolve in the TE solution overnight at 4 °C. 
2.3.4 Isolation of mouse genomic DNA from ES, primary pre-B 
and mature B cells 
5 x 107 cells for each cell types were collected and washed twice with ice cold 
PBS. Cells were then pelletted in 15m1 falcon tubes and 1 ml Tail buffer and 20 IA 
proteinase K (10 mg/ml) were added. Samples were incubated at 55 °C overnight 
and the procedure described in section 2.4 was followed. 
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2.3.5 Oligonucleotides 
Oligonucleotides were purchased from MWG BIOTECH (UK) LTD. (Milton 
Keynes, UK) and Sigma-Genosys Biotechnologies (Europe) Ltd., (Cambridge, UK). 
The lyophilised oligonucleotides were resuspended in sterile distilled water to a final 
concentration of 1 ng/µ1 (standard PCR) and stored at —20 °C. 
2.3.6 Quantification of nucleic acids 
To determine the concentration of genomic and plasmid DNA, a 
spectrophotometer was used to measure the OD260. Concentration was estimated 
from optical density as solution containing 50 µg/m1 of double stranded DNA has an 
absorbance of 1 at 260 nm. Concentration of DNA obtained from ChIP experiment 
was determined by PicoGreen® ds DNA Quantification Kit (Molecular probes, 
Cambridge Biosciences, Cambridge, UK) with a standard spectrofluorometer and 
fluorescein excitation (480 nm) and emission (520 nm) wavelengths. 
2.4 Standard manipulations of DNA 
2.4.1 Restriction enzyme digestion of plasmid DNA 
All restriction enzymes and buffers used were obtained from NEW ENGLAND 
Biolabs® Inc. (NEB (UK) Ltd., Hertfordshire, UK). Unless otherwise stated 
reaction conditions used were as directed in the published protocols, in a total 
volume of 20 µI with incubation periods of 1-16 hours at 37 °C. 
2.4.2 Restriction enzyme digestion of genomic DNA. 
10 to 50 µg of genomic DNA were digested with up to 150-200 U of the 
appropriate restriction enzymes (range of 5-20 U/µ1) in a final digest volume which 
varied from 25 up to 200 IA and incubated for a minimum of 2 to a maximum of 16 
hours at 37 °C. 
2.5 DNA electrophoresis 
2.5.1 Agarose gel electrophoresis 
Unless otherwise stated, gels were made at 0.8 % (w/v) agarose supplemented 
with EtBr to a final concentration 0.1 i_tgli.t1. Bacteriophage X DNA digested with 
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BstE II (NEB) was run alongside the samples as a molecular weight standard. In 
some cases a 100 bp DNA ladder (NEB) was used as a size marker. Electrophoresis 
was carried out at a potential of between 40-95 V. DNA was visualised on the EtBr 
stained gels by long-wave ultraviolet light (UV). 
2.5.2 Non-denaturing polyacrylamide gel electrophoresis 
(PAGE) 
Non-denaturing polyacrylamide gels were used to assess chromatin preparations 
to be used in ChIP experiment. The gels were prepared at 6.0 % (29:1) 
polyacrylamide and run in 0.5 % x TBE at 200 V for 3 hours then stained in an EtBr 
bath (EtBr final concentration of 0.1 µg/41). Bands were visualised by long-wave 
ultraviolet light (UV). 
2.5.3 isolation of DNA from agarose gels 
DNA samples were electrophoresed on 0.7 % (w/v) agarose gels with the 
appropriate molecular weight marker and assessed by long-wave UV 
transillumination as described. Gel slices of the required DNA fragments were 
carefully cut out using a scalpel. Fragments were purified using GENECLEAN /1°  
Kit BIO 101 Inc., (Anachem, La Jolla, CA, USA) as described in the manufacturers 
protocol. This method uses glass milk (silica matrix) to bind DNA. Agarose gel 
bands are first solubilised with sodium iodide at 55 °C. Proteins and most RNA do 
not bind to the silica matrix and are eliminated during the washes. The bound DNA 
is eluted using low-salt buffer. Modifications were made to increase incubation time 
to overnight on a rotator. Samples were eluted from the glass milk in a 30 pl volume 
of TE at 55 °C and quantified by spectrophotometry. 
2.6 Radio-labelling of DNA 
DNA probes between 0.35-2.0 kb were used at a concentration of 50 ng/µ1 per 
reaction. The probes were labelled by random-priming using STRATAGENE Prime 
It® random priming kit according to the manufacturers protocol. 50 plCi of 32P a 
dATP was used in each reaction (3000 Ci/mmol, Amersham Pharmacia Biotech Inc, 
Piscataway, NJ, USA). Unincorporated label was removed using Microspin G-25 
Columns (Amersham Pharmacia Biotech Inc.,) according to manufacturers 
instructions. 
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The reaction was assembled as follows: 
50 ng DNA 
2 µ1 Random 9mer Primer 
distilled water to a final volume of 10 µI 
The mixture was heated at 95 °C for 3-5 minutes and then chilled on ice for 1 
minute. The radio-labelling reaction was then assembled by adding: 
10 µI DNA/oligonucleotide reagent mixture (as above) 
4 µ1 5 x dATP buffer (STRATAGENE) 
1 µI exo (-) KLENOW (5 U/µ1) (STRATAGENE) 
5 µI 32P a dATP (Amersham) 
Labelling was carried out for 1 hour at 37 °C, and stopped by adding 80 1.1.1 of 
stop solution (see section 2.2.11.4). The labelled probe was then denatured by 
heating at 95 °C for 5 minutes and immediately chilled on ice before adding it to 
hybridisation buffer (see section) preheated to 65 °C. Blots were hybridised in a 
hybridisation oven overnight at 65 °C. 
2.7 Generation of DNA probe templates by PCR 
DNA probes were generated by PCR with the following reaction mix: 
5 ng plasmid DNA 
110 forward primer (1 ng/µ1 stock) 
1 µ1 reverse primer (1 ng/µ1 stock) 
4 µI MgC12 (50 mM stock, Bioline) 
8 µI dNTPs (2.5 mM stock, Pharmacia Biotech) 
1 IA Imolase DNA polymerase (Bioline) 
741 µ1 distilled water 
Primers were as described in (Minaee et al., 2005). PCR was carried out using a 
DNA thermal cycler. The samples were denaturated at 94 °C for 7 minutes, followed 
by 32 cycles of denaturation at 94 °C for 30 seconds, annealing at 55 °C for 1 
minute and extension at 72 °C for 1 minute. A final extension cycle was performed 
at 72 °C for 10 minutes. The samples were stored at -20 °C until use. 
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2.8 Southern blot analysis 
Southern blotting hybridisation solutions: 
Pre-hybridisation buffer 
15 ml 	20 x SSC 
20 ml 	50 x Denhardt's 
1 ml 	10% SDS 
500 gl 	5014/m1 denatured salmon sperm DNA 
distilled water to 100 ml total volume 
Hybridisation buffer 
15 m1 	20 x SSC 
20 ml 	50 x Denhardts 
1 ml 	10% SDS 
500 tl 	501.tg/m1 denatured salmon sperm DNA 
10 g 	Dextran Sulphate (Amersham Pharmacia Biotech AB, Uppsala 
Sweden) 
distilled water to 100 ml total volume 
Stop Solution 0.5% (w/v) SDS, 10 mM EDTA 
Genomic DNA was extracted from liver, brain tissues and cultured cells as 
described in sections 2.3.3 and 2.34. DNA was digested for 2-3 hours with 
increasing amounts of McrBC. Digested DNA was extracted with an equal volume 
of 1:1 phenol-chloroform, ethanol precipitated and dissolved in 10 mM tris. The 
recovered DNA was then digested again overnight with the appropriate restriction 
enzymes at 37 °C and was run on a 0.9 % agarose gel for 16-20 hours at 35 V. 
200 ng of DNA BstE II and 200 ng of 2Log ladder molecular weight markers (NEB) 
were used as size markers. The DNA was visualised by staining with ethidium 
bromide and exposure to UV. The gel was then first soaked for 20 minutes in 500 ml 
0.25 M HC1, which resulted in partial depurination and fragmentation of the DNA. 
This procedure is necessary to give efficient transfer of larger DNA fragments onto 
the membrane. Afterward the gel was soaked in a 0.5 M NaOH/1.5 M NaC1 solution 
for a minimum 40 minutes. Capillary transfer to Zeta-Probe® Genomic Tested 
Blotting Membrane (Bio-Rad Laboratories, Hercules, California, USA) was carried 
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out as described by (Botchan et al., 1976). The DNA was fixed to the membrane by 
baking for two hours at 80 °C. The membrane was transferred to a bottle and 
incubated with pre-hybridisation buffer at 65 °C for a minimum of 4 up to 16 hours 
in a rotating hybridisation oven (Hybaid Mini10). The membrane was hybridised in 
hybridisation buffer containing radio-labelled probe (prepared as described in sec 
2.7) overnight at 65 °C. After incubation the membrane was washed twice with 
500 ml 3 x SSC for 1 minute at room temperature in the bottle, transferred to a 
receptacle and washed twice with 0.1 x SSC, 0.1 % SDS for 20 minutes in a shaking 
water bath at 65 °C. The membrane was wrapped in cling-film and exposed to a 
PhosphorScreen (Molecular Dynamics) and left at room temperature for 3-16 hr 
before being exposed using a 445 SI phosphorimaging machine (Molecular 
Dynamics) and analysed using ImageQuant Version 5.2 Build 039 Copyright 
1997 Molecular Dynamics software. Blots were also visualised by exposure to 
Kodak Xomat film. 
2.9 Histone proteins SDS PAGE 
Histone proteins from native chromatin preparations were checked on sodium 
dodecyl sulfate (SDS) denaturing acrylamide gels. 
Solutions: 
Gel stacking: 
5% (29:1) polyacrylamide 
1% SDS 
pH 6.8 
Gel separating: 
12% (29:1) polyacrylamide 
1% SDS 
pH 8.8 
10x Glycine running buffer: 
0.25M Tris base, 
1.92M Glylcine 
1% (w/v) SDS. 
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2x Loading buffer: 
Tris-HC1 12.5 mM pH 6.8 
4% (w/v) SDS 
20% (v/v) glycerol 
2% 13 mercaptoethanol 
bromophenol blue in deionized water 
Fixation solution:  
40% methanol 
10% acetic acid 
Blu Coomassie solution:  
40%Trichloric acetic acid 
10% methanol 
0.2% Blue coomassie 
An equal volume of 2x loading buffer was added to 10-20 i.tg of chromatin. The 
sample was boiled at 95 °C for 5 minutes and chilled on ice for 2 minutes before 
being loaded on SDS polyacrylamide gel. Elecrophoresis was performed for one 
hour at 40 mA. The gel was fixed for 30 minutes / 1 hours in fixation solution and 
stained for 30 minutes at room temperature with light rocking in Blue Coomassie 
solution. Decoloration was performed with fixation solution until the bands of 
interest were not clearly visible. Gels were dried for 45 minutes at 80 °C in a gel 
drier. 
2.10 Cells culture 
2.10.1 Transformed cell lines 
Abelson transformed pre-B cell (AB1028) and Mature B cell (WeHi) lines were 
grown in RPMI 1640 media (Sigma) with 10% foetal calf serum (Sigma), 2 mM 
glutamine (Gibco), 50 µg/m1 gentamicyn (Sigma), 50 µM 13-mercaptoethanol 
(Sigma). All cultures were grown at 37 °C. 
The AB-1028 non-transgenic pre-B cell line was generated in the laboratory by 
Andrew Georgiou. Primary pre-B cell cultures from non-transgenic foetal livers 
were grown in the presence of interleukin-7 (IL-7) for 5-7 days. The cells were then 
split and transferred onto irradiated ST-2 stromal cell feeder layers. After a total of 
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12-15 days in culture, transformation of the pre-B cells with Abelson leukaemia 
virus (Waneck and Rosenburg, 1981) was carried out as described in Sabbattini et 
al., (1999). FACS analysis of the clone showed that the cells are —73% positive for 
both the surrogate light chain (SLC) component X5 and the B lineage specific 
marker CD45R (B220) (Fig.2.10.1). 
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Fig. 2.10.1 FACS analysis of Abelson-transformed non-transgenic pre-B cell (A) Unstained 
negative control. (B) Percentage of cells positive for the Lambda5 intracellular marker. (C) Double 
staining for Lambda5 and cell surface B220 markers. 
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2.10.2 Activation of primary foetal pre-B cell cultures from 
foetal liver 
In order to generate primary pre-B cell cultures from foetal samples, individual 
livers were dissected and homogenised by passing them through fine meshes. The 
cells were re-suspended in RPMI media with 15% foetal calf serum supplemented 
with IL-7 (2 ng/ml; R&D System) and cultured on 'y-irradiated ST2 stromal feeder 
layers. After a total of 12-15 days in culture, FACS analyses of bulk IL-7 dependant 
foetal liver cultures stained withµ heavy chain was carried out by A. Georgiou to 
determine their Ig expression status and also to asses the heterogeneity of the cell 
populations. There was some variation between different bulk foetal liver cultures, 
but in general the cells were found to be between 10-30% t+ and 95% B220+ and 
X5+. A representative FACS analysis is showed in fig. 2.10.2. 
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Fig. 2.10.2 FACS analysis of bulk foetal liver primary pre-B cell cultures (A) Percentage of bulk 
IL-7 dependant foetal liver cells positive for the Lambda5 intracellular marker and B220 cell surface 
marker. (B) Double staining for Kappa (x) and Mu (11.) intracellular markers. 
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2.10.3 Activation of primary mature B cell cultures 
Activated B cells were generated from non-transgenic spleens dissected from 
wild type mice. The spleens (3-5) were homogenised by passing through a fine sieve 
and re-suspended in 20m1 of RPMI media. Cells were purified on Ficoll and then re-
suspended in RPMI 15% foetal calf serum supplemented with LPS (2 ng/ml) at a 
final concentration of 0.5 x 106 cells/ml. After Ficoll the cell population is 
constituted mainly from B lymphocite (60%) and T cells (35%). After activation for 
three days with LPS, the cell population was constituted 95% from B lymphocites. 
FACS analysis was carried out by A. Georgiou on several samples during 
ottimization of the activation protocol. Cells were found 98% positive for the B cell 
specific surface marker B220 and negative for the T cell specific Thyl marker. They 
also showed to be 93% positive for Kappa (k) that, in mature B cells, is expressed 
on the surface (Fig. 2.10.3). 
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Fig. 2.10.3 FACS analysis of bulk LPS activated mature B cell cultures (A) Percentage of 
cells positive for the B220 cell surface marker and negative for the T cell specific Thyl marker. (B) 
Staining for Kappa (x) surface marker. 
2.10.4 ES cells 
E14 ES cells were cultured in 0.1% gelatin coated flasks on a 1-irradiated ST2 
stromal feeder layer. Culture medium was Dulbecco minimal essential medium 
(DMEM) supplemented with 15% foetal calf serum, 2 mM glutamine (Gibco), 50 
P-mercaptoethanol (Sigma), 2 mM non-essential amminoacids (Sigma), 2 mM 
sodium pyruvate (Sigma), 1.8 Unit/µl LIF (Leukemia Inhibitory Factor from 
Chemicon). 
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2.10.5 C3H10T1/2 cells 
C3H10T1/2 cells were expanded in complete expansion medium (CEM), 
constituted by DMEM (Dulbecco's Modified Eagle Medium) supplemented with 
10% FCS, 100 U/ml penicillin, 100 [tgr/m1 streptomycin, 2 mM glutamax, 2 mM 
non-essential amino acids (sigma) and 2 mM sodium pyruvate (sigma). Cells were 
kept below 80-90% confluency to preserve their multipotent status as from 
manufacture directions. 
Osteogenic differentiation was performed as in Peister et al., 2004 with minor 
modifications. 107 C3H10T1/2 cells were plated in 175 cm2 flasks and left overnight 
in CEM. The day after the medium was changed to IMDM (Iscove's Modified 
Dulbecco Medium) supplemented with 10% FCS, 10% HS, 100 U/ml penicillin, 100 
µg/ml streptomycin, 2 mM glutamax, 20 mM Pglycerolphosphate, 50 ngr/ml 
thyroxine, 1 nM dexamethasone and 0.5 µM ascorbate (all from Sigma). The media 
was changed two times per week for three weeks. The cells were then fixed for 
maximum 2minutes with 1% formalin and then stained for phosphatase activity. 
Adypocites differentiation was as well as in Peister et al., 2004, differentiation 
media was constituted from IMDM supplemented with 10% FCS, 10% HS, 
100 U/m1 penicillin, 100 psr/m1 streptomycin, 2 mM glutamax, 20 mM 
g 1 yc erolpho s ph at e , 5 psr/m1 insulin, 50 1.tM indomethacin, 10-6 M dexamethasone, 
0.5 p.M isobutyl methylxantine (IBMX). The medium was changed two times a 
week for three weeks. Cells were fixed with 10% formalin for 20 minutes and 
stained with 0.5% Oil Red 0 in methanol for 20 minutes. 
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2.11 Chromatin Immunoprecipitation (ChIP) 
2.11.1 Unfixed Chromatin preparation 
Preparation of unfixed chromatin and ChIP were carried out as previously 
described (Crane-Robinson et al., 1997; Hebbes et al., 1994; O'Neill and Turner, 
1995) with some modifications. 
Solutions (all the solution were supplemented with inhibitor cocktail tablets from 
Roche): 
1 X TBS: 
0.01 M Tris-HC1 PH 7.4 
3 mM CaC12 
2 mM MgC12 
5 mM sodium butyrate 
Digestion Buffer: 
50 mM Tris-HC1 PH 7.4 
1 mM CaC12 
4 mM MgC12 
5 mM sodium butyrate 
0.32 M sucrose 
Lysis Buffer: 
1 mM Tris-HC1 PH 7.4 
0.2 mM EDTA 
5 mM sodium butyrate 
Other solutions: 
PBS + 5 mM sodium butyrate 
25% sucrose in TBS 
50% sucrose in TBS 
1% NP40 in TBS 
108 cells for each sample were harvested and washed 3 times with ice cold PBS 
plus 5 mM Sodium Butyrate. Cell pellets were resuspended in 1 X TBS to a final 
concentration of 2 x 107 cell/ml. An equal volume of 1% NP40 solution and 1/2000 
of the volume of 100 mM PMSF were then added and the cells suspension was left 
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for 40-60 minutes to equilibrate on ice while stirring. After stirring on ice for 40-60 
minutes cells suspensions were homogenizer in a glass homogenizer (tight pestel) 
with nuclei extrusion. Homogenates were centrifuged at 600 rcf for 20 minutes at 
4°C. The pellet was resuspended in 25% sucrose in TBS (20 ml) and 2 ml of 50% 
sucrose in TBS were underlined below. After centrifugation at 1500 rcf for 20 
minutes at 4°C, the nuclear pellet was washed once in 25% sucrose in TBS and 
resuspended in digestion buffer to a concentration of 0.5 mg of DNA/ml. Chromatin 
was released from the nuclei by digestion with micrococcal nuclease (15 U/ml) for 5 
minutes at 37 °C. 
Digestion was stopped by addition of EDTA to a final concentration of 5 mM and 
by cooling on ice. Samples were centrifuged at 11600 rcf for 10 minutes, the 
supernatant (Si) was recovered and the pellet was resuspended in lysis buffer 
(1-2m1), left for 30 minutes at 0 °C and then frozen overnight at -20 °C to complete 
nuclei lysis. Si was kept overnight at 4 °C after addition protease inhibitor. The day 
after the samples in the lysis buffer were centrifuged at 4000 rpm in eppendorf tubes 
and the second supernatant (S2) was collected. Chromatin concentration was 
determined by UV reading at 260 nm. MNase digestion was assessed on a 6% 
acrylamide gel or on a 1.2% agarose gel (Fig. 2.11.1). Evetually S1 and S2 were 
mixed together and used for the immuno precipitation. Proteins were also routinely 
checked by SDS PAGE as described in section 
Fig.2.11.1 Native ChIP. (A) Agarose gel (1.2%).Chromatin extracted by micrococcal nuclease 
digestion (DNA-histone complexes) of nuclei from primary pre-B and mature B cells. S 1 fraction 
showed to be constituted mainly by mononucleosome (MN). S2 fraction composition ranged between 
mono nucleosome and tri nucleosome arrays. (B) Denaturing protein gel. Proteins were extracted 
from micrococcal digested chromatin as described in sec 2.9 and run on a 12% separating gel to 
control the presence and the equimolarity of all the four core nucleosome. 
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2.11.2 Immunoprecipitation of unfixed chromatin (N-ChIP) 
Solutions (all the solution were supplemented with inhibitor cocktail tablets from 
Roche): 
ChIP buffer 1: 
50 mM NaC1 
1 0mM Tris-HC1 PH 7.4 
10 mM sodium butyrate 
1 mM EDTA 
ChIP buffer 2: 
100 mM NaC1 
10 mM Tris-HC1 PH 7.4 
10 mM sodium butyrate 
1 mM EDTA 
ChIP buffer 3: 
150 mM NaC1 
10 mM Tris-HC1 PH 7.4 
10 mM sodium butyrate 
1 mM EDTA 
Protein A agarose beads: before use protein A agarose beads were precleared as 
follows. 100 µI beads stock per IP sample were washed 2 times with ChIP buffer 1 
and then incubated with lml ChIP buffer 1 containing 1 mg/ml BSA and 1 mg/ml 
salmon sperm DNA for lhour with rotation. After incubation beads were spin down 
at 1200 rpm for 5 minutes and resuspended in 200 p1 of Chip buffer 1 per IP. 
150 lig of unfixed chromatin were used for each immunoprecipitation. Samples 
were adjusted to 1 ml with ChiP buffer 1 and were pre-cleared with 200 µ1 of 
Protein A agarose beads each. The samples were left for 1 hour on a rotating 
platform at 4 °C. After 1 hour they were centrifuged at 1400 rpm for 5 minutes. 
50-100 µ1 of pre-cleared chromatin were taken as input material. 
Immunoprecipitations were carried out overnight with rotation at 4 °C. 
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Immunoprecipitation: 
150 ttg of chromatin were immunoprecipitated with: 
50 ill of anti acetyl histone H4 serum (Upstate cat. numb. 06-866) 
50111 of anti dimethyl histone H3 lysine 4 serum (Upstate cat. numb. 07-030) 
20 pl of anti diacetylated histone H3 (200mgr pack Upstate cat. numb. 06-599) 
15 [tg of normal IgG as a control for aspecific immuno-precipitation (Santa Cruz 
Biothecnology). 
A no antibody sample was also included. 
Antibody Host Type Specificity 
Anti acetyl histone H4 rabbit polyclonal Histone H4 acetylated at lysines 
5,8,12 and 16. 
Anti acetyl histone H3 rabbit polyclonal Histone H3 acetylated at lysines 
9 and 14 
Anti dimethyl histone H4 lysine 4 rabbit polyclonal Histone 	H3 	dimethylated 	at 
lysine 4 
Tab. 2.10.2 List of antibodies used in unfixed chromatin immunoprecipitation. Data from Upstate 
(http://www.upstate.com). 
After overnight incubation, 200 µl of protein A agarose beads were added to the 
samples. Samples were left on the rotating platform for 3 hours, and then 
centrifuged for 5 minutes at 1400 rpm. The supernatant was discarded and the pellet 
was washed 1 time with 1.5 ml ChIP buffer 1, 1 time with 1.5 ml of ChIP buffer 2 
and two times with 1.5 ml of ChIP buffer 3. 
The bound fraction was eluted twice with 250 Ill of ChIP Buffer 1 with 1% SDS 
for 15 minutes on rotating wheel at room temperature. DNA was extracted two times 
with phenol/chloroform, ETOH precipitated and resuspended in 100 pi of tris 
10 mM. Glycogen (0.1 14) was added to each sample before ETOH precipitation to 
facilitate visualization of the pellet. DNA concentration was determined by Pico 
green as described in section 2.3.6. 
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2.11.3 Fixed Chromatin preparation 
ChIP of formaldehyde-cross-linked chromatin was carried out essentially as 
described by (Soutoglou and Talianidis, 2002). 
Solutions (all the solution were supplemented with inhibitor cocktail tablets from 
Roche): 
Swelling buffer 
25 mM Hepes pH 7.9 
1.5 mM MgC12 
10 mM KC1 
0.1% NP-40 
Sonication buffer 
50 mM Hepes pH 7.9 
140 mM NaC1 
1 mM EDTA 
1% Triton X-100 
0.1% Na-deoxycholate 
0.1% SDS 
Wash buffer A  
50 mM Hepes pH 7.9 
140 mM NaC1 
1 mM EDTA 
1% Triton X-100 
0.1% Na-deoxycholate 
0.1% SDS 
500 mM NaC1 
Wash buffer B  
20 mM Tris pH 8.0 
1 mM EDTA 
250 mM LiC1 
0.5% NP-40 
0.5% Na-deoxycholate 
100 
Elution buffer 
50 mM Tris pH 8.0 
1 mM EDTA 
1% SDS 
Protein G sepharose beads: before use protein protein G sepharose beads were 
precleared as follows. 100 IA beads stock/IP sample were washed 2 times with 
sonication buffer and then incubated with lml sonication buffer containing 1 mg/ml 
BSA and 1 mg/ml salmon sperm DNA for 1 hour with rotation. After incubation 
beads were spin down at 1200 rpm for 5 minutes and resuspended in 200 gl of 
sonication buffer. 
1 x 108-3 x 108 cells for each sample were harvested and crosslinked by addition 
of formaldehyde to the medium to a final concentration of 1%. After 10 minutes 
incubation at 37 °C, the reaction was stopped by adding glycine to a final 
concentration of 0.125 M. Cells were incubated at RT for 5 minutes, and then 
washed 3 times with ice-cold PBS plus protease inhibitors. Cells were resuspended 
in 10m1 of swelling buffer, chilled on ice for 10 minutes and homogenized in a glass 
homogenizer (tight pestel) with nuclei extrusion. The nuclei samples were 
centrifugated at 5000 rpm for 5 mM at 4 °C and resuspended in sonication buffer. 
Chromatin was sonicated by using Soniprep 150 equipment to obtain DNA 
fragments of approximately 400-500 bp (Fig 2.11.3). After sonication the chromatin 
sample was spin at 14000 rpm for 15 minutes at 4°C, the supernatant was recovered 
and spin again. Chromatin was then used for immunoprecipitations. 
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Fig.2.11.3 Fixed ChIP. Agarose gel (1.2%). (A) Chromatin before revarsal of cross linking from 
ES cells and C3H10T1/2 cells. (B) ES cells DNA after reversal of cross linking and 
phenol/chloroform extraction. Fragment size ranges between 100 and 500bp. 
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2.11.4 Immunoprecipitation of fixed chromatin (X-ChIP) 
The total amount of chromatin needed for several immunoprecipitations (variable 
between 125 to 500 jag for each sample depending on the antibody used) was pre-
cleared with protein-G-Sepharose beads. Chromatin was spin at 1300 rpm for 5 
minutes, the supernatant was collected and the concentration adjusted to 500 µg/ml. 
Immunoprecipitations were carried out in 1 ml, 500 iu,1 or 250 µI depending on the 
efficiency of the antibody used. 1/10 of the material used for the 
immunoprecipitation was kept aside as input. Immunoprecipitations were carried out 
overnight with rotation at 4°C with the following antibodyes: 
Immunoprecipitations carried out with 125µgr of chromatin (in 250µ1 volume): 
12.5 µ1 anti dimethylated histone H3 lysine 4 serum (Upstate, cat. numb. 07-030) 
12.5 lag antibody diacetylated histone 113 (200gr pack, Upstate, cat. numb. 06-599) 
Immunoprecipitations carried out with 2501.tg of chromatin (in 500µ1 volume): 
25 lig anti trimethylated histone H3 lysine 9 (Upstate, cat. numb. 07-442) 
125 IA anti H3K9me3/phSerlO (200µ1 pack, Abcam, cat. numb. ab5819) 
25 µg anti-rabbit immunoglobulin G (IgG) (Santa Cruz Biothecnology) 
Immunoprecipitations carried out with 500µ,g of chromatin (in lml volume): 
50 µg anti dimethylated histone H3 lysine 9 (Upstate, cat.numb 07-441) 
50 µg anti Flag (Sigma) 
A no antibody, sample was also included. 
Antibody Host Type Specificity 
Anti acetyl histone H3 rabbit polyclonal Histone H3 acetylated at lysines 
9 and 14. 
Anti dimethyl histone H4 lysine 4 rabbit polyclonal Histone 	H3 	dimethylated 	at 
lysine 4 
Anti dimethyl histone H3 lysine 9 rabbit polyclonal Histone 	H3 	dimethylated 	at 
lysine 9 
Anti trimethyl histone H3 lysine 9 rabbit polyclonal Histone 	H3 	trimethylated 	at 
lysine 9 
Anti H3K9me3/phSer10 rabbit polyclonal Histone H3 phosphorylated at 
residue 	serine 	10 	and 	tri 
methylated at residue lysine 9 
Tab. 2.10.4 List of antibodies used in fixed chromatin immunoprecipitation. Data from Upstate 
and Abcam (http://www.upstate.com, http://www.abcam.com). 
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Immunoprecipitated samples were recovered as described in section 2.9.2. 
Washes were performed twice with sonication buffer, twice with wash buffer A, 
twice with wash buffer B and twice with TE before eluting two times with 250 pl of 
elution buffer. 
After elution cross link was reversed adding 16 p,1 5M NaC1 and 1µl 10 mg/ml 
DNase-free RNase A to the combined eluates and the input sample and incubating 
overnight at 65 °C. The day after 5 1.1.1 of 10 mg/ml proteinase K were added and 
samples were incubated for 2 hours at 45 °C before phenol/chloroform extraction 
and ETOH precipitation. Glycogen (0.1 µg) was added to each sample before ETOH 
precipitation to facilitate visualization of the pellet. DNA concentration was 
determined by Pico green as described in section 2.3.6. 
2.12 Real time PCR 
Real time PCR amplifications were performed on DNA Engine Opticon system 
(MJ research, Inc.). Reactions were set up in 20 p.1 using SYBR Green PCR Master 
Mix (Applied Biosystem). Reactions were carried out in duplicates on 2 ng of DNA 
for N-ChIP and 2µl of DNA for X-ChIP. 
2.12.1 Primers 
Primers across the 2.5-VpreB1 locus and for housekeeping and tissue specific 
genes were designed by using Primer Select or Primer Express software. The 
sequence of the entire 19-kb AS-VpreB1 locus has been determined elsewhere 
(accession number AJ852426; Minaee et al., 2005). The positions of the primers in 
the locus were calculated relative to that of an EcoRI site 2.8 kb upstream from the 
initiation site for VpreBl. 
Sequences, concentrations, and annealing temperatures are shown in table 2.10.1a 
and table 2.10.1b. The thermal cycling conditions were as follows: initial 
denaturation at 95 °C for 10 minutes, followed by 40 cycles at 95 °C for 15 seconds, 
annealing at a primer-dependent temperature for 15 seconds, and extension at 72 °C 
for 15seconds. For each experiment, the threshold was set to cross a point at which 
real-time PCR amplification was linear (0.02 to 0.05 for the majority of the 
experiments). See also section 3.4. 
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Primer Primer sequence (5' - 3) Position Conc.Annealing 
(kb) 	(nM) temp. (C) 
Primer Primer sequence (5' - 3') Position Conc. Annealing 
(kb) 	(nM) temp. (C) 
1 TTC TTT GCC ACA CCT CAC TAA T 0.204 900 52 29 GGA TAG ACT TTG CAT GTT TIT GAT 7.285 400 52 
2 CCT TTT GGG GCT CCT CA 0.31 900 52 30 GGG GGA TAT TAC CTG CTC TTT 7.394 400 52 
3 TGC CGG TCA CAG GTC AG 0.522 900 57 31 TGG ATA TCA GTC AGG CAG AG 7.869 900 60 
4 GAT GGC TCA GCG CTC TTA CAA 0.623 900 57 32 CCC GGT TGT GGT TGG 7.968 900 60 
5 TAC CCA AGT TTT CTC CTA ATC TGC 0.856 900 57 33 CTA AGA GGA GGG GGC TGT GC 8.487 900 70 
6 GGC CTG CGG TIT GCG TTC T 0.974 900 57 34 GGA GGT GGG CTA TGG ATG TGG 8.586 900 70 
83 AGT CCG AGA ACA GCC TGG GT 0.888 400 68 35 TCA GCA ACC ATT CAT CTA CTA TCA 9.001 900 65 
84 AGT TGT GCT GCC CAC AGA GG 0.998 400 68 36 CCT GCC TCT TCC TCC CAA CT 9.119 900 65 
708 ITTATITTTATTTGATATGCATTGGTGIT 1.587 900 57 37 AGG CCC TAA CAG Ca CAT CTA CTC 9.777 400 55 
808 ATA TGG CAG CTC ACA ACT ATC CC 1.665 400 57 38 GCA TCT GGG CCT CGG TIT A 9.894 900 55 
II TAG AAG GTT GAG ACA GCG AGT TAG 1.831 900 58 39 GGC TGC ACC TGG AAA ACC TTA 11.701 900 55 
12 AGG TGC ITT GTT TTG TTT TGT CM' 1.934 900 58 40 Alt AAA ATC TIC CCC TCA ATC TGT 11.801 400 55 
13 CAA ACC CAG AGC CAC AAA G 2.759 900 62 43 AGG AGA CCA GAA GGG GCA GTT 13.382 900 53 
14 GGG GAG AGG GTC ACT GC 2.875 900 62 44 GGT TCA ATG TIT AAG AGC AAG TIT 13.491 900 53 
15 GGG CTT CTT TGC TCC TCC TAT GG 3.027 900 60 45 ACC TIT GCT TTC 'LTG Trc Ti• 14.357 900 50 
16 GAA GAT GCT AAT GGT GGC TGA TGC 3.137 900 60 46 TTG AAA TTT TTA GGG ACT GTG AGA 14.456 900 50 
17 CAA GTG ACA GGT GTG GAG CAA GTT 3.939 900 60 47 CAC AGA AGA GCA GAG AAC AGA 15.322 900 60 
18 GGA GAG CAC ACC CCA GTA GGA TTA 4.046 900 60 48 CAC CCC ATG AGA CAA CCA G 15.432 900 60 
19 GTG ACA GAC CCG TTA CCA A 4.445 900 52 49 ACC CAG TAA GCA AGT TTT CA 16.262 900 55 
20 AGA AAG AGA AGG GGA AAA AGA G 4.589 400 52 50 ATA AGC TCT CCT CCC TCA AG 16.372 400 55 
25 TCC CCA TTG CCA GAT AGA GAC ACA 5.434 900 61 51 TGG AGT ATG AGG CAG TGA TTG TTA 16.731 400 53 
26 TGG GCC CAA CAG ATT AAC ACA GAG 5.538 900 61 52 AGA GTT TTG ACG GCT TCC AGA 16.861 900 53 
27 TGA CTT GCT TGT GCT TGC CTG GAC 5.732 400 58 53 TGT AAG CTC CTG TAT TM GTT TIT 16.977 900 54 
28 ATA ATA ACA AAG TAC TGA GAA AAC 5.841 900 58 54 GCC CTA CAG AGC TTT TGG AGA 17.103 900 54 
57 TGG ATA ACT GCA GGA AGC TGT 6.608 600 68 55 ACC CCT CCC TCC CCG TAT G 17.927 900 62 
58 GCA GTG CCA GAT CTC CAG AC 6.728 600 68 56 TCC TTC CCT GAC CAC TCC 18.031 900 62 
Table 2.12.1a Sequence and position of PCR primers across the 25-VpreB1 locus. Positions in 
kilobases correspond to the 5' end of each primer pair. Primer pairs 708/808, 13/14 and 31/32 were 
respectively in the Topo3/3, VpreB1 and 25 promoters. 
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gene Primer Primer sequence (5' - 3') 
Position 
(kb) 
Conc. 
(nM) 
Annealing 
temp. (C) 
forward GCA GGC CTA GTA ACC GAG ACA 400 
13 actin-p -336 61 
reverse AGT TTT GGC GAT GGG TGC T 400 
forward TCC TGG CCT CAC TGT CCA C 400 
13 actin-t +2832 62 
reverse GTC CGC CTA GAA GCA CTT GC 400 
forward AGT CCG GAT TGG CTG TGA GT 400 
132-m-p 
reverse GAA GCG ACC GCG ACT GAA 
-54 
400 
61 
forward CTG ATA CAT ACG CCT GCA GAG TTA A 400 
132-m-t +3408 61 
reverse TGG AGC GTC CAG AAA GTA AGG 400 
forward TTT ATT TIT ATT TGA TAT GCA TTG GTG TT 900 
Topo313-p -477 57 
reverse ATA TGG CAG CTC ACA ACT ATC CC 400 
forward AGT CCG AGA ACA GCC TGG GT 400 
Topo313-t +276 65 
reverse AGT TGT GCT GCC CAC AGA GG 400 
forward GAG GTC AGT ACA GGC TGG AGG A 400 
MyoD-p -308 61 
reverse GAG GGC AGA GAG ACT GGC AG 400 
forward GGG CAT CCC TAA GCG ACA 900 
MyoD-t +1806 62 
reverse CAC CTG ATA AAT CGC ATT GGG 900 
forward TTT GCT TTT GCG CAG AAT CC 400 
NFL-p -152 61 
reverse TAT ACG CCG GGA CTC TGA CG 400 
forward CTC CTA CTT GAT GTC TGC TCG CT 400 
NFL-t +2723 61 
reverse CAG CTT TCG TAG CCT CAA TGG 400 
forward TIT CTC TTT GGA ATG GTG CAA TAC A 900 
Amy-p -337 61 
reverse GTG ACC TCC ACC AAC CCG TA 900 
forward ATG TTC GTA CCA AGG TGG CTG 400 
Amy-t +2701 61 
reverse TAT GTC TCC AGG CCA CAT GTG 400 
forward CAA ACC CAG AGC CAC AAA G 900 
VpreBl-p -61 62 
reverse GGG GAG AGG GTC ACT GC 900 
forward GGG CTT CTT TGC TCC TCC TAT GG 900 
VpreB1-t +207 60 
reverse GAA GAT GCT AAT GGT GGC TGA TGC 900 
forward TGG ATA TCA GTC AGG CAG AG 900 
k5-p -473 60 
reverse CCC GGT TGT GGT TGG 900 
forward AGG CCC TAA CAG CTT CAT CTA CTC 400 
A.5-t +1731 55 
reverse GCA TCT GGG CCT CGG TIT A 900 
forward GAT CGC TAG CTT CCT GTC GC 300 
Blimpl-p -312 61 
reverse CGA AGT CGT CGG TCC TGT AA 300 
Pax5-p 
forward AAA GTG GAA ACT TTT CCT CGC TGT C 
-255 
400 
57 
reverse AGT AAG CAT GGA TGA ATC CCG TTT C 400 
Table 2.12.1b Sequence and working conditions for housekeeping and tissue-specific genes. 
Position of the amplicons is given respect to the transcription start site as obtained from Sanger 
genome data base www.ensembl.org. For the 32 microglobulin gene (52-m) the position of the 
primers are as in Lonergan M. et al. (1993) Mol Cell Biol 13: 6629-6639. "P" indicates promoter and 
"t" transcribed regions. Primer pairs Topo3P-p, Topo3P-t, VpreBl-p, VpreB1-t, X.5-p and A.5-t 
correspond respectively to primer pairs 708/808, 83/84, 13/14, 15/16, 31/32 and 37/38 in table 
2.10.1a. MyoD=myoblast determination protein 1; Nfl=neurofilament light chain; Amy2=pancreatic 
a-amylase; PaxS=paired box gene 5, Blimpl.B -lymphocyte-induced maturation protein 1. 
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2.12.2 Data Analysis 
Real-time PCR reactions were performed with the same amount of material for 
the immunoprecipitated and for the input sample used as a reference standard. To 
determine the enrichment of the immunoprecipitation for a specific antibody in a 
specific region, the relative abundance for each primer pair amplicon was 
determined from the difference in the number of PCR cycles necessary to reach a 
fixed threshold. Values were determined by dividing the amount of target sequence 
in the immunoprecipitated fraction by the amount of target sequence in the input 
DNA. 
The amount of DNA produced in any PCR reaction can be described by the 
formula X=X0 2ct where X and Xo are respectively the final and the initial DNA 
concentration of a target sequence and Ct is the number of cycles. The number of 
cycles required to reach the value X is inversely related to the initial target sequence 
concentration Xo. 
X(Input)= Xo(Input) 2CtInput 
X(IP)= Xo(IP) 2CtIP 
If data are collected at a fixed threshold value the final concentration X became a 
constant and X(Input)=X(IP). 
Therefore, for the same target sequence 
X0(IP) 2ctIP = Xo(Input) 2CtInput from which: 
Fold Difference = Xo(IP) / X0(Input) = 2(CtInput-CLIP) 
The threshold value is set as the point in which the PCR reaction enters the linear 
range. Errors bars have been calculated as standard deviation on the whole set of 
value obtained for every single target sequence. 
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3. Patterns of histone H3 and H4 acetylation and H3 
K4 dimethylation across the X.5-VpreB1 locus in 
pre-B and mature B cells 
3.1 Introduction 
Chromatin is a highly flexible structure that regulates gene expression through 
spatially and temporally coordinated changes between transcriptionally 
repressive/condensed states, and active/accessible states. Histone proteins, which are 
important structural components of this architecture, are now recognised for their 
central role in maintaining this dynamic equilibrium. Many studies have pointed to 
the flexible, N-terminal histone tails as targets of numerous post-translational 
modifications that can either activate or repress transcription, depending on the type 
of chemical modification and its location. This has led to the "histone code" 
hypothesis, which envisions that patterns of histone modifications could alter 
chromatin structure and promote recruitment of effector molecules recruitment. 
Recently, there are many indications pointing to histone modifications as important 
players in the maintenance of ES cell pluripotency and in the specification of their 
differentiation potential (Szutorisz et al., 2005; Vieira et al., 2004). 
Some of the major questions in developmental biology concern how fate choices 
are made, what determines patterns of gene expression and how, in early precursor 
cells, information about activation, or silencing, at later stages are conserved through 
cycles of self renewal. The aim of this project was to study the chromatin structure 
of the 2S-VpreB1 locus in different silenced states. The A5 and VpreB1 genes are 
activated at the pro-B cell stage and are transcribed in pro- and pre-B cells before 
being silenced during the transition to the immature B cell stage (Dul et al., 1996; 
Karasuyama et al., 1994; Kudo and Melchers, 1987; Sakaguchi and Melchers, 
1986). The tight stage-specific control that the genes are subjected to render this 
domain particularly suitable for the investigation of developmental silencing. Our 
goal was to characterise the silenced state of the locus in early precursor cells with 
different levels of plasticity and to assess whether the features of silenced states of 
the domain could be influenced by early fate decisions. For this purpose a chromatin 
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immunoprecipitation assay followed by real-time PCR analysis was used to analyse 
histone modifications linked with active and inactive chromatin across the domain. 
3.2 Overview of ChIP 
The most powerful tool that is available to investigate the in-vivo distribution of 
histone modifications across defined genomic regions is chromatin 
immunoprecipitation (ChIP). Technically there are two major variations in the ChIP 
protocol that differ in how the starting material (input chromatin) is prepared. Native 
chromatin immunoprecipitation (N-ChIP) uses chromatin prepared by micrococcal 
nuclease (MNase) digestion of cell nuclei. Cross linked chromatin 
immunoprecipitation (X-ChIP) uses chromatin cross-linked by the addition of 
formaldehyde to growing cells and fragmentation of the DNA by sonication. 
Histone proteins, which are tightly bound to the DNA, can be investigated both by 
X-ChIP and by N-ChIP. Non-histone proteins can only be analysed by X-ChIP since 
they are not retained on DNA during nuclease digestion. Both methods have 
advantages and disadvantages. N-ChIP allows a better control of the average size of 
the fragments generated. The length of the nucleosome arrays can be modulated by 
modifying the amount of MNase and the time of exposure. Resolution can be further 
increased purifying mono-nucleosome particles on a sucrose gradient. Control over 
the size of the generated fragments is very important since this represents a 
fundamental step to assure reproducibility of the experiments. However, it should 
also be noted that there is a risk of bias caused by selective nuclease digestion and 
over-digestion that can deplete specific regions from the input chromatin. Another 
disadvantage is that some of the nuclease-digested chromatin might be difficult to 
recover. Part of the material (in particular the bigger fragments) is trapped into the 
insoluble residual fraction left after the first extraction step. The amount of 
chromatin trapped in this fraction can be reduced incubating the nuclear pellet with 
hypotonic lysis buffer at 0 °C for half an hour followed by overnight freezing at 
-20°C. This procedure causes first the swelling of the nuclei and then their lysis, 
releasing most of the chromatin. 
It has been shown that, in vitro, the histone octamer is capable of sliding along 
the DNA over significant distances in a temperature and salt dependent manner 
(Flaus et al., 1996; Hamiche et al., 2001; Meersseman et al., 1992). Therefore it is 
important to have tight control both of the temperature and of the salt content of the 
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solutions used to prevent chromatin rearrangement. One of the main advantages of 
N-ChIP is that most antisera are raised against un-fixed, synthetic peptide antigens 
and the epitopes they recognize may be masked or destroyed by formaldehyde 
treatment. However, proteins that bind weakly or indirectly to DNA can only be 
analysed by X-ChIP and formaldehyde treatment has been widely used in recent 
years. 
There are obviously some issues that need to be addressed when using X-ChIP. 
One of the most important parameters is the time of exposure to the cross-linking 
agent. The most widely used time of cross-linking for the analysis of nucleosomal 
proteins is 10 min at a concentration of formaldehyde of 1% of the total volume 
(Kuo et al., 1996; Solomon et al., 1988). Longer exposure and higher concentrations 
of formaldehyde may leads to poor yield of inmiunoprecipitated (IP) material. Two 
potential problems should be considered; prolonged crosslinking might favour the 
binding of nucleosome associated proteins, thereby masking histone epitopes. It is 
also important to consider the chemistry of the reaction. Formaldehyde is a dipolar 
compound with a nucleophilic carbon atom that can react very quickly to form a 
Schiff base with the amino and imino groups of lysines, arginines and histidines, on 
amino acids, and adenines and cytosines on DNA. This means that some epitopes 
might be lost because of the engagement with formaldehyde reactive sites. 
Formaldehyde is also a moderate denaturing agent for proteins and it is known to 
interfere with secondary and, particularly, tertiary structures that could result in 
unfolding of the protein of interest. 
Another parameter to be considered when adjusting fixation conditions is the 
susceptibility of the fixed material to mechanical shearing. Over-fixation leads to 
poor chromatin preparations since it becomes very difficult to sonicate the DNA to 
the desired length. Formaldehyde treatment of chromatin can also fix temporary 
superstructures such as loops (Fig. 3.2.1) and produce misleading positive results. 
Sequences not marked by the investigated modification can be immunoprecipitated 
because they become linked to the target sequence by crosslinked proteins. 
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Fig. 3.2.1 Sequences not carrying any modification (green) can be crosslinked to the modified 
ones (red). This will cause them to be immunoprecipitated, creating a false positive result. 
Another parameter that has to be considered is antibody specificity. ChIP grade 
antibodies purchased from Upstate LTD and Abcam LTD were tested for specificity 
by western blot and/or ELISA. To reduce the level of background in both fixed and 
native ChIP, respectively protein G and A beads were treated, prior to use, with 
BSA and salmon sperm DNA. Also, before elution the beads-immunoprecipitated 
sample complex was washed several times with buffers at increasing ionic strength. 
High salt concentration disrupts weak non-specific binding. 
3.3 Data analysis 
Immunoprecipitated material from X-ChIP and N-ChIP was analysed by 
real-time PCR and enrichment values were obtained from C(t) readings. Two 
different approaches were chosen depending on which experimental procedure was 
followed. When performing N-ChIP experiments levels of immunoprecipitated and 
input DNA were quantified by Pico Green (Molecular Probes) fluorescent dye and 
duplicate PCR reactions were carried out using 2ng of DNA per reaction. A typical 
output is shown in Fig. 3.3.1. The C(t) value was calculated from the intersection of 
the curve of interest with a manually set threshold (intensity of fluorescence 
corresponding to the beginning of the exponential phase of the PCR reaction). 
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Fig.3.3.I Typical output from a real time PCR experiments. Samples were run in duplicates, input 
is in green and yellow while the immunoprecipitated sample is in blue and red. The C(t) values 
relative to primer pair 83/84 (Topo.3(3 transcribed region) are indicated below. PPB is abbreviation for 
primary pre-B cells. Immunoprecipitation was carried out with anti dimethyl lisine 4 histone H3 
antibody (H3K4me2). 
C(t) 	 C(t) 
(green) 83/84 PPB input 24.71757 	 (red) 83/84 PPB H3K4me2 21.67311 
(yellow) 83/84 PPB input 24.78094 	 (blue) 83/84 PPB H3K4me2 21.59698 
As described in section 2.12.2 of material and methods, the ratio between the 
fraction of target sequence in the immunoprecipitated sample and the fraction of 
target sequence in the input DNA (fold enrichment) can be calculated by the 
formula: 
Xon)/ Xoinput — 2[C(t)input - C(t) IP] 
A fold enrichment equal to 20 would imply that in 2ng of immunoprecipitated 
samples there is 20 times more target sequence than in an equal amount of starting 
material. 
When performing X-ChIP a different approach was chosen to analyse the data. 
After ethanol precipitation input and immunoprecipitated samples were dissolved in 
the appropriate volumes, DNA was not quantitated and PCRs were performed with 
21.0 of each sample. The percentage of the input immunoprecipitated with the 
specific antibody was calculated with an equation similar to the one described in sec 
2.10.2. 
X0IP/ X0input = 2[C(t)input - C(t) IP]  
A correction term was added to take into account the volumes in which input 
(Vmput) and immunoprecipitated (VIP) samples were dissolved and the fact that only 
1/10 of the total volume used for the specific immunoprecipitation was taken as 
input material (see section 2.11.4 matherial and methods). 
Xow/ &Input (%) = 1[2(c("inPut- C(t) 	x [VIP/1O x  Vinpntl  }x 100 
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The values obtained represent, for each target sequence, the percentage of the 
input that has been immunoprecipitated. 
The volume method allows detection of modifications that are widespread across 
the genome more efficiently than when equal amounts of DNA are used. When a 
modification is widely present in the genome the sequence profile of the IP sample 
will be similar to that of the input material and, therefore if equal quantities of DNA 
are analysed by PCR, the enrichment will not be not detectable. The volume method 
also allows the analysis of modifications that are present at very low level; very 
small percentages of immunoprecipitated input can be detected. Obviously when the 
percentage of immunoprecipitated sequence is very low, it is important to have good 
negative controls to validate the result. Appropriate controls include 
immunoprecipitations with non-specific antibodies or with no-antibody. 
3.4 Primers 
The first step that was necessary to investigate histone modifications in the 
A5-VpreB1 locus was to generate a set of primer pairs evenly spaced across the 
domain so that the distance between two adjacent primer sets would be less than 
lkb. Primers were positioned in crucial regions of the domain such us hypersensitive 
sites and promoters (Fig. 3.4.1). A total of 60 primer pairs were tested from which a 
final set of 25 was chosen. Optimal design of the PCR primers was essential for 
accurate and specific quantification by real-time PCR. Detection is based on the 
binding of SYBR-Green dye into double stranded PCR products, a sequence-
independent process. The sensitivity of detection using SYBR-Green may be 
compromised by the formation of primer-dimers, by lack of specificity of the 
primers and by the formation of secondary structures in the PCR product. These 
factors could lead to the creation of non-specific double-stranded DNA products, 
which would incorporate SYBR-Green and register a fluorescent signal. The primers 
were selected by Primer Select software according to the following criteria: 1) 
minimal propensity to form 3' annealed primer dimers, 2) AG value of the 3' end of 
the primers to be as low as possible to minimise the probability of mis-priming. The 
average length of the amplicons was maintained below 120 bp since longer PCR 
products could lead to non-linear incorporation of the fluorescent dye therefore to a 
decreased accuracy of the quantification. 
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Optimization of primer concentration was essential to avoid primer-dimer 
formation; each set described here worked best under different conditions, which 
were identified by testing combination of different concentrations for each forward 
and the reverse primer following the scheme showed in table 3.4.1. 
Reverse Primer 
cone. (nM) 
Forward Primer conc. (nM) 
50 (nM) 300 (nM) 600 (nM) 900 (nM) 
50 (nM) 50/50 300/50 600/50 900/50 
300 (nM) 50/300 300/300 600/300 900/300 
600 (nM) 50/600 300/600 600/600 900/600 
900 (nM) 50/900 300/900 600/900 900/900 
Tab. 3.4.1. Optimal operative concentration for the forward and reverse primer was investigated 
by testing all the possible combinations showed in this table. 
Each primer pair was tested for all of the possible concentration combinations 
and the products were visualised on 1% agarose gels. The combinations giving the 
best yield were used in real time PCR experiment and the primer pairs showing the 
better signal/amplification efficiency ratio were chosen. Melting curves were also 
analysed to exclude non-specific amplification and primer-dimer formation in the 
presence of SYBR-Green. The position of the primers across the locus is shown in 
Fig. 3.4.1. The sequences, annealing temperatures and working concentrations are 
listed in table 2.12.1a section 2.12.1 matherials and methods. 
Topo33 	VpreB1 	
► 	
15 
	
OA 11.11 g=11 	a BO I I 	 IIB 	 I  
1. 	 1 	 t 	ft 	I 	 I 	t 	i 	I 	t 
12 11 10 	 9 8 7 6 5 4 	3 2 1 	HS 
Fig. 3.4.1 Position of primers in of the k5-VpreB I locus. Primer positions are shown as red 
vertical lines. Black arrows represent HS sites. The 26, VpreB1 and Topo313 genes are indicated by 
coloured boxes. 
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3.5 Analysis of histone H3 and H4 acetylation across the 
AS-VpreB1 locus in Abelson transformed cell lines 
Acetylation is thought to be able to activate transcription in two different ways, by 
direct inhibition of chromatin condensation and by generating a signal for the 
binding of general and/or specific transcription factors. The 25-VpreB1 locus is 
active in pro and pre-B cells and silenced at the immature B cell stage. Changes in 
the pattern of histone modifications during this transition could play an important 
role in the process of silencing the two genes, especially since positive regulators 
such as EBF and E2A are still present in immature and mature B cells. Histone 113 
and H4 acetylation patterns across the locus were initially investigated in Abelson 
transformed pre-B (AB-1028) and in the immature B cell line (We-Hi 231). These 
cells have the advantage that they can be easily grown in large numbers providing 
sufficient material for chromatin preparation. Chromatin was extracted by MNase 
digestion and immunoprecipitated with antibodies against di-acetylated histone H3 
and tetra-acetylated histone H4. In the pre-B cell line, histone H3 and H4 acetylation 
showed a pattern of peaks and troughs across the locus (Fig. 3.5.1 top panel). There 
were three main regions of H3 acetylation (red line), one of these was located 
between the Topo3fl and VpreB1 genes. A second region, which extended between 
VpreB1 and A5 consisted of two peaks, the first located on HS 8 and the second 
upstream of the 25 promoter. The third region was located in the 3'end of the A5 
gene. Histone H4 (blue line) presented a broadly similar pattern, with peaks between 
Topo3 fi and VpreB1, between VpreB1 and A5, and upstream of the A5 promoter. The 
3' region of the locus, containinging HS 1 to HS5 has been shown to be required for 
full expression of both genes in transgenic experiments (Sabbattini et al., 1999). 
However, despites its functional importance, the region showed only low levels of 
H3 and H4 acetylation. This result suggests that functional elements of this type can 
exert their effects without necessarily being subject to active histone modifications. 
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Fig. 3.5.1 Pattern of histone H3 (red) and histone H4 (blue) acetylation across the 25-VpreB1 
locus in the pre-B cell line AB 1025 and in the mature B cell line WeHi. Antibodies against anti 
acetylated histone H3 and anti acetylated histone H4 (both from Upstate) were used for the 
immunoprecipitations. On the y axis is shown the fold enrichment. The x axis represents the position 
of the amplicons across the A5-VpreB1 domain. Error bars indicate standard deviations relative to 
three different ChIP experiments. A locus map is shown below the plots; red vertical lines indicate 
amplicons positions, black arrows indicate the positions of the DNAseI hypersensitive sites. 
The 25 and VpreB1 genes and the neighbouring Topo3/3 gene are all expressed in 
pre-B cells. The promoter regions of these three expressed genes show a moderate 
level of acetylation but do not constitute peaks. Instead, peaks were located in the 
intergenic regions and at some of the HS. One explanation for the reduced degree of 
acetylation at promoters might be nucleosome depletion. Several independent 
studies (Bernstein et al., 2004; Liu et al., 2005; Sekinger et al., 2005) have observed 
nucleosome depletion at promoters in yeast suggesting that it might represent a 
fundamental feature of eukaryotic transcriptional regulation. However ChIP analysis 
of chromatin isolated from human cells with anti histone H3 antibody suggested that 
marked nucleosome depletion is not a feature of active mammalian chromatin 
(Bernstein et al., 2005). A recent study reported a correlation between nucleosome 
density in the vicinity of transcription start sites (TSS), histone H3 lysine 9 
acetylation and gene expression level. The authors suggested that nucleosome 
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density is low in proximity to TSS at promoters that are significantly enriched in 
histone H3 K9 acetylation, regardless of their transcriptional activation status 
(Nishida et al., 2006). 
Analysis of histone H3 and H4 acetylation was also performed on chromatin 
from the immature B cell line WeHi-231 (Fig. 3.5.1 bottom panel). H3 and H4 
acetylation were enriched only on the Topa313 gene, which is expressed in mature B 
cells, and were largely absent from the rest of the locus. 
The AS and VpreB1 genes are inactive in mature B cells, and the disappearance of 
histone modification marks suggest the formation of a repressive chromatin 
structure. Nevertheless the AS promoter appeared to be undermethylated in mature B 
cells and still accessible to restriction enzymes (Sabbattini et al., 2001). 
3.6 Analysis of histone H3 and H4 acetylation across the 
.15-VpreB1 locus in primary pre-B and mature B cells 
A similar analysis of histone H3 and H4 acetylation and H3K4 methylation was 
conducted on primary pre-B cells and LPS activated primary B cells (Fig. 3.6.1). 
Primary pre-B and mature B cells cultures were established and characterised by 
FACS analysis as described in material and methods (section 2.10.2 and 2.10.3). 
One of the main differences between the primary and transformed cells was that 
the levels of enrichment were much lower for both H3 and H4 acetylation for 
primary pre-B cells compared with the corresponding cell line. This was especially 
true for H4 acetylation. Expression studies have shown that AS and VpreB1 genes 
are slightly over expressed in the AB1028 cell line relative to primary pre-B cell 
cultures (Szutorisz, H., personal communication). Correlations between 
transcriptional activation and hyperacetylation have long been established 
(Braunstein et al., 1993; Hebbes et al., 1988; Jeppesen and Turner, 1993; Kuo et al., 
1998), and particularly between hyperacetylation and gene reactivation (Mariani et 
al., 2003) and hyperacetylation and induction of transcription (Parekh and Maniatis, 
1999). It is possible to speculate that over expression of the genes is correlated with 
their hyperacetylation in AB1028. 
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In primary pre-B cells H4 tetra-acetylation levels were generally lower (Fig. 
3.6.1) and more uniform, with fewer peaks, compared to H3 di-acetylation levels 
observed both in primary pre-B cells and in the Abelson transformed cell line. The 
pattern observed across the locus suggests that H4 acetylation might not be involved 
in the establishment of an active k5-VpreB1 domain in primary pre-B cells. 
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Fig. 3.6.1 Pattern of histone H3 (red) and histone H4 (blue) acetylation across the 25-VpreB1 
locus in primary pre-B cells and in LPS activated mature B cell. Antibodies against anti acetylated 
histone H3 and anti acetylated histone H4 (both from Upstate) were used for the 
immunoprecipitations. On the y axis is shown the fold enrichment. The x axis represents the position 
of the amplicons across the 25-VpreB1 domain. Error bars indicate standard deviations relative to two 
different ChIP experiments. A locus map is shown below the plots; red vertical lines indicate 
amplicons positions, black arrows indicate the positions of the DNAseI hypersensitive sites. 
In LPS-activated B cells, peaks of H3 and F14 acetylation were only observed on 
the Topo313 gene while the rest of the locus appeared depleted of both types of 
modifications. Topo3/3 is ubiquitously expressed (Szutorisz et al., 2005) and is 
transcribed on the opposite strand with respect to X5 and VpreB 1. Its TSS is only 1.5 
Kb away from the VpreB I start site. It is noteworthy that both the acetylation peaks 
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are shifted towards the 5'end of the Topo3/3 gene. Instead, in pre-B cells, where 
VpreB1 is active, they span the region across the two adjacent genes. A very 
interesting feature is the sharp transition observed between the active Topo3/3 gene 
and the inactive VpreB1, which is underlined by a drop in the levels of histone 
modifications occurring approximately 600bp upstream of the VpreB1 gene 
promoter. It is noteworthy that the transcription start sites of Topo3/3 and VpreB1 are 
only 1.5kb apart. 
These results suggest a tight controlled epigenetic determination of differentially 
expressed domains over a very short genomic distance. The short region comprised 
between the two genes does not contain any DNase I HS or intergenic promoter 
(Minaee et al., 2005) that can have an insulator function, which suggest that the 
separate histone modification profiles could be generated by the differential 
assembly of transcription factors complexes on their cis-regulatory elements. 
The levels of enrichment on the Topo3I3 gene were lower than in the cell line 
suggesting an overall increment in gene expression in the transformed cells. 
Increased levels of expression have been observed for the Rag-1 and Rag-2 genes in 
Ableson transformed lymphoid cells (Rosenberg, 1994). 
3.7 Pattern of histone H3 Lysine 4 dimethylation in primary 
pre-B and mature B cells. 
Lysine residues within histones can be mono, di and tri-methylated. Different 
numbers of methyl groups on a given residue confer different biological readouts, 
which give methylation a greater combinatorial potential compared with other types 
of modifications. In contrast to acetylation, which correlates almost without 
exception with transcriptional activation, histone methylation can result in either 
transcription activation or repression, depending on which residues are modified. 
H3K4me2 correlates with a permissive state of chromatin, in which genes are either 
active or potentially active (Santos-Rosa et al., 2002). Other experiments in yeast 
have shown that the presence of H3K4me2 in the coding regions correlates mainly 
with transcriptional activity (Santos-Rosa et al., 2002). 
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Fig. 3.7.1 Pattern of histone H3K4me2 (green) across the A5-VpreB1 locus in primary pre-B cells 
(top panel) and LPS activated mature B cell (bottom panel). An antibody against histone H3 
dimethylated lysine 4 (Upstate) was used for the immunoprecipitations. On the y axis is shown the 
fold enrichment. The x axis represents the position of the amplicons across the A5-VpreB1 domain. 
Error bars indicate standard deviations relative to two different ChIP experiments. A locus map is 
shown below the plots; red vertical lines indicate amplicons positions, black arrows indicate the 
positions of the DNAseI hypersensitive sites. 
In the 25-VpreB1 locus enrichment for H3K4me2 was spread across the entire 
domain (Fig. 3.7.1) in pre-B cells where the genes are active. Three highly enriched 
regions were found, one corresponding to a peak of H3 acetylation, between Topo3 
and VpreB1 and another located between the two pre-B cell specific genes. A 
broader region spanned the coding region of the 25 gene. In activated B cells the 
two broad domains on the VpreB1 and 25 genes are lost and only the peak on the 
Topo3/3 is still present, even though the level of enrichment is quite reduced. It has 
been shown that H3K4me2 can be present in inactive genes (Cuthbert et al., 2004) 
but this does not seem to apply to the developmentally regulated A5 and VpreBl. 
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3.8 Summary 
The active 25-VpreB1 locus in primary pre-B cells was found to be marked by 
the presence of three broad domains of H3K4me2, which spanned the Topo3/3 gene, 
the region between VpreB1 and 25 and the 25 gene itself. Histone H3 acetylation 
was present as two major regions, one of these was located at HS8, and the other 
covered the length of the 25 gene. Histone H4 acetylation showed a low background 
level of enrichment across the entire domain and did not seem to participate in 
triggering the activation of the domain. Primary mature B cells showed peaks of the 
H3 and H4 acetylation and H3 lysine dimethylation only on the Topo3/3 gene while 
they were largely absent from the rest of the locus. 
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4. Inactive versus active chromatin modifications 
during B cell development 
4.1 Introduction 
A fertilised egg contains all of the genetic information required for the 
development of a new organism. During development the totipotent cells of the 
blastocyst will make fate choices that lead to the expression of some genes and to 
the silencing of others. Cellular identity is usually described in terms of expressed 
genes and most of the studies on gene regulation have focused on mechanisms of 
transcriptional activation. However, cell identity can also be described in terms of 
genes that are actively silenced. Gene silencing is known to be important for cell 
fate decisions, developmental progression and cell activation (Fisher, 2002; Fisher 
and Merkenschlager, 2002; Grewal and Elgin, 2002). One of the aims of this project 
was to investigate developmentally regulated silencing during the transition from the 
inner cell mass (ICM)/ES cell stage to multipotent and fully differentiated cells. 
There are least two types of situations where the 25-VpreB1 locus is silenced, one of 
these is established in mature B cells, as the result of stage specific silencing, during 
normal B cell development, while the other is observed in non lymphoid cells in 
which the locus has never been expressed. Investigation of the chromatin structure 
of the A5-VpreB1 locus led to the discovery of a small intergenic region marked by 
histone H3 acetylation and histone H3 lysine 4 dimethylation in ES cells (Szutorisz 
et al., 2005). This area, which was named early transcription competence mark 
(ETCM), is also a centre for recruitment of general transcription factors (GTFs) and 
Pol II in ES cells and contains an enhancer element that is active in pre-B cells. It 
has been proposed that the presence of a localized epigenetic mark in ES cells is 
important for establishing the transcriptional competence of the genes and that it 
could offer a solution to the problem of how ES cell plasticity is propagated during 
cell division (Szutorisz and Dillon, 2005). These results raise the question of 
whether active marks co-exist with repressive modifications and whether the silent, 
pluripotent state observed in ES cells is somehow different from the one observed in 
the fully committed B cell, after the genes have gone through both activation and 
silencing. To answer these questions analysis of histone H3 K9 dimethylation 
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(H3K9me2), histone H3 K9 trimethylation (H3K9me3) and of the double 
modification histone H3 K9 tri-methylation/S10 phosphorylation (H3K9me3S lOph) 
was performed at different stages of B cell development (Fig. 4.1.1). A number of 
housekeeping and tissue-specific gene promoters and transcribed regions were also 
analysed for comparison. 
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Fig. 4.1.1 Cells used to analyse epigenetic modifications during B cell development. 
4.2 Patterns of histone H3K9me2 across the X5-VpreB1 
locus during B cell development 
H3K9me2 has been associated with the silencing of euchromatic regions. There 
is evidence that the two HMTases, G9a and G9a related protein (GLP) responsible 
for the mono and di-methylation of lysine 9 (Tachibana et al., 2001; Tachibana et 
al., 2002), form complexes with HP17 and a subset of E2F transcription factors, 
causing silencing of individual genes (Ogawa et al., 2002). These findings suggested 
that H3K9me2 could play a role in the silencing of the 25 and VpreB1 genes. The 
pattern of the modification was investigated across the entire locus at different 
stages of B cell development. The results presented in this and the following 
chapters have been obtained by X-ChIP (see section 3.3). Attempts were also made 
to analyse H3K9me2 by N-ChIP but the outcome of the experiments was not 
satisfactory in terms of the yield of immunoprecipitated chromatin and of the fold 
enrichment at specific positions in the genome. The difficulties encountered in 
immunoprecipitating histone H3K9me2 with native chromatin preparations could be 
explained by the presence of an active demethylase. Histone methylation has long 
been considered to be a permanent modification. However, a number of histone 
demethylases have been identified recently. These include LSD1, which acts on 
H3K4me and H3K4me2 (Shi et al., 2004); JHDM1, which specifically demethylates 
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H3K36me2 (Tsukada et al., 2006) and lately JMJD2 which demethylates H3K9me3 
and I-13K936me3 (Whetstine et al., 2006). 
In ES cells H3K9me2 was observed in the promoters and coding regions of the 
25 and VpreBl genes, but not at the 5' end of the domain, where the active Topo313 
gene is located (Fig. 4.2.1). It is also notable that the ETCM region (located in the 
intergenic region at HS7 and HS8) showed a decrease in H3K9me2 with the lowest 
level observed at HS8. A peak of H3K4me2 and H3 acetylation has been observed 
previously at this region in ES cells (Szutorisz et al., 2005). 
The IL-3 dependent cell line Ba/F3 was used to analyse the pattern of histone H3 
K9 dimethylation at the early pro-B cell stage. Ba/F3 cells are already committed to 
the B cell lineage and express B cell specific genes such us mb-1, B29 and the 
germline 41. They do not express A5, VpreB1, Pax5, EBF, TdT, Ragl, CD19, and 
IL7R (Sigvardsson et al., 1997). The pattern of H3K9me2 in Ba/F3 did not present 
any dramatic variation compared to what was observed in ES cells (Fig. 4.2.1). 
In pre-B cells, where the two genes are fully active, H3K9me2 was observed at 
only one site, corresponding to primer pair 47/48 located on HS3. This has been 
identified as a repetitive LTR sequence that is also a site of DNA methylation in pre-
B cells (see section 6.3). No specific immunoprecipitation was observed at any other 
site. Interestingly the background level in pre-B cells is higher than in the other cell 
types analysed. This feature, specific of the active A5-VpreBI domain, could be due 
to a more open and accessible chromatin structure that is more accessible to 
antibody epitopes. 
A5 and VpreB/ are repressed at the small resting pre-B cell stage, and are 
completely silenced in activated mature B cells. Surprisingly the pattern of 
H3K9me2 in mature B cells is quite similar to the one observed in ES cells. The 
modification is present in the genes promoters and coding regions, but is reduced the 
3' end of the locus, where DNase I HS 1 to 5 are located. The level of H3K9me2 on 
the A5 gene is also slightly lower in mature B cells compared to ES cells. 
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Fig. 4.2.1 Pattern of H3K9me2 (blue bars) across the A,5-VpreB1 locus at different stages of 
B-cell development. An antibody against histone H3 dimethylated lysine 9 (Upstate) was used for the 
immunoprecipitations. A non-specific anti-Flag antibody was used to confirm that histone 
modification signals were detected above background (black bars). A horizontal red bar highlights 
the ETCM region. The percentage of immunoprecipitated input is shown on the y axis of each plot. 
The x axis represents positions across the X5-VpreB1 domain. The expression status of the genes at 
different stages of B-cell development is showed on the right side of each graph. Error bars indicate 
standard deviations calculated on minimum two ChIP experiment. A locus map is shown below the 
plots; red vertical lines indicate amplicons positions, black arrows indicate the positions of the 
DNAseI hypersensitive sites. 
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These results show that, when silenced, the 2.5 and VpreB1 genes are marked by 
histone H3 lysine 9 dimethylation on their promoters and coding regions. The 
ETCM region showed a reduced level of H3K9me2 that was especially pronounced 
in ES cells. It is possible to speculate that, in ES cells, recruitment of generic 
transcription factors and Pol II at the ETCM are necessary to prepare the locus for 
later activation while the presence of H3K9me2 at the gene promoters helps to keep 
them in a silenced state. In activated B cells silencing does not seem to require an 
increase in the level of H3K9me2 compared to ES cells. This suggest that the 
mechanism that triggers /15 and VpreB1 silencing after activation in pre-B cells 
might involve the action of repressor molecules such as Ikaros (Sabbattini et al., 
2001) and/or the presence of DNA methylation (chapter 6) rather than epigenetic 
mechanisms involving histone methylation. 
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4.3 Patterns of histone H3K9me3 and H3K9me3S10ph 
across the A5-VpreB1 locus in ES and mature B cells 
The pattern of H3K9me2 did not differ significantly in ES and mature B cells. In 
order to further investigate the silent states of the domain in ES and mature B cells 
other modifications associated with inactive chromatin were analysed. H3K9me3 
has been mainly linked to heterochromatic regions and it is thought to provide a 
docking site for HP1 (Aagaard et al., 1999; Rea et al., 2000). Recently it has also 
been observed in the transcribed region of active genes (Vakoc et al., 2005). ChIP 
analysis of H3K9me3 showed extremely low levels across the entire .15-VpreB1 
locus both in ES and activated B cells (Fig. 4.3.1 next page). This finding suggests 
that the 25-vpreBl domain is in a quite open and accessible chromatin structure in 
both the cell types. This is in agreement with the fact that the A5 promoter was 
found to be undermethylated and accessible to restriction enzymes in activated B 
cells (Sabbattini et al., 2001). 
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Fig. 4.3.1 Pattern of H3K9me3 across the A5-VpreB1 locus in ES (top panel) and mature B cells 
(bottom panel). An antibody against histone H3 trimethylated lysine 9 (Upstate) was used for the 
immunoprecipitations. Non-specific anti-Flag antibody, anti IgG and no antibody control were used 
to confirm that histone modification signals were detected above background (black bars). The 
percentage of immunoprecipitated input is shown on the y axis of each plot. The x axis represents 
positions across the X5- VpreB1 domain. The expression status of the genes is showed on the right 
side of each panel. Error bars indicate standard deviations calculated on minimum two ChIP 
experiments. A locus map is shown below the plots; red vertical lines indicate amplicons positions, 
black arrows indicate the positions of the DNAseI hypersensitive sites. 
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The double trimethyl H3 K9 phospho S10 modification (H3K9me3S 1 Oph) is 
known to be associated with condensation of mitotic chromosomes (Hirota et al., 
2005) but its function is still not completely understood. Fischle et al, suggested a 
role for S10 phosphorylation in reducing the affinity of HP1 for the K9 methylation 
mark, thus allowing a dynamic control of the HP1-H3K9me3 interaction. Mateescu, 
B., et al (2004) instead proposed that association of HP1 with H3K9me3S lOph is 
more stable than its association with histone H3 tails that have only the methylation 
mark and that therefore the effect of the mitotic S10 phosphorylation is to tightly 
bind HP1 outside the heterochromatic foci promoting silencing. However, it has to 
be pointed out that different methyl groups and different HP1 isoforms were 
considered in the two studies. Recent unpublished results from Sabbattini, P. et al 
provide evidence that the double modification is associated with the formation of 
facultative heterochromatin in terminally differentiated cells. 
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Fig. 4.3.2 Pattern of H3K9me3S 1 Oph across the X5-VpreB1 locus in ES (top panel) and mature B 
cells (bottom panel). An antibody against histone H3 trimethylated lysine 9 phosporylated serine 10 
(Abcam) was used for the immunoprecipitations. Non-specific anti-Flag antibody, anti IgG and no 
antibody control were used to confirm that histone modification signals were detected above 
background (black bars). The percentage of immunoprecipitated input is shown on the y axis of each 
plot. The x axis represents positions across the X5-VpreB1 domain. The expression status of the genes 
is showed on the right side of each panel. Error bars indicate standard deviations calculated on 
minimum two ChIP experiments. A locus map is shown below the plots; red vertical lines indicate 
amplicons positions, black arrows indicate the positions of the DNAseI hypersensitive sites. 
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ChIP analysis of H3K9me3S 1 Oph in ES cells showed a small enrichment 
compared to the negative controls across the all 25-VpreB1 locus (Fig. 4.3.2 top 
panel). In activated B cells (Fig. 4.3.2 bottom panel) the amount of 
immunoprecipitated input was higher and mainly homogeneous across the domain 
showing an increase (from 2 to 4%) in the VpreB1 and 25 genes promoters and 
coding regions. Levels of H3K9me3S lOph in mature B cells showed to be higher 
than in ES cells; on average (3.0 ± 1.1)% versus (1.2 ± 0.6)%. This result raises the 
possibility that this modification is involved in determining the silenced state of the 
25 and VpreB1 genes in activated B cells. 
4.4 Patterns of H3K9me2 and H3K4me2 in tissue-specific 
and ubiquitously expressed genes at different stages of B 
cell development 
The analysis of histone modifications linked to inactive chromatin in the 
25-VpreB1 locus during B cell development revealed few differences between the 
two silent states represented by ES and mature B cells. Depletion of H3K9me2 was 
observed at the ETCM region in ES cells, which was less pronounced in mature B 
cells. The 25 gene appeared more enriched in H3K9me2 in ES than in mature B 
cells. Levels of H3K9me3S lOph across the domain were higher in mature B cells 
than in ES cells, although this enrichment was generalised and not specific to 
regulatory regions of the locus. To further investigate the role of histone methylation 
in gene silencing and to generalise the results obtained from the analysis of the 
25-VpreB1 locus, a set of tissue specific and housekeeping genes promoters and 
transcribed regions was analysed. Primers used for this analysis were described in 
materials and methods tab. 2.12.1b. 
Current evidence suggests that active genes are enriched in H3K4me2 and 
depleted of H3K9me2, and that the contrary is true for inactive genes. In ES cells 
ubiquitously expressed genes followed this pattern while a number of tissue specific 
genes, such us MyoD, VpreB1 and A5, showed the simultaneous presence of the two 
modifications in the promoter and/or in the coding region (Fig. 4.4.1 ES cells, first 
panel). Other genes, such as Neurofilament (Nfl) and Blimpl, showed relatively high 
level of enrichment for H3K4me2 in their promoters. Hypermethylation of histone 
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H3 lysine 4 at Nfl promoter has been previously described in ES cells (Kimura et al., 
2004) despite the gene not being expressed (Rohwedel et al., 1998). Blimp] is quite 
widely expressed in mouse and it has shown to be important for primordial germ 
cells (PGCs) specification (Ohinata et al., 2005) and, althought not expressed in ES 
cells (Ancelin et al., 2006) it has shown to be present at day 6.5 of embryonic 
development (Ohinata et al., 2005). Therefore it is possible to speculate that, in ES 
cells, H3K4me2 might mark the gene promoter in preparation for its activation early 
in embryonic development. Among the remaining tissue specific genes, Amylase 
showed the expected inactive/active modification pattern with high levels of 
H3K9me2 at the promoter and transcribed regions. 
These results suggest that in ES cells the histone modifications associated with 
tissue specific genes are variable and do not conform to a single rigid pattern. 
Commitment to the B cell pathway result in a much more defined pattern of 
histone modifications. In Ba/F3 early pro-B cells tissue-specific genes that are 
expressed outside the B lineage were all depleted for H3K4me2, both in the 
promoters and in the transcribed regions and were enriched in H3K9me2. Active 
genes presented an opposite pattern and were found to be enriched in H3K4me2 and 
devoid of HK9me2 (Fig. 4.4.1), Ba/F3, second panel). The A5 and VpreB1 genes, 
which are not yet active at this developmental stage, showed an intermediate 
percentage of immunoprecipitation of both of these modifications. This result 
indicates that the two modifications are not mutually exclusive and that in the 
transition from an inactive to an active state the increase in the activating mark 
H3K4me2 happens before the inactivating one is completely erased. 
In primary pre-B cells, the AS and VpreB1 genes are fully active, a status that is 
underlined by the high levels of H3K4me2 and the absence of H3K9me2. High 
levels of H3K4me2 marked all of the housekeeping genes examined, while silenced 
genes showed mainly the presence of H3K9me2. Silenced genes appeared to be 
more enriched in H3K9me2 in their transcribed regions than in their promoters 
(Fig.4.41 pre-B cells, third panel). Interestingly, depletion of lysine 9 dimethylation 
was observed at the silent MyoD and Nfl genes in pre-B cells and corresponded to 
enrichment in lysine 4 dimethylation. 
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Fig. 4.4.1 Patterns of H3K9me2 (blue bars) and H3K4me2 (green bars) in tissue specific and 
housekeeping genes. Antibodies against histone H3 dimethylated lysine 9 and histone H3 
dimethylated lysine 4 were used for the immunoprecipitations (both Upstate). Anti-Flag antibody, 
anti IgG and no antibody control were used to confirm that histone modification signals were 
detected above background. Values on the Y axis represents the percentage of immunoprecipitated 
input, on the x axis are indicated the genes of interest. The expression status of the genes is showed 
on the bottom of each panel. Error bars indicate standard deviations calculated on minimum two 
ChIP experiments. P and t indicate respectively promoter and transcribed regions. 
In mature B cells, among the tissue specific genes that are not expessed in the B 
lineage, the two modifications appear to mirror each other; any enrichment in 
H3K4me2 corresponded to a decrease in H3K9me2 and vice versa (Fig. 4.4.1 
mature-B cells, fourth panel). The only exception was the MyoD gene, which 
showed a peak of H3K4me2 in the transcribed region. In contrast, genes active at 
this stage of B cell development such as Blimp] and Pax5 presented high levels of 
H3K4me2 in their promoters (Fig 4.4.1, mature-B cells, fourth panel). 
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These results suggest that in ES cells lineage specific genes can have a variety of 
histone modification profiles. H3K9me2 and H3K4me2 were either both present at 
the same sites (MyoD, A5, VpreB1) or alternating between the promoter and 
transcribed region of the gene (NFL, 162m). ES cells are able to differentiate into all 
lineages, a property that can be explained by the ability of these cells to keep lineage 
specific genes in a "poised" state from which it would be easier to progress into an 
active or inactive state. The results described in this section suggest that tissue-
specific genes have a mixture of modifications associated with their promoters or 
coding regions in ES cells and are kept in a hybrid condition until a fate decision in 
taken and there is a need to silence or express them. This is confirmed by the 
observations made in Ba/F3 cells, since once the B cell pathway is engaged, the 
genes present a more defined pattern of modifications. 
4.5 Patterns of histone H3K9me3 and H3K9me3S10ph at 
tissue-specific and ubiquitously expressed genes in ES 
and mature B cells 
The results described in the previous section show that non-lymphoid tissue 
specific genes have a more defined pattern of H3K9me2 in mature B cells compared 
with ES cells (Fig. 4.4.1). These observations were extended by ChIP analysis of 
H3K9me3. Tissue specific genes that are not expressed in the B lineage were 
enriched in H3K9me3 in mature B cells but not in ES cells (Fig.4.5.1). Myod 
represented an exception and was found enriched in K4me2 (Fig. 4.4.1) and 
depleted in H3K9me3 similar to the pattern that was observed for H3K9me2 (Fig. 
4.5.1) in its transcribed region. In contrast, B lineage-specific genes, even if inactive, 
were not marked by H3K9me3 in mature B cells. These results suggest that genes 
that undergo long term silencing during cell differentiation are marked by 
H3K9me3, and are probably heterochromatinised in fully differentiated cells. In ES 
cells, the chromatin of tissue specific genes seems to adopt a permissive 
conformation with reduced levels of heterochromatic modifications. 
Housekeeping genes such as fi-actin and )62-m showed high values of H3K9me3 
in their transcribed regions both in ES and mature B cells. The presence of 
H3K9me3 in transcribed regions of active genes has been described previously 
(Vakoc et al., 2005) and it has been proposed, that this modification acts in 
132 
14. 
G 
5 2. 
 
grtnrc 
oxprcslior 
L_a 	i _a _ L.LE.  
4•• 
 
conjunction with the presence of HPly and RNA pol II to create a pattern that 
identifies transcribed regions in the genome. 
anti h.stone H3 trirnetnyi K3 
Avg neg. controls 
TissJe sec t c genes 
ES 	 non-B Lineage 	 a-Lineage 
iJoicuitous y expressed 
genes 
Mature B 
6 
     
'8 2. 
    
fiton*$ 0 
exprosaion 
  
III  
   
e 
R N 
oe 	,er 
.49 
  
Fig. 4.5.1 Patterns of II3K9me3 (grey bars) in ES and mature B cells in tissue-specific and 
housekeeping genes. An antibodys against histone H3 trimethylated lysine 9 was used for the 
immunoprecipitations (Upstate). Anti-Flag antibody, anti IgG and no antibody control were used to 
confirm that histone modification signals were detected above background. Values on the y axis 
represents the percentage of immunoprecipitated input, on the x axis are indicated the genes of 
interest. The expression status of the genes is showed on the bottom of each panel. Error bars indicate 
standard deviations calculated on minimum two ChIP experiments. P and t indicate respectively 
promoter and transcribed regions. 
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In mature B cells H3K9me3S lOph appeared enriched in all the tissue specific 
genes, both in their promoters and transcribed regions. Housekeeping genes, such as 
Jiactin and )52-m, showed instead a pattern similar to H3K9me3, with a higher level 
of enrichment in the transcribed region (Fig. 4.5.2). The amount of H3K9me3SlOph 
increased progressively from the housekeeping to the non-lymphoid lineage-specific 
genes suggesting that the presence of the double modification could be correlated to 
both long term and stage specific silencing. Nevertheless some enrichment was 
observed on Blimp] and Pax5 promoters, which are expressed in mature B cells. In 
these two genes the level of H3K9me3S lOph is actually comparable to the level 
observed at 25 and VpreB1 promoters, which are silent at this stage of development. 
In ES cells a background level of enrichment (1.5 ± 0.5)% was observed at most 
gene promoters and transcribed regions. 
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Fig. 4.5.2 Patterns of H3K4me3S 1 Oph (pink bars) in ES cells (top panel) and mature B cells 
(bottom panel) in tissue-specific and housekeeping genes. An antibodys against histone H3 
trimethylated lysine 9 phosphorylated S10 was used for the immunoprecipitations (Abcam). 
Anti-Flag, anti IgG and no antibody control were as negative controls. Values on the y axis represents 
the percentage of immunoprecipitated input, on the x axis are indicated the genes of interest. The 
expression status of the genes is showed on the bottom of each panel. P and t indicate respectively 
promoter and transcribed regions. 
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4.6 Summary 
The silent state of the 25 and VpreB1 genes in ES and mature B cells was found 
to be marked by H3K9me2. Enrichment in the dimetylation mark was detected at the 
genes promoters and transcribed regions. In ES cells only a decrease in H3K9me2 
was observed at HS8, a site that had previously shown to coincide with a peak of 
H3K4me2 (Szutorisz et al., 2005). Analysis of a set of tissue-specific genes in ES 
cells showed a varied pattern of histone H3 dimethylation at K9 and K4. The two 
modifications were often present at the same sites (i.e. MyoD, A.5, VpreB1) or 
alternating between the gene promoter and transcribed region (i.e. NFL, /32m). 
Histone H3 K9 trimethylation was instead largely absent both from the locus and 
from the lineage-specific genes analysed. This result suggested an open, permissive, 
chromatin conformation. In mature B cells, tissue-specific non-lymphoid genes were 
found enriched in both H3K9me2 and H3K9me3. The double modification 
H3K9me3S lOph presented a low, background, level in ES cells and was slightly 
enriched in mature B cells. 
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5. Epigenetic modifications of tissue-specific genes 
in the C3H1OT1/2 mesenchymal stem cell line 
5.1 Introduction 
Recent findings suggest the possibility that genes might be marked in ES cells by 
chromatin modifications that are associated with gene activation. These localised 
epigenetic marks would keep the genes in a potentiated state that would render them 
ready for expression at later stage of development (Szutorisz et al., 2005; Vieira et 
al., 2004). According to this hypothesis when the cells commit to a specific lineage 
tissue-specific genes that are not expressed in that lineage would lose their marks 
and be silenced. Genes that need to be activated will acquire transcriptional 
competence through recruitment of specific transcription factors and expansion of 
the active epigenetic marks (Szutorisz and Dillon, 2005). 
One of the aims of this project was to investigate how early cell fate decisions 
and differentiation can affect the chromatin structure of the 25-VpreB1 locus. The 
C3H10T1/2 mesenchymal stem cell line was chosen as a model system to analyse 
the features of the silent 25-VpreB1 domain in a multipotent progenitor with a 
restricted differentiation potential (which does not include the B cell pathway) and 
in its product of differentiation (Fig. 5.1.1). C3H10T1/2 cells have been used 
extensively as an in vitro model to examine mesenchymal differentiation into 
various lineages (Ahrens et al., 1993; Denker et al., 1999; Katagiri et al., 1990). The 
A5-VpreB1 locus has never been active and will never be activated in these cells 
even upon differentiation. 
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Fig. 5.1.1 model system used to analyse epigenetic modifications during cell differentiation. 
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5.2 C3H10T1/2 differentiation 
Differentiation of the mesenchymal stem cell line C3H10T1/2 (CHT) towards 
osteocytes and adypocites was performed as described in Peister A., et al., (Blood, 
2004) with minor modifications (see materials and methods and Fig. 5.2.1 and 
5.2.2). Adipogenesis was partially effective since only 30-40% of the cells gave 
bright red staining with Oil Red and assumed the characteristic granular phenotype. 
Cells incubated with the osteogenesis medium showed instead a complete change in 
morphology during the first week of treatment and after three weeks 70%-80% gave 
a positive stain with alkaline phosphatase. Counting of the number of cells stained 
was difficult since the alkaline phosphatase coloured reaction could not be detected 
after staining of the nuclei with GIEMSA. Therefore the number of cells positive for 
alkaline phosphatase was determined as follows. Two 175 cm2 flask containing 
osteocytes originating from the same differentiation experiment were analysed. One 
of the flasks was used for GIEMSA staining and counting of the nuclei. Cells in the 
other flask were treated with the alkaline phosphates reagent and those giving 
positive staining counted. Comparison of the number of cells positive for GIEMSA 
and alkaline phosphatase staining showed that an average of 70-80% of cells that 
could be considered to have successfully differentiated. 
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Fig.5.2.1 Differentiation of the mesenchymal stem cell line C3H10T1/2 into osteocytes. Cells 
were grown to 70% confluency (A) and incubated for three weeks with adipocytes differentiation 
media (B). Differentiation was assessed by Oil red staining (C). 
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Fig.5.2.2 Differentiation of the mesenchymal stem cell line C3H10T1/2 into osteocytes. Cells 
were grown to 70% confluency (A) and incubated for three weeks with osteocytes differentiation 
media (B). Differentiation was assessed by alkaline phosphatase staining (C). 
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5.3 Patterns of histone H3K4me2 and histone H3 
di-acetylation across the .15-VpreB1 locus during 
C3H10T1/2 cell differentiation 
Histone H3 acetylation and H3K4me2 were analysed across the A5-VpreB1 locus 
in multipotent C3H10T1/2 cells (CHT) and in osteocytes (CHTD) obtained by 
differentiation of these cells. The aim of this analysis was to investigate the effects 
of long term silencing on the 25-VpreB1 locus. The pattern of H3 acetylation (red 
bars in Fig. 5.3.1, top panel) in the mesenchymal stem cell line showed a strong 
peak on the Topo3/3 gene, and a smaller one on HS8. A peak was also observed on 
HS3 (Fig. 5.3.1 right side, top panel), but the error bars indicated a high variability 
in the ChIP analysis of this specific site that raises questions about the significance 
of this particular result. The region containing the pre-B cell-specific hypersensitive 
sites 7 and 8 showed a rise in H3K4me2 (green bars in Fig. 5.3.1, top panel). Upon 
differentiation along the osteogenic pathway the pattern of histone modifications did 
not change dramatically. The small peak of H3 acetylation on HS8 disappeared, 
while the overall level remained constant (Fig.5.3.1 bottom panel). The locus 
showed a generalised low level of enrichment of H3K4me2 although this was 
significantly lower then the level observed at the active Topo3 P promoter. From this 
analysis it can be concluded that the region marked by HS7 and HS8 presents a 
slight enrichment in H3 acetylation and H3K4me2, but it is not possible to discuss 
this result in relation to the already published data on ES cells since different 
chromatin preparation methods have been used. The experiment showed in this 
thesis have been performed with X-ChTP, while results obtained by Szutorisz et al 
were obtained with N-ChIP (Szutorisz and Dillon, 2005). 
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Fig. 5.3.1 Patterns of histone H3 acetylation (red) and histone H3K4me2 (green) across the 
X5-VpreB1 locus in the multipotent mesenchymal stem cell line CHT (top panel) and in its product of 
differentiation along the osteogenic pathway CHTD (bottom panel). Antibodies against acetylated 
histone H3 and histone H3 dimethylated K4 (both from Upstate) were used for the 
immunoprecipitations. The percentage of immunoprecipitated input is shown on the y axis. The x axis 
represents the position of the amplicons across the X5- VpreB1 domain Error bars indicate standard 
deviations relative to two different ChIP experiments. The locus map is in scale; red vertical lines 
indicate the positions of the amplicons, arrows indicate DNAse I HS. Negative controls (not shown) 
were calculated as the average of the values obtained with anti-flag, anti-IgG and no antibody and 
were always below 1% of IP input. 
5.4. Patterns of histone H3 lysine 9 methylation in the 
X5-VpreB1 locus in undifferentiated and differentiated 
C3H10T1/2 cells 
Analysis of the 25-VpreB1 locus in undifferentiated and differentiated 
C3H10T1/2 cells showed that modifications characteristic of active chromatin are 
localised to the Topo3/3 gene and are largely absent from the rest of the locus. To 
investigate the epigenetic signature of this developmentally regulated domain when 
it is undergoing long term silencing, methylation of histone H3 at lysine 9 was 
investigated. Immunoprecipitations were performed with antibodies against di- and 
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trimethylated lysine 9 and against the double trimethylated lysine 9 phosphorylated 
serine 10 modification. 
5.4.1 Histone H3 lysine 9 dimethylation 
The pattern of H3K9me2 observed in the undifferentiated cells (Fig. 5.4.1) 
resembled that observed in ES cells, with the highest levels of enrichment located on 
the genes promoters and coding regions. In the differentiated osteocytes a dramatic 
increase in H3K9me2 was observed across the entire domain (Fig. 5.4.1, bottom 
panel). The enrichment was particularly high on the gene promoters and coding 
regions. 
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Fig. 5.4.1 Patterns of histone H3K9me2 (blue) across the 25-VpreB1 locus in ES cells, in the 
multipotent mesenchymal stem cell line C3H10T1/2 (CHT) and in its product of differentiation along 
the osteogenic pathway (CHTD bottom panel). An antibody against histone H3 dimethylated K9 
(Upstate) was used for the immunoprecipitations. Negative controls were calculated as the average of 
the values obtained with anti-flag, anti-IgG and no antibody. The percentage of immunoprecipitated 
input is shown on the y axis. The x axis represents the position of the amplicons across the 
X5-VpreB1 domain Error bars indicate standard deviations relative to at least two different ChIP 
experiments. The locus map is in scale; red vertical lines indicate the positions of the amplicons, 
arrows indicate DNAse I HS. 
Calculation of the average value of enrichment across the 25-VpreB1 locus 
confirmed that the level of H3K9me2 increased with the restriction of the 
differentiation potential. ES cells showed an average value of (1.6 ± 0.5) % while 
the value for the mesenchymal stem cell line was (3.3 ± 1.4) %. Mature B cells gave 
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a value of (1.4 ± 0.7) % of immunoprecipitation, which is very similar to the level in 
ES cells. This result when compared with the (8.5 ± 0.6) % observed in the 
differentiated osteocytes suggests a more prominent role for H3K9me2 in long term 
silencing than in stage-specific silencing of the 25-VpreB1 locus. 
5.4.2 Histone H3 K9 trimethylation and Histone H3 K9 
trimethylation / S10 phosphorylation 
The presence of H3K9me3 is considered a hallmark of heterochromatin 
formation. The .15-VpreB1 locus was depleted of the modification in ES cells, 
showing that prior to activation, the domain is not in a heterochromatic 
configuration. Analysis of H3K9me3 in undifferentiated C3H10T1/2 cells revealed 
again a very similar pattern to the one observed in ES cells (Fig.5.4.2, top panel), 
suggesting that although X5 and VpreB1 are on their way being permanent silenced, 
they are most probably not packaged into heterochromatin. 
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Fig. 5.4.2 Pattern of H3K9me3 across the A.5-VpreB1 locus in ES (top panel) and in the 
multipotent mesenchymal stem cell line C3H10T1/2 (CHT, bottom panel). An antibody against 
histone H3 trimethylated lysine 9 (Upstate) was used for the immunoprecipitations. Non-specific 
anti-Flag antibody, anti IgG and no antibody control were used to confirm that histone modification 
signals were detected above background (black bars). The percentage of immunoprecipitated input is 
shown on the y axis of each plot. The x axis represents positions across the 7'5-VpreB1 domain. The 
expression status of the genes is showed on the right side of each panel. Error bars indicate standard 
deviations calculated on minimum two ChIP experiments. A locus map is shown below the plots; red 
vertical lines indicate amplicons positions, black arrows indicate the positions of the DNAseI 
hypersensitive sites. 
The result obtained from the analysis of the H3K9me3 ChIP experiments after 
differentiation showed large error bars, which made it difficult to drawn definitive 
conclusions and therefore have not been presented in this thesis. 
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The double H3K9me3S lOph modification was largely undetectable across the 
25-VpreB1 locus in undifferentiated C3H10T1/2 (Fig. 5.4.3, CHT top panel), while 
the level increased upon differentiation along the osteogenic pathway (Fig. 5.4.3, 
CHTD bottom panel). The same behaviour was observed during B cell development, 
levels of H3K9me3S lOph were very low in ES cells and increased in mature B cells 
(section 4.3 Fig. 4.3.2). 
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Fig. 5.4.3 Patterns of histone H3K4me3S lOph (pink bars), across the A5-VpreB1 locus in the 
multipotent mesenchymal stem cell line C3H10T1/2 (top panel) and in its product of differentiation 
along the osteogenic pathway (bottom panel). An antibody against histone H3 trimethylated lysine 9 
phosporylated serine 10 (Abcam) was used for the immunoprecipitations. Non-specific anti-Flag 
antibody, anti IgG and no antibody control were used to confirm that histone modification signals 
were detected above background (black bars). The percentage of immunoprecipitated input is shown 
on the y axis of each plot. The x axis represents positions across the k5-VpreB1 domain. The 
expression status of the genes is showed on the right side of each panel. Error bars indicate standard 
deviations calculated on minimum two ChIP experiments. A locus map is shown below the plots; red 
vertical lines indicate amplicons positions, black arrows indicate the positions of the DNAseI 
hypersensitive sites. 
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5.5 Histone modifications in tissue specific and 
ubiquitously expressed genes during in vitro osteocyte 
differentiation 
5.5.1 Histone H3 acetylation and H3 lysine 4 dimethylation 
The analysis of histone H3 acetylation and histone H3K4me2 in the 25-VpreB1 
locus showed that the level of enrichment of the two modifications at the genes 
promoters and transcribed regions was identical for the undifferentiated and 
differentiated C3H10T1/2. The same analysis was performed on a number of 
lineage-specific genes (Fig. 5.5.1) confirming this result. Tissue-specific genes were 
not enriched in H3 acetylation or H3K4me2 either in their promoters or in their 
transcribed regions, with the exception of Nfl and Blimpl. Housekeeping genes, 
instead, showed high percentages of immuno precipitation both in their promoters 
and transcribed regions. These results suggest that in multipotent precursor cells 
most of the genes belonging to alternative lineage choices are not marked by 
modifications characteristic of an active chromatin conformation. 
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Fig. 5.5.1 Patterns of H3K4me2 (green bars) and H3 acetylation (red bars) in the multipotent 
undifferentiated C3H10T1/2 (CHT, top panel) and following differentiation along the osteogenic 
pathway (CHTD, bottom panel). Antibodies against acetylated histone H3 and histone H3 
dimethylated K4 (both from Upstate) were used for the immunoprecipitations. Values on the y axis 
represents the percentage of immunoprecipitated input, on the x axis are indicated the genes of 
interest. The expression status of the genes is showed on the bottom of each panel. Error bars indicate 
standard deviations relative to two different ChIP experiments. Negative controls (not shown) were 
calculated as the average of the values obtained with anti-flag, anti-IgG and no antibody and were 
always below 1% of IP input. 
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5.5.2 Histone H3 lysine 9 dimethylation 
Analysis of H3K9me2 across the 25-VpreB1 locus showed a dramatic increase in 
the levels of enrichment of the modification in differentiated osteocytes compared to 
the multipotent progenitor cells. The study of the panel of tissue specific genes 
confirmed this result. In the undifferentiated cells (Fig. 5.5.2 top panel) the pattern 
was similar to that observed in ES cells (section 4.4.1). 
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Fig. 5.5.2 Patterns of H3K9me2 (blue bars), in ES cells (top panel), in the multipotent 
mesenchymal stem cell line C3H10T1/2 (CHT middle panel) and in its product of differentiation 
along the osteogenic pathway (CHTD bottom panel). An antibody against histone H3 dimethylated 
lysine was used for the immunoprecipitations (Upstate). Anti-Flag antibody, anti IgG and no 
antibody control were used to confirm that histone modification signals were detected above 
background. Values on the y axis represents the percentage of immunoprecipitated input. On the x 
axis are indicated the genes of interest. The expression status of the genes is showed on the bottom of 
each panel. Error bars indicate standard deviations calculated on minimum two ChIP experiments. P 
and t indicate respectively promoter and transcribed regions. 
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The enrichment was particularly low at the MyoD, Nfl and Blimp] promoters. It 
should be noted that MyoD and Nfl showed enrichment in H3K4me2 at the same 
sites in both the undifferentiated and the differentiated cells (section 5.5.1, 
Fig. 5.5.1). Upon differentiation (Fig. 5.6.1 bottom panel) the overall level of 
H3K9me2 rose dramatically in all of the tissue-specific genes. A small level of 
increase was also observed in the ubiquitously expressed gene f3--2m, in particular in 
the transcribed regions. These results confirm the conclusion withdrawn in the 
specific case of the 25-VpreB1 locus that H3K9me2 plays an important role not only 
in developmental silencing and formation of facultative heterochromatin but also in 
long term silencing. 
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5.5.3 Histone H3 lysine 9 trimethylation 
The analysis of the H3K9me3 at lineage specific gene promoters and transcribed 
regions in the mesenchymal stem cell line C3H10T1/2 showed very low levels of 
enrichment, comparable to ES cells. This result suggests that in a multipotent 
progenitor chromatin still retains an open conformation although the differentiation 
potential is severely restricted compared to ES cells. 
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Fig. 5.5.3 Patterns of H3K9me3 (grey bars), in ES cells (top panel) and in the multipotent 
mesenchymal stem cell line C3H10T1/2 (bottom panel). An antibodys against histone II3 
trimethylated lysine 9 was used for the immunoprecipitations (Upstate). Anti-Flag antibody, anti IgG 
and no antibody control were used to confirm that histone modification signals were detected above 
background. Values on the y axis represents the percentage of immunoprecipitated input, on the x 
axis are indicated the genes of interest. The expression status of the genes is showed on the bottom of 
each panel. Error bars indicate standard deviations calculated on minimum two ChIP experiments. P 
and t indicate respectively promoter and transcribed regions. 
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5.5.4 Histone H3 K9 trimethylation / S10 phosphorylation 
The double modification seems to play a role in silencing of the A5-VpreB1 locus 
in differentiated cells. Analysis of the panel of lineage-specific and housekeeping 
genes in ES cells is showing in Fig. 4.5.2 that H3K9me3S 1 Oph presents a low level 
of enrichment independently of the gene being active or inactive. This low signal 
was not observed in the undifferentiated C3H10T1/2 cells (Fig. 5.4.3, CHT top 
panel). Analysis of selected gene promoters and coding regions showed levels of 
enrichment comparable to negative controls. H3K9me3S lOph has been associated 
with cells entering mitosis, the multipotent mesenchymal precursor cells are not 
dividing as rapidly as ES cells are. This data suggest that, in ES cells, the presence 
of the double modification could be actually due exclusively to the very rapid cell 
cycle. After differentiation the levels of enrichment increased in the lineage specific 
but not in the housekeeping genes (Fig. 5.5.4, bottom panel). Amylase, VpreB1 and 
X5 seemed to be the less enriched among the tissue specific genes. Although 
H3K9me3S lOph has never been associated with the regulation of gene expression, 
the data herein shown provide some evidences that the double modification might be 
associated with both developmental and long term silencing. 
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Fig. 5.5.4 Patterns of H3K4me3S I Oph (pink bars), in ES cells, in the multipotent mesenchymal 
stem cell line C3H10T1/2 (CHT) and in its product of differentiation along the osteogenic pathway 
(CHTD, bottom panel). An antibodys against histone H3 trimethylated lysine 9 phosphorylated S10 
was used for the immunoprecipitations (Abcam). Anti-Flag antibody, anti IgG and no antibody 
control were used to confirm that histone modification signals were detected above background. 
Values on the y axis represents the percentage of immunoprecipitated input, on the x axis are 
indicated the genes of interest. The expression status of the genes is showed on the bottom of each 
panel. Error bars indicate standard deviations calculated on minimum two ChIP experiments. P and t 
indicate respectively promoter and transcribed regions. 
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5.7 Summary 
The results showed in this chapter demonstrate that the mesenchymal stem cell 
line C3H10T1/2 possesses a quite defined pattern of activating histone 
modifications. Restriction of differentiation potential caused depletion of H3 
acetylation and H3K4me2 from gene promoters and transcribed regions of tissue 
specific genes. Nevertheless histone modifications characteristic of inactive 
chromatin were not enriched in the multipotent progenitors cells, suggesting the 
retaining of an open accessible chromatin conformation at this stage of development. 
Upon differentiation both the X5-VpreB1 locus and non lymphoid tissue specific 
genes showed a dramatic increase in the levels of H3K9me2 and H3K9me3S 1 Oph, 
suggesting that those modifications play a role in long term silencing of tissue 
specific genes. 
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6. DNA methylation analysis of the X5-VpreB1 locus 
6.1 Introduction 
DNA methylation, histone deacetylation, and methylation of histone H3 at lysine 
9 are the three best characterised covalent modifications associated with a repressed 
chromatin state; the existence of an epigenetic "interaction" between them leading to 
transcriptional silencing is well established although the precise sequence of events 
is still unclear. There is evidence that DNA methylation influences the histone 
modification pattern. In fact DNA methyltransferases (DNAMTs) and some methyl-
CpG-binding domain (MBD) proteins have been shown to recruit repressor 
complexes containing histone deacetylases (HDACs) (Fuks et al., 2001; Robertson 
et al., 2000). There is also evidence that histone modification can influence DNA 
methylation. Observation made in fungi, plants and mammals identified methylation 
of histone H3 K9 as a signal for DNA methylation (Jackson et al., 2002; Lehnertz et 
al., 2003; Tamaru and Selker, 2001). In the previous chapters it has been shown that 
the silent state of the 25-VpreB1 locus in ES is characterised by the presence of 
H3K9me2 within the transcription units of the two genes. Histone H3K9me3 was 
absent from the domain in ES cells. After activation at the pro-B cell stage ?5 and 
VpreB 1 are downregulated in immature B cells and completely silenced in mature B 
cells. This latest silent state was shown to be characterised by enrichment in 
H3K9me2 especially on the VpreB1 gene and in the intergenic region. In order to 
further characterise the epigenetic profile of the silent A5-VpreB1 locus DNA 
methylation was investigated across the entire domain at different stages of B cell 
development. 
6.2 Strategy for southern blot analysis of DNA methylation 
The enzyme McrBC was used to digest genomic DNA extracted from ES, 
primary pre-B cells, activated mature B cells and brain tissue. McrBC is an 
endonuclease that cleaves DNA containing methyl-cytosine (Sutherland et al., 1992) 
on one or both strands. Sites on the DNA that are recognized by McrBC consist of 
two half sites of the form (G/A)mt. These half sites can be separated by up to 3kb 
but the optimal separation is 50-100 base pairs (Panne et al., 1999; Stewart and 
Raleigh, 1998). Analysis of McrBC cutting sites across the locus compared to the 
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number of possible methylated CpGs showed that 75% of them could be recognized 
by McrBC and, if methylated, cut. 
The Southern blot strategy used is shown in Fig. 6.2.1. The locus was divided 
into three broad regions of approximately 5kb each; three non-repetitive probes were 
used for end labeling. Probes 1 and 4 were previously described by (Minaee et al., 
2005) and were used to detect methylated regions in the 3' and 5' end of the domain. 
The X5 probe used for the central region of the locus was a restriction fragment 
generated by a Sad and SphI digestion and purified by agarose gel electrophoresis. 
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Fig.6.2.1 southern blot strategy. Horizontal red lines indicate the position of non-repetitive 
probes. 
Genomic DNA was digested with increasing amounts of McrBC and purified. 
DNA was then run on agarose gel, etidium bromide stained (Fig.6.2.2), southern 
blotted and detected by indirect end labeling. Fragments cut by McrBC appeared as 
bands migrating below the parental restriction enzyme band. 
Fig. 6.2.2 Etidium bromide staining of southern blots showed respectively in Fig. 6.3.1 
(A) and in Fig. 6.3.3 (B). Etidium bromide staining was used to ensure that genomic DNA was 
properly digested by McrBC and that the electrophoresis run was satisfactory. 
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6.3 DNA methylation analysis of the AS-VpreB1 locus 
To map the region containing the Topo3/3 and VpreB1 genes a probe located at 
the 5' end of the locus was used (Minaee et al., 2005). Genomic DNA treated with 
McrBC was digested with EcoRI and SphI to yield a 5.4 kb parent fragment. Sites of 
methylation were detected in the second exon of the VpreB1 genes in mature B cells 
and in brain (Fig. 6.3.1). Three sites of methylation were observed in brain and one 
in mature B cells. No sites of methylation were observed in primary pre-B and in ES 
cells. 
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Fig. 6.3.1 A) DNA from McrBC treated ES cells, primary pre-B cells, primary mature B cells and 
brain tissue was digested EcoRI and SphI and hybridized with probe 4. Red arrows in the right 
margin indicate bands generated by McrBC cutting. B) Schematic illustration of the strategy used. 
Red vertical arrows indicate the position of the metylated residues on the VpreB1 gene. The red 
horizontal line indicates the position of the probe. 
The central region of the locus, containing HS 7 and 8 and the A5 gene, was 
analysed using a probe spanning the third exon of A5 (Fig. 6.3.2). Genomic DNA 
treated with McrBC was digested with Sph I and produced a 6kb parental fragment. 
The analysis detected a methylated cytosine in A5 exon III in mature B cells, brain 
and surprisingly, in pre-B cells. Methylation at exon II instead was detected only in 
mature B cells and brain. ES cells did not show any methylation sites in this region. 
The presence of methylation in the third exon of the A5 gene in pre-B cells was 
unexpected since the gene is expressed at this stage of development. 
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Fig. 6.3.2 A) DNA from McrBC treated ES cells, primary pre-B cells, primary mature B cells and 
brain tissue was digested Sph I and hybridized with the .15 probe. Red arrows in the right margin 
indicate bands generated by McrBC cutting. B) Schematic illustration of the strategy used. Red 
vertical arrows indicate the position of the metylated residues on the 25 gene. The red horizontal line 
indicates the position of the probe. 
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Fig. 6.3.3 A) DNA from McrBC treated ES cells, primary pre-B cells, primary mature B cells 
and brain tissue was digested Ase I and BamH I and hybridized with probe 3. Red arrows in the 
right margin indicate bands generated by McrBC cutting. B) Schematic illustration of the 
strategy used. Red vertical arrows indicate the position of the metylated residues on the 25 gene. 
The red horizontal line indicates the position of the probe. The region between HS 1 and 3 has 
been enlarged to show the position of the methylated cytosine 
The region containing HS s 1 to 5 was analysed with a probe located at the 3' 
edge of the A5-VpreB1 domain (Minaee et al., 2005). Hypersensitive sites 1 to 5 are 
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required for efficient expression of both A5 and VpreB1 in single and two copy 
integrations in transgenic mice (Sabbattini et al., 1999). This region also has a strong 
enhancer activity (Minaee S. characterisation of the 25 VpreB1 functional domain, 
London University 2002). McrBC digestion revealed a cluster of three methylated 
cytosines downstream from HS3 (LTR region) thet were present at the pre-B cell 
stage and conserved in mature B cells and brain. DNA methylation was not detected 
in ES cells in this region (Fig. 6.3.3). 
The analysis of DNA methylation across the 25-VpreB1 locus with the McrBC 
enzyme revealed the presence of methylated cytosines in the X5 exon III and 
downstream HS3 already in pre-B cells, when the genes are fully active. 
Methylation of the locus increased in mature B cells and reached its maximum in 
Brain, where additional sites were detected at VpreB1 exon II and X5 exon III. 
Interestingly, ES cells did not show DNA methylation at any of these sites (Fig. 
6.3.4). 
Fig. 6.3.4 Summary of the methylation sites detected by McrBC digestion. Red arrows indicate 
methylated cytosine. 
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6.4 Summary 
McrBC analysis revealed a substantial difference between the methylation status 
of the 26-VpreB1 locus in ES and Mature B cells. The domain appeared completely 
non-methylated in ES cells and showed instead methylation in the two genes and on 
HS3 in mature B cells. The amount of methylated sites increased in brain compared 
to mature B cells. These results therefore suggest that the AS-VpreB1 locus is less 
methylated in ES cells than in Mature B cells. The results presented in this chapter 
can not be considered conclusive and bisulphite analysis of the genes will be 
necessary to determine the number of methylated cytosine in each cell types and 
asses if the methylation status of the locus can actually mark the difference between 
the two silent states observed in ES and mature B cells. 
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7 Discussion 
7.1 Overview 
The problem of how a single fertilised egg can develop into a complex multi-
cellular organism is one of the major questions in biology. The fertilised egg and the 
cells of the 2- and 4-cell embryo are totipotent and can give rise to every cell type in 
the body. By the time that the blastocyst stage is reached a certain degree of 
differentiation as already occurred. The inner cell mass (ICM) can still give rise to 
all somatic lineages but lack the ability to differentiate into the placenta and the 
extra-embryonic membranes. Thus, the essential component of development is cell 
differentiation and the restriction of differentiation potential as cell commit to 
various fates. During development, tissue-specific patterns of gene expression need 
to be established, maintained throughout the life of the organism, and changed when 
and where appropriate. Many studies on gene regulation have focused on 
mechanisms of transcriptional activation. However, gene silencing is known to be 
equally prominent than gene activation in cell fate decisions and developmental 
progression. In the study described in this thesis the A5-VpreB1 locus was used as a 
model system to investigate the epigenetic regulation of gene silencing during stem 
cell commitment and differentiation. The locus has a number of advantages for this 
type of study. Its small size allows ChIP analysis to be carried at very high 
resolution and the tight tissue and stage-specific regulation of the genes makes it an 
excellent system for studying mechanisms of transcriptional control during cell 
commitment. The epigenetic features of developmental and long term silencing of 
the locus were investigated during B cell development and during in vitro 
differentiation of osteocytes from the mesenchymal stem cell line C3H10T1/2. The 
use of these two cells system allowed a comparison between stage-specific and long-
term lineage-specific silencing of a developmentally regulated locus. 
7.2 The active 25-VpreB1 locus 
In order to understand the role of histone modifications in defining the active 
25-VpreB1 locus, the pattern of histone H3 and H4 acetylation was analysed across 
the entire domain in pre-B cells. The analysis revealed the presence of distinct peaks 
of H3 acetylation that were localised in intergenic regions (between the Topo3I3 and 
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VpreB1 and on HS 7 and 8) and on the 25 gene. The 3' region of the locus did not 
show enrichment for H3 acetylation despite being able to promote full expression at 
single copy in euchromatin and variegated expression in heterochromatin (Lundgren 
et al., 2000). 
Interestingly, the promoter regions of the Topo3fi, VpreB1 and 25 genes also 
appeared to be less enriched for histone acetylation compared to the body of the 
genes. Nucleosome remodelling or nucleosome loss at active promoters has been 
observed previously. Studies on the PHO5 promoter in yeast showed that a dramatic 
loss of acetylation signal occurs upon induction of the promoter and Chip analysis 
suggested that this could be caused by a progressive loss of histones (Reinke and 
Horz, 2003). Severe histone H3 hypoacetylation in the promoter regions of yeast 
genes does not affect the ability of TBP to bind TATA elements, or the ability to 
transcribe the gene (Kristjuhan et al., 2002). By contrast, similar hypoacetylation of 
the coding region correlates with inhibition of transcription (Eberharter and Becker, 
2002). Our results indicate that transcriptional competence of the 25-VpreB1 domain 
is characterised by discrete peaks of H3 acetylation instead of the formation of a 
broad hyperacetylaed domain such as the one observed in the 13 globin locus (Litt et 
al., 2001; Schubeler et al., 2001). The fact that acetylation of histone H4 showed 
much lower levels of enrichment compared with H3 acetylation, suggests that if an 
"acetylation code" is established in the active 15-VpreB1 domain, it is likely to be 
mainly based on modifications to histone H3. The low uniform level of histone 114 
acetylation that was observed is in agreement with previously published results 
describing H4 hypoacetylation across the human growth hormone and human p-
globin loci (Kimura et al., 2004; Schubeler et al., 2001) but is in contrast with the 
observation of peaks of H4 acetylation in the active murine (3-globin locus (Forsberg 
et al., 2000; Kiekhaefer et al., 2002). 
Histone acetylation has been linked with transcriptional activation (Turner, 
2000) and with a generalised "open" and accessible chromatin structure. It has been 
shown that histone acetylation may decrease the stability of the compacted 30nm 
chromatin fibre (Bird and Wolffe, 1999) and destabilise higher order structures (Tse 
et al., 1998). This unfolding of active chromatin regions may facilitate transcription 
and correlates with a variety of indirect observations such as accessibility to 
160 
endonuclease digestion, timing of replication, nuclear position and patterns of DNA 
methylation (Anguita et al., 2001). 
In contrast to the localised peaks of histone H3 acetylation, levels of di-methyl 
H3K4 were found to be increased across the entire domain in pre-B cells. This result 
suggests that this epigenetic mark plays a major role in defining the extent of 
functional gene expression domains. Work carried out in parallel with this study 
showed that the first evidence of active histone modifications in the domain is the 
presence of a localised peak of histone H3 acetylation and H3K4 dimethylation at 
HS8 in ES cells. This mark expands to include HS7 in lymphoid precursors 
(Szutorisz et al., 2005) before expanding to cover the entire domain (this study). The 
spreading coincides with a dramatic increase in the binding of general transcription 
factors, TBP, Brg1 and pol II (Szutorisz et al., 2005). 
An important question concerns the mechanisms by which the patterns of 
histone H3 acetylation and H3 K4 dimethylation are established in the 25-VpreB1 
domain. Previous analysis of the domain has revealed the presence of 12 DNase I 
hypersensitive sites at the pre-B cell stage (Minaee et al., 2005). Although peaks of 
H3 acetylation are found at HS8 and HS11, several of the other acetylation peaks do 
not correlate with the presence of HS. In particular, a strong peak was observed 
within the first intron of the A5 gene. High levels of H3 K4 dimethylation were 
observed across the entire domain but peaks of this modification were also observed 
and several of these coincided with peaks of H3 acetylation. However, a particularly 
strong peak of K4 dimethylation upstream of the 25 promoter coincided with a 
region of H3 hypoacetylation which does not contain a DNase I HS. Theoretical 
considerations suggest that formation of sequence-specific histone modifications 
should be driven by binding of sequence specific transcription factors, which would 
then recruit histone methyltransferases and acetyltransferases. Histone modifications 
could also spread from centers of factor driven HAT and HMT recruitment. The 
results obtained for the A5-VpreB1 locus suggest a complex relationship between 
factor binding, HS formation and recruitment of histone modification enzymes. 
Ultimately, understanding this relationship will require functional studies involving 
deletion of specific sequences and analysis of the effect on histone modifications. 
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7.3 Epigenetic features of the 25-VpreB1 domain in the B 
cell lineage and in non lymphoid lineages 
The two best-known traits of silent chromatin in mammalian cells are the 
absence of acetyl groups at the amino termini of histone H3 and H4 and DNA 
methylation. In recent years methylation of lysine 9 on histone H3 has also been 
shown to be a hallmark of silent genes. Di-methylation on histone H3K9 has been 
linked with formation of facultative heterochromatin while tri-methylation is 
correlated with constitutive heterochromatin and binding of HP(1) (reviewed by 
S male, 2003). 
The epigenetic profile of the 25-VpreB1 locus was analysed in ES cells and in 
the multipotent mesenchymal stem cell line C3H10T1/2 and was found to be 
remarkably similar in both cell types, which suggests that the first step toward 
developmental restriction might not involve dramatic epigenetic changes. H3K9me2 
was found to be enriched in the 25 and VpreB1 genes promoters and within 
transcribed regions in both cell types, although the levels were slightly higher in the 
multipotent precursor cells than in ES cells. In addition, in ES cells the region 
marked by HS7 and 8 showed a pronounced reduction in the level of H3K9me2 
compared to the rest of the locus. HS7 and 8 have previously been shown to 
constitute a peak of H3K4me2 and a centre of recruitment of Pol II and general 
transcription factors in ES cells (Szutorisz et al., 2005). The presence of a trough of 
H3K9me2 at this specific site is in agreement with these findings. 
The C3H10T1/2 multipotent stem cells showed a slightly higher level of 
H3K9me2 compared with ES cells and K9 trimethylation was largely absent from 
the locus at both of these stages. Differentiation of C3H10T1/2 cells into osteocytes 
resulted in a striking increase in the level of H3K9me2 across the entire domain. The 
sharp increase in H3K9me2 observed in the differentiated C3H10T1/2 cells is in 
agreement with recent published observations. CUP on chip analysis of a total of 56 
large regions containing highly conserved noncoding elements (HCNEs) in ES cells 
has revealed extended regions of H3 lysine 27 methylation that harbour smaller 
regions of 113 lysine 4 methylation. This pattern has been named "bivalent domains" 
and has been suggested as a mechanism that silences developmental genes in ES 
cells while keeping them poised for activation. Upon differentiation of the ES cells 
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the H3K27me marks expanded in regions containing genes that were not expressed 
in the differentiated cells (Bernstein et al., 2006). 
Taken together these results lead to two important conclusions. Firstly a gene 
locus that is not expressed in mesenchymal lineages appears to retain a relatively 
plastic epigenetic profile in multipotent mesenchymal stem cells. Secondly 
differentiation into a specific lineage represents a major commitment event, which 
involves the acquisition of substantial levels of H3 K9 methylation as genes become 
permanently silenced. These results suggest that multipotent stem cells may be more 
epigenetically plastic than was originally thought and could be susceptible to trans-
differentiation into other lineages. They are also in line with recent functional 
studies showing that neural stem cells, when used as donors for nuclear 
transplantation, produce embryonic stem cells at a higher efficiency than blastocysts 
derived from terminally differentiated neuronal donor cells (Blelloch et al., 2006). 
7.4 Developmental versus long term silencing of the B 
cell-specific .15-VpreB1 domain 
One of the aims of this study was to investigate differences between 
developmental and long term silencing of a tissue specific gene expression domain. 
The stage specific silencing of the 15-VpreB1 locus during B cell development made 
it possible to address this question by comparing the epigenetic profile of the silent 
domain in mature B cells and in vitro differentiated osteocytes. 
Analysis of H3 K9 dimethylation in mature B cells gave the unexpected result 
that the modification was present at similar levels across the domain to those 
observed in ES cells with the exception of the ES cell-specific trough at HS8. In 
contrast, histone H3 K9 dimethylation was highly enriched across the domain in the 
differentiated C3H10T1/2 cells. H3 K9 trimethylation was shown to be largely 
absent from the domain in mature B cells. Taken together, these results indicate that 
there are significant differences between the epigenetic mechanisms that govern 
stage-specific repression and long-term lineage-specific silencing of transcription. 
In general, stage specific silencing of gene expression is initiated by binding of 
repressors to promoters and enhancers with the activators often still present in the 
cells. Silencing of the /15-VpreB1 locus in mature B cells has been shown to depend 
on the presence of a binding site for the transcription factor Ikaros (Sabbattini et al., 
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2001). EBF, which is involved in activating 25, has been shown to be still present in 
the cells at this stage. The results described in this thesis show that repression at the 
mature B cell stage does not require the high levels of H3K9 dimethylation that are 
associated with long-term silencing of the locus in non lymphoid lineages. The 
findings from this study differ from the results of an analysis of Ikaros dependent 
silencing of the mouse Dntt gene, which is silenced and repositioned to pericentric 
heterochromatin during thymocyte maturation. Dntt silencing was accompanied by 
ordered deacetylation of histone H3 K9, loss of methylation of 113 K4 followed by 
bidirectional spreading of histone H3 lysine 9 from the promoter region to a distance 
of several kb upstream and downstream (Su et al., 2004). The difference in the 
epigenetic profiles of the two loci suggests that there is significant heterogeneity in 
the mechanisms that mediate stage specific silencing of transcription at different 
genes. 
Whereas tissue-specific silencing depends on repressors, long-term 
lineage-specific silencing is more likely to result from absence of appropriate 
activators. It seems that in this situation genes are more susceptible to H3 K9 
methylation and this could be important for fixing the silent state in fully 
differentiated cells. 
7.5 Histone H3 K9 methylation is a general marker for gene 
silencing during cell differentiation 
To generalise the results obtained for the A5-VpreB1 locus, a set of tissue 
specific and ubiquitously expressed genes was analysed both during B cell 
development and during in vitro differentiation of osteocytes. Histone H3K9 and 
H3K4 dimethylation presented a varied pattern at tissue specific gene promoters and 
transcribed regions in ES cells and in C3H10T1/2 mesenchymal stem cells. In 
general tissue specific genes showed lower levels of histone H3 K4 dimethylation 
compared to ubiquitously expressed genes while the contrary was observed for 113 
K9 dimethylation in both cell types. Tri methylation of 113 K9 was not observed in 
tissue specific genes both in ES cells and in the mesenchymal stem cell line. 
Previous studies have shown that global levels of histone H3K9me3 are low in ES 
cells and increase upon differentiation (Lee et al., 2004). Interestingly tissue-specific 
genes that are not expressed in the B cell lineage showed enrichment of H3K9me3 
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in mature B cells. Ubiquitously expressed genes showed enrichment of H3K9me3 in 
their transcribed regions in all of the cell types that were analysed, this is in 
agreement with previous observations (Vakoc et al., 2005) and suggests a dual role 
for this modification in gene regulation and maintenance of a transcriptionally active 
or inactive status. 
The double histone H3 K9 trimethylated/ S10 phosphorylated (H3K9me3S lOph) 
modification was also analysed in this study. This modification has been implicated 
in chromosome condensation and effects on binding of chromatin proteins during 
mitosis (Fischle et al., 2005). The results described in this thesis suggest a novel role 
for H3K9me3S lOph in gene silencing. Increased levels of the double modification 
were observed in tissue specific genes in mature B cell compared to ES cells and in 
osteocytes compared to C3H10T1/2 cells. Experiments conducted by Sabbattini et al 
suggest that phosphorylation at H3 S10 blocks the binding of HP1[3 to the 
neighbouring di-and tri-methyl H3 K9 allowing the binding of other factors involved 
in chromatin condensation and the formation of an alternative form of facultative 
heterochromatin (P. Sabbattini, personal communication). 
In summary, the analysis of epigenetic modifications during development and 
differentiation described in this thesis suggests that non-expressed tissue-specific 
genes, in pluripotent and multipotent precursor, are marked by H3K9me2. This level 
of H3K9me2 is maintained at silent tissue-specific genes in fully committed somatic 
cells and reach its maximum in terminally differentiated cells. The results obtained 
in mature B cells, suggest that genes that are subject to long-term lineage-specific 
silencing will acquire the lysine 9 trimethylation mark in their promoters as well as 
in the transcribed regions in order to favour the formation of a long-term silent state. 
7.6 DNA methylation of the 25-VpreB1 locus during B cell 
development 
The patterns of H3K9me2 and H3K9me3 across the 25-VpreB1 locus in ES and 
mature B cells did not reveal major differences in the silent state of the domain 
between these two cell types. In order two further investigate epigenetic changes in 
the locus during B cell development, a Southern blot approach using the methylation 
sensitive enzyme McrBC was used to analyse DNA methylation across the entire 
domain. Interestingly, methylation was not observed in ES cells despite the fact that 
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the locus is silent at this stage. At the pre-B cell stage, when the genes are fully 
active two sites of CpG methylation were detected. One of these was at an LTR 
element located at HS3, while the other was in X5 exon 3 and did not correspond to 
any known elements. The number of methylated cytosines increased progressively 
in mature B cells and reached its maximum in brain tissue. Analysis of ES cell 
genomic DNA with the methylation sensitive Aval enzyme further supported the 
conclusion that the locus is undermethylated in ES cells. 
It has been shown that there is a progressive loss of methylation in the early 
embryo, which reaches its lowest point in the morula and shows some increase by 
the blastocyst stage. Jackson et al showed that Dnmt3a and 3b knock down in ES 
cells caused a global DNA hypometylation, which resulted in a failure to 
differentiate and inappropriate expression of trophectoderm-specific genes. 
Although these observations indicate that DNA methylation plays an important role 
in gene regulation in ES cells, the results described here suggest that at least some 
tissue-specific genes may be silenced in ES cells in the absence of methylation. This 
finding is further evidence that developmentally regulated genes are in a potentiated 
state in ES cells, ready for expression at later stages. 
The presence of methylated residues in the locus in pre-B cells was unexpected 
and highlights the difficulty of making a direct correlation between DNA 
methylation and transcription. Analysis of the mouse Dntt locus during thymocyte 
maturation showed relatively low levels of methylation in unstimulated thymocytes 
where the gene is active. Inactivation following stimulation was accompanied by 
only a modest increase in methylation. The results obtained for the 25-VpreB1 locus 
show some similarities to these observations and suggest that DNA methylation may 
not be a primary silencer of developmentally regulated loci. 
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